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Introduction  
 
 
 Living beings are made of cells, the fundamental biological units that carry out all specific tasks 
to maintain the well-being of living organisms. Proteins are the workhorse macromolecules of the 
cells. They play a significant role in virtually all cellular functions, are diverse in structures and have 
different roles. To perform a particular biological function, proteins naturally associate and 
dissociate with other molecules (e.g., ligands). In cellular sensing and responses, involving signal 
transduction cascades, protein-protein interactions are responsible for conveying the extracellular 
signaling stimuli to the cell’s interior, activating intracellular receptors, and terminating the signal-
transduction pathway. The failure or disruption of any signaling process can lead to uncontrollable 
or inappropriate cell growth, and eventually stimulating cancers or other disease states, such as 
hypertension, heart diseases, and diabetes. Therefore, information of the interaction dynamics or 
kinetics of protein-protein interactions is central not only to understand the underlying mechanisms 
of biochemical cascades and other cellular processes, but also to allow the discovery and 
development of potential treatments for combating diseases. For instance, kinetic profiling is an 
important element in drug optimization, which reveals drug’s efficiency and toxicity. A drug which 
possesses a long dissociation time may offer clinical benefits and increase patient compliance but at 
the same time may induce side-effects to the patients. 
 Affinity-based biosensors have been recognized as dominant tools for characterizing protein-
protein interactions in real-time, hence enabling the quantification of kinetic parameters of these 
interactions. They rely on the affinity recognition between the target analyte in solution and 
immobilized biomolecules on the transducer surface. Among affinity-based biosensors, surface 
plasmon resonance (SPR) is currently a standard and mature technology routinely used in the field 
of pharmaceutical and life science research to study protein binding kinetics. While this technique 
offers a label-free detection, it still has limitations in terms of sensitivity when analyzing small 
molecules, such as hormones or drug-fragments. Furthermore, the observed kinetic rates of 
extremely fast reactions (high association rate) are not accurate due to inherent mass transport 
limitations. More importantly, SPR necessitates expensive and specialized instruments and high-
skilled personnel to accomplish the measurements, thus restricting its accessibility to the classical 
chemical and biological laboratories.   
 In this PhD work, we present a simple alternative biosensor platform which facilitates real-time 
monitoring of protein-protein interaction in a cost-effective manner. Our approach involves the use 
of biofunctionalized uniaxial confined nanofluidic slit (nanoslit) in combination with a conventional 
fluorescence microscope and a charge-coupled device (CCD) camera system. This miniaturized 
system undeniably offers great promises for high device performances in terms of sensitivity, assay-
time, and allows low-volume sample handling and increases sample throughput. Similar to SPR 
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technique, our approach allows the quantification of individual kinetic parameters, but with 
additional advantages of simplicity, enhanced binding efficiency, and optimized response times, with 
no analyte mass dependence. To demonstrate our device capability, we study the reaction kinetics of 
two dedicated biological models with different binding affinities, streptavidin-biotin and IgG/anti-
IgG interactions. The kinetic parameters associated with these interactions are extracted by means of 
three different fitting methods, including finite element model, analytical model, and a commercial 
software package. In order to validate our device performances, we compare the estimated kinetic 
parameters with those obtained from the SPR setup and the values found in the literature. 
Additionally, we propose to incorporate a concentration gradient generator to the biofunctional 
nanoslits. This novel approach allows one-shot parallel kinetic studies to be realized, which could 
potentially be applied for high-throughput drug screening and other biologically relevant reactions. 
 The dissertation consists of 5 chapters. 
 Chapter 1 first discusses the importance of kinetic studies of biomolecular interactions. Protein 
structures and forces involved in protein-protein interactions are then presented. After introducing 
the methods used to characterize protein-protein interactions including homogeneous and 
heterogeneous formats, we explain how to determine the kinetic parameters with surface-based 
assays. In addition, we review the tools that are currently available for protein kinetic studies with a 
particular focus on affinity-based biosensors. Finally, challenges related to affinity-based biosensor 
development are discussed. 
 Chapter 2 provides an introduction to nanofluidic technology along with its leading 
applications. The literature on biosensing and kinetic studies using nanofluidics is discussed together 
with associated issues. Then, we present the concept of our approach, based on nanofluidic 
biosensors in combination with fluorescence detection, and their unique features that give rise to 
real-time monitoring of protein binding kinetics. Finally, we provide a general description of mass 
transport and reaction phenomena involved in surface-based biosensors and the key dimensionless 
numbers useful for device design and understanding. 
 Chapter 3 deals with the implementation of our cost-effective sensing platform. It includes the 
device design and the microfabrication process used to manufacture our nanofluidic devices. We 
present the biointerface that consists of two representative models of protein-ligand pairs and we 
describe the surface functionalization protocols used to graft the bioreceptors within the nanoslits. 
The chip encapsulation and packaging are presented as well as the experimental setup used to carry 
out the kinetic studies. 
 Chapter 4 concerns the experimental validation of our fabricated devices through kinetic studies 
of two dedicated biological models with different binding affinities: streptavidin-biotin and mouse 
IgG/anti-mouse IgG interactions. We then validate the output measurements of our biosensor 
platform with the well-established SPR technology as well as literature values. The range of 
operation, detection limit, and repeatability of our devices for the detection of IgG are also 
discussed.     
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 Chapter 5 describes our intention of providing an effective and high-throughput means to 
achieve one-shot kinetic measurements in a parallel manner. We incorporate an on-chip microfluidic 
concentration gradient network to our validated nanofluidic-based biosensor device. In this manner, 
simultaneous interrogations of multiple binding events of up to 10 different analyte concentrations 
are achieved in a single-experiment, thus minimizing the assay time with a minimum of sample 
handling. 
 Finally, a general conclusion is provided at the end of this dissertation.   
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Chapter 1     
                                                   
Kinetic study of biomolecular interactions 
 
In this chapter, we firstly discuss the importance of kinetic studies of biomolecular interactions, 
particularly in drug discovery process. Then, we give an introduction to protein-protein interactions 
including protein structures and forces involved in their interactions. The methods to measure 
protein-protein interactions including solution-based and surface-based approaches are presented. In 
addition, we provide the fundamental methodology relying on equilibrium and kinetic analysis for 
determination of the affinity and kinetic parameters using surface-based assays. Special attention is 
put on a literature review of current tools used for real-time monitoring of protein binding kinetics. 
Finally, we intend to discuss challenges related to affinity-based biosensor development which 
clearly drive advancements of this field toward alternative bioanalytical systems.          
1.1    Importance of kinetic studies of biomolecular interactions 
Knowledge of the binding affinity of interacting biomolecules is of paramount importance in 
facilitating the study of cellular functions and underlying biological events responsible for heath 
symptoms of hereditary diseases, such as cancers and amyloidosis-related diseases (e.g., Alzheimer’s, 
Parkinson’s diseases). This basic comprehension regarding the cellular functions has led to the 
exploration and the engineering of complex biological processes, including cell adhesion and viral 
infection, as well as the development of novel clinical therapeutic drugs to combat life-threatening 
maladies [1, 2]. Besides, kinetic studies offer insight information concerning the relationships 
between structure and biochemical activities as well as the mechanism of complex formation, hence 
improving our understanding of life at the cellular level. Since biomolecular interactions are dynamic 
processes, deliberating distinctive association and dissociation rates of these interactions provides 
clues that might be concealed in the conventional equilibrium analysis [3].  
 Kinetic analysis of biomolecular interactions has found prevalent applications in various 
domains, including drug discovery and development (Figure 1.1), kinetic profiling of 
immunotherapeutic, and life science research. Biomolecular affinity is solely not an ideal parameter 
because different compounds having comparable affinities can possess on-off kinetic rates that can 
span several orders of magnitude. In drug screening, knowing the kinetic profile is pivotal for 
pharmaceutical industries to fish out the potential drug candidates, based on their efficacy, stability 
and durability, which produce a desired therapeutic response [4].  
1.1 Importance of kinetic studies of biomolecular interactions 
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Figure 1.1 Drug discovery procedures (adapted from [5]). 
 
 Resolving kinetic features of drug-ligand interactions offers benefits to medical optimization of 
potential lead compounds [6]. According to drug-receptor theory, the drug action is accomplished 
only when a drug is bound to its target receptor [7]. A splendid balance between efficient drug 
transport and sequestration is a prime for drug action against diseases [8]. In fact, the efficient 
transport requires moderate drug affinity (i.e., rapid association and dissociation rates), providing a 
safe profile of the drug. On the one hand, if the association rate is slow, a great quantity of the drug 
is necessary to facilitate drug-target binding, thus boosting the risk of side effects to the patients. On 
the other hand, if the dissociation rate is too low, the drug is potentially sequestered in the body and 
thereby suppresses the interaction with its target receptor. Accordingly, kinetic considerations have 
important therapeutic implications for the identification of clinical drug reagents with optimal in vivo 
efficacy and minimal toxicity [9].  
 A drug residence time (the time a drug remains bound to its target), dictated by its dissociation 
rate constant (𝑘𝑑), has been recognized to play a major role in clinical success of drug design and 
development. Knowing this parameter, ineffective or dangerous candidates can be isolated earlier in 
the drug discovery procedures, thus reducing drug attrition rates and costs [10, 11]. The quantitative 
binding kinetics of drug/disease-related receptor interactions also reveals the source of drug 
resistance developed by the patients, which triggers failures of the therapy [12]. In addition, kinetic 
analysis has positive impact on the pharmacokinetic studies of patient sera during clinical trials [13]. 
Once the drug candidate is approved, kinetic profiles are very useful for quality inspection of the 
manufactured biotherapeutic proteins and vaccines [14]. 
 
Kinetic study of biomolecular interactions 
 
 7 
 Apart from the applications in clinical arena, kinetic evaluations can be used to select 
monoclonal antibodies (mAb) for specific uses. The association and dissociation rates are considered 
to be the prime indicators for evaluating their performances, and indicating a decent antibody 
candidate for an immunopurification procedure [15]. For instance, the best mAb choice for an 
affinity support is the one that possesses high association and dissociation rates because it allows the 
use of high flow rates and mild elution conditions.   
 The abovementioned examples, thereby, demonstrate the importance of kinetic studies of 
biomolecular interactions taking place in virtually every biological process in a living cell. There are 
numerous varieties of biomolecular interactions, including protein-protein, protein-DNA, ligand-
receptor, cell-antibody interactions, etc. The main focus of our study concerns protein-
protein/ligand interactions.  
1.2 Protein-protein interaction 
1.2.1 Structures of proteins and interaction forces 
Proteins are very important biological macromolecules consisting of long chains of amino acid 
residues. They have a particular three-dimensional shape that modulates their biological activities.  
Linderstrom-Lang et al. [16] named different levels of protein structures, comprising the primary 
structure or amino acid sequences, the secondary structure (alpha helix and beta sheets), and the 
tertiary structure (protein folding into a globular shape). Moreover, some proteins containing more 
than one polypeptide chain exhibit quaternary structure, which involves the spatial arrangement of 
subunits. These proteins include hemoglobin and DNA polymerase [17] (Figure 1.2).  
 
 
 
Figure 1.2 Levels of protein structures (from [18]). 
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 Proteins maintain the structural and functional integrity within our cells: examples of their roles 
include the regulation of enzymes and hormones in the metabolic pathways, defensive functions 
against the foreign invaders, signal transduction and gene expression, to name a few. Protein 
malfunction can lead to the development of neurological disorders, such as Creutzfeld-Jacob and 
Alzheimer’s disease [19]. Studies of protein-protein interaction are thus central for understanding 
how they interact with each other or with other molecules (referred as ligands) in order to perform 
physiological functions and for unraveling the molecular machinery within cells [20].  
 Protein-protein/ligand interactions are regulated by a variety of weak noncovalent interactions 
(since the biological reaction requires reversibility), i.e., van der Waals attractions, hydrogen bonds, 
electrostatic forces, and hydrophobic interactions [21]. Protein binding usually displays an 
extraordinary specificity in which a protein binds to only a certain molecule among an abundance of 
other substances it confronts. This ability is achieved thanks to the simultaneous formation of those 
weak bonds, giving that the ligand must fit precisely into the protein binding sites. These binding 
sites are cavities located on the protein surface containing specific arrangement of amino acids, 
which are created upon protein folding (Figure 1.3). Upon interactions, proteins may undergo 
conformation changes in such a way that their chemical reactivity is enriched, which is known as 
induced-fit effects [22]. 
 
 
 
Figure 1.3 (a) The folding of polypeptide chain results in the creation of a cavity or a binding site on 
the protein surface. The binding site contains a specific arrangement of amino acid chains in a way 
that the protein can recognize only certain incoming ligands. (b) A zoom in of the binding site 
depicting hydrogen and ionic bonds formed between a protein and its ligand (cyclic AMP) (from 
[23]).  
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 Antibodies or immunoglobulins are one class of proteins that are responsible in the immune 
system for tagging or neutralizing the foreign objects. With no doubt, all living organisms need to 
defend themselves against infection by harmful invaders or pathogens, such as bacteria or viruses 
[24]. Antibodies are typically secreted from the lymphosites, called B cells, in response to these 
foreign molecules. It is Y-shaped and possesses two identical binding sites (one on each arm of the 
Y) for specific recognition of its target, called an antigen, via the variable domain. 
 The antibody structural unit is composed of four polypeptide chains; two identical heavy chains 
and two identical light chains linked together by disulfide bonds [25], forming an antibody structure 
with a molecular weight of about 150 kDa . Heavy chains define different types of antibody isotopes 
(IgA, IgD, IgE, IgG and IgM). The antibody binding site (paratope) interacts with a particular 
complementary region or an antigenic determinant (epitope) located on the antigen surface. The 
unique specificity of the antibody for binding a certain antigen epitope is modulated by the loop of 
polypeptide chain (carrying specific amino acid sequences) at the tip of the antibody structure, 
referred as the complementary-determining regions or CDRs [26] (Figure 1.4).   
 
 
 
Figure 1.4 (a) An antibody molecule consisting of two light chains and two heavy chains. (b) The 
variable domain of light chain with finger-like loop involved in antigen binding (from [27]). 
 
 Antibodies can be produced either as monoclonal or polyclonal antibodies. Monoclonal 
antibodies are made from the same immune cell thus they are identical and bind to the same epitope. 
Polyclonal antibodies, on the other hand, are generated from different cell clones, resulting in the 
mixture of antibodies with the different affinity properties, each recognizing a different epitope. 
Despite the fact that monoclonal antibodies are expensive to produce, therapeutic mAB antibodies 
are now very important in clinical use for the treatment of human diseases such as breast cancer, 
asthma, arthritis, and leukaemia. 
1.2 Protein-protein interaction 
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1.2.2 Measuring protein interactions – solution vs surface 
The characterization of protein interactions is prerequisite to unraveling cellular metabolism. A 
variety of biophysical methodologies have been employed for measuring protein-protein 
interactions, which can be categorized into two main approaches: solution (homogeneous) and 
surface-based (heterogeneous) assays (Figure 1.5). The former involves the measurement of 
protein binding while both partners are freely diffusing in the solution whereas the latter deals with 
the interaction of a protein in solution phase (analyte) with a surface-immobilized protein partner 
(receptor or ligand). Both sensing formats concomitantly display advantages and drawbacks and, 
they do both represent real situations of protein interactions occurring in nature, for example, 
enzymatic reactions in blood or cytoplasm [28] or receptor-ligand interactions at the cell membranes 
[29, 30]. 
    
 
 
Figure 1.5 Schematic diagrams depicting two different approaches for protein interaction 
measurements including solution- and surface-based techniques.  
 
 Solution-based assays benefit from the well-defined three dimensional protein structure and 
translational and rotational diffusion properties as well as homogeneous microenvironments of the 
binding sites [31]. Despites these benefits, interactions in solution-based assays are unlikely to 
represent many biological interactions that occur in vivo. Surface-based assays have become an 
important new tool for probing protein interactions taking place on the surface in recent years, 
owing to their versatility and simplicity. Numerous types of transducer technologies, typically based 
on optical, mechanical and electrical principles, are currently available to probe the binding events. 
The sensor surface itself permits the discrimination between bound complexes and free analytes. 
Kinetic study of biomolecular interactions 
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Contrary to solution-based techniques, the surface-based format offers the possibility to integrate 
parallel sensors for high-throughput analysis and perform multiple reagent injections and rinsing. As 
a result, the binding and dissociation of protein targets can be investigated using the same receptor 
surface. 
 However, the immobilization of proteins onto a surface can cause potential measurement 
artifacts and thus can complicate the interpretation of the experimental data. Indeed, first, surface 
grafting can lead to conformational changes or even denaturation of proteins. Moreover, the protein 
orientation and binding site accessibility associated with the steric hindrance have substantial impact 
on the binding properties [32, 33]. Secondly, non-specific adsorption constitutes an important 
problem with real-world samples wherein a low concentration of the analyte has to be detected in 
the presence of a higher concentration of other macromolecules. These factors therefore need to be 
considered when designing the surface-based technique for protein analysis. It has been 
demonstrated that when the surface-based techniques is performed with care, the equilibrium, 
thermodynamic and kinetic constants match those conducted in solution-based methods [34]. 
 Both sensing formats either rely on end-point detection wherein the detection is carried out 
when the reaction reaches equilibrium, or real-time monitoring of both binding and debinding 
events. While end-point analysis allows qualitative analysis (presence/absence of a target specie or 
calculation of unknown concentrations) and provides knowledge concerning thermodynamic 
properties of an interaction, real-time detection yields more detailed dynamic information underlying 
protein complex formation owing to its possibility to extract kinetic parameters of a given 
interaction. Therefore, the choice of protein sensing format depends directly on the initial aim of the 
measurement whether one requires a yes/no outcome or detailed kinetic information of the 
interactions. 
 As mentioned above each sensing method has its own pros and cons, we chose to work with 
surface-based techniques owing to their versatility and wider applicability. Addition to resource-
saving benefits, this technique conveniently enables high-throughput sensing formats for probing 
multiple binding events in a parallel manner. In the following section, we will explain the 
methodology to obtain affinity and kinetic information of an interaction with surface-based assays.  
1.2.3 Affinity and kinetic determination with surface-based assays 
The strength of an interaction between proteins is termed as the protein affinity, which is translated 
into the physio-chemical property, called the equilibrium dissociation constant (KD). For a 
reversible reaction assuming a simple 1:1 stoichiometry interaction, we can write:  
𝐶0 + 𝐵 
𝑘𝑎,𝑘𝑑
↔  𝐶𝑠                                                                   (1.1) 
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𝐶0 denotes the concentration of free proteins in solution (analyte), B denotes the concentration of 
free surface-immobilized protein partner (receptor), and 𝐶𝑠 denotes the concentration of the bound 
complex (product) (Figure 1.6). B and 𝐶𝑠 are two-dimensional analogs of concentration (surface 
density) and are expressed in units such as mol/cm2. 𝑘𝑎 and 𝑘𝑑 are the forward and reverse reaction 
rate constants, respectively. 
 
Figure 1.6 Schematic representation of the interaction between free proteins in solution and 
surface-immobilized receptor partners. 
 
 𝐾𝐷 is defined at equilibrium (when the rate of complex formation is equal to the rate of complex 
dissociation) as the ratio between the reactants and the bound complex as follows: 
𝐾𝐷 =
𝑘𝑑
𝑘𝑎
=
𝐶0𝐵
𝐶𝑠
                                                                  (1.2) 
In fact, the lower the value of 𝐾𝐷, the stronger the interaction, and thus the more complex is 
formed. The equilibrium dissociation constant can be determined either from the equilibrium 
analysis (measuring the degree of reactions), in which the concentration of bound complex is 
measured as a function of free analyte concentration when the reactions equilibrate; or from the 
kinetic approach (how fast the reactions occur).  
1.2.3.1  Equilibrium analysis 
As the reactions occur on the surface, it is convenient to define the term: 𝑏𝑚 = 𝐵 + 𝐶𝑠; the surface 
density of total immobilized receptors. From this relationship, equation 1.2 can be transformed into 
the Langmuir binding equation [35] as: 
𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛 𝑠𝑎𝑡𝑢𝑟𝑎𝑡𝑖𝑜𝑛 =
𝐶𝑠
𝑏𝑚
=
𝐶0
𝐶0 + 𝐾𝐷
                                              (1.3) 
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 A plot between the fraction saturation and the analyte concentration performed at a constant 
temperature is termed as the Langmuir binding isotherm (Figure 1.7a). This rectangular-hyperbola 
isotherm shows distinctive regions: when 0 < 𝐶0 ≤ 0.1𝐾𝐷, only a fraction of receptors are bound 
to analyte molecules at equilibrium (≤ 9% fraction occupancy), half-saturation of receptors is 
obtained at 𝐶0 = 𝐾𝐷, and most receptor molecules are occupied when 𝐶0 ≥ 10𝐾𝐷(≥ 91% fraction 
occupancy). Since there is a fixed amount of receptors on the surface, the maximum concentration 
of bound complex is thus equal to 𝑏𝑚, which is the total concentration of receptors on the surface.  
 
 
 
Figure 1.7 (a) A plot of fractional saturation as a function of target concentration, referred as 
hyperbolic binding isotherm. (b) A binding isotherm replotted with logarithm of the target 
concentration (x-axis), displaying a characteristic sigmoidal curve.  
 
 The equilibrium dissociation constant (𝐾𝐷) is most commonly used by biochemists to describe 
the affinity of protein interactions rather than its inversed form: the equilibrium association constant 
(𝐾𝐴). This is simply due to its unity in molarity (M) which can be directly equated to the 
concentration of the analyte at which half of receptor binding sites are occupied at steady-state. For 
typical binding isotherm analysis, the target concentration should span a wide range from less than 
𝐾𝐷 where target binding barely occurs to high enough for saturating virtually all surface receptors 
[36]. This range typically covers more than two orders of magnitude around 𝐾𝐷 [37]. 
 However, it is often difficult to estimate the value of 𝐾𝐷 by visual inspection from the hyperbola 
binding curve because all the informative data points are gathered close to the left side of the curve 
where the concentrations are very low. As a result, the fraction saturation is usually plotted as a 
function of the logarithm of the target concentration. This plot yields a sigmoidal curve (Figure 1.7b) 
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which would allow more convenient read out for the value of 𝐾𝐷. This curve is nearly linear 
between 0.1-fold and 10-fold 𝐾𝐷. Important biological interactions have 𝐾𝐷 ranging from mM-µM 
for the weak interactions (e.g., protein kinase-ATP complex, signaling protein binding to a target) to 
nM-pM for the stronger interactions (e.g., small molecule inhibitors (drugs) binding to their target 
proteins) [38].   
1.2.3.2  Kinetic analysis 
Kinetic analyses yield dynamic characteristics of the reversible interactions, which are 
associated with two individual parameters; the association rate constant (𝑘𝑎, M
-1s-1) and the 
dissociation rate constant (𝑘𝑑 , s
-1). The former determines how fast the complex is formed whereas 
the latter defines the stability of the complex or the rate of complex dissociation. The basic concept 
of kinetic analysis is to follow the rates of forward and reverse reactions under transient state by 
varying the concentration of free analytes in solution while keeping the amount of immobilized 
partners comparatively low. In this manner, there is a negligible change in the concentration of free 
analytes in a solution, and thus the association reaction proceeds with pseudo-first order kinetics.  
 Figure 1.8 depicts a typical kinetic sensorgram that shows the change of response signal versus 
time. When the analyte is injected, the binding of analyte to the immobilized receptor leads to an 
increase in the signal corresponding to the association phase. The signal reaches a plateau when the 
equilibrium is established. The analyte injection is replaced by a continuous flow of the buffer 
solution and a decrease of sensor signal is observed, indicating the dissociation of analyte from the 
surface-bound complex. The kinetic rate constants can be derived from the association and 
dissociation phases of this real-time sensorgram by fitting it to an appropriate model. To perform 
the next cycle of kinetic measurement, the surface is regenerated to remove the remaining bound 
analyte without damaging the immobilized receptor.  
 For a simple biomolecular reaction (equation 1.1), the rate of complex formation is equal to the 
difference between the association rate and the dissociation rate as: 
𝑑𝐶𝑠
𝑑𝑡
= 𝑘𝑎𝐶0𝐵 − 𝑘𝑑𝐶𝑠                                                              (1.4) 
B is defined as the concentration of free receptors at the surface and can be written as                        
𝐵 = 𝑏𝑚 − 𝐶𝑠. Substituting B into equation 1.4 gives: 
𝑑𝐶𝑠
𝑑𝑡
= 𝑘𝑎𝐶0(𝑏𝑚 − 𝐶𝑠) − 𝑘𝑑𝐶𝑠                                                    (1.5) 
The amount of complex formation at time 𝑡 is commonly obtained by integrating this differential 
equation, resulting in a single exponential behavior as:  
𝐶𝑠 = 
𝑘𝑎𝑏𝑚𝐶0(1 − 𝑒
−(𝑘𝑎𝐶0+𝑘𝑑)𝑡)
𝑘𝑎𝐶0 + 𝑘𝑑
                                                   (1.6) 
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Figure 1.8 A typical kinetic sensorgram. 
  
A new parameter associated with the exponential term 𝐾𝑎𝑝𝑝 or the apparent time constant is defined 
as 𝐾𝑎𝑝𝑝 = 𝑘𝑎𝐶0 + 𝑘𝑑 . 𝐾𝑎𝑝𝑝 can be determined by fitting the association phase of the binding curve 
to equation 1.6 using the nonlinear-squares best fit. In practice, kinetic measurement of the 
association process is carried out for a series of analyte concentrations. Reliable kinetic analysis 
requires data from 4-6 analyte concentrations, spanning in the range of 0.1-fold to 10-fold 𝐾𝐷 [39]. 
For each analyte concentration, the value of 𝐾𝑎𝑝𝑝 is obtained. A replot of 𝐾𝑎𝑝𝑝 as a function of 
analyte concentration yields a linear fit whose slope equals to 𝑘𝑎 and y-intercept equals to 𝑘𝑑 (Figure 
1.9). This fitting concept was employed to extract the kinetic constants in Chapter 4. However, 𝑘𝑑 
determined in this manner can be erroneous, particularly for low 𝑘𝑑 values [40]. In practice, 𝑘𝑑 is 
preferably derived from the dissociation phase of the sensorgram via an exponential decay fit as:  
𝐷𝑖𝑠𝑠𝑜𝑐𝑖𝑎𝑡𝑖𝑜𝑛: −
𝑑𝐶𝑠
𝑑𝑡
= 𝑘𝑑𝐶𝑠                                                    (1.7) 
𝐶𝑠 = 𝐶𝑠,𝑒𝑞𝑒
−𝑘𝑑𝑡                                                                (1.8) 
𝐶𝑠,𝑒𝑞 is the concentration of complex at equilibrium which is equal to the concentration of the initial 
complex concentration prior to dissociation. 𝑘𝑑 is independent on the analyte concentration and as a 
result its variations are indicative of other artifacts. The determination of both association and 
dissociation rate constants leads to the calculation of the equilibrium dissociation constant via 
𝐾𝐷 = 𝑘𝑑/𝑘𝑎. Hence, knowing two of these constants gives rise to the determination of the third 
parameter. 
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Figure 1.9 The plot between the apparent time constant (𝐾𝑎𝑝𝑝) and the analyte concentration (𝐶0), 
showing a linear fit. The association and dissociation rate constants can be deduced from its slope 
and y-intercept, respectively.  
 
The kinetic rate constants can also be calculated by means of numerical integration curve fit 
(global fitting), which allows the analysis of more complex interactions. However, it should be 
highlighted that the raw data must be of high quality for global fitting routines to be fruitful. The 
detailed information concerning global fitting method is described in Chapter 4.   
The verification of the determined kinetic rate constants can be achieved by several means. For 
instance, it is advisable to calculate 𝑘𝑎 and 𝑘𝑑 using different fitting models and also compare the 
value of 𝐾𝐷 derived from kinetic analyses with that obtained from the equilibrium binding 
experiment [41]. Furthermore, it is always revealing to compare the results from surface-based 
techniques with those performed in solution or with alternative methods (e.g., calorimetry, light 
scattering), which utilize different principles to elucidate biomolecular interactions. 
1.2.3.3  Deviation from Langmuir binding 
In practice, the kinetic sensorgrams are not always accurately described by the expected simple 1:1 
Langmuir model. These deviations may stem from several contributing factors including physical 
effects, such as mass transport limitation, non-specific binding, and steric hindrance [42, 43], or they 
may arise from the presence of a more complex interaction between the interaction partners.   
 Mass transport limitation relies on the fact that the rate at which the analyte in solution reaches 
the sensor surface, via convection/diffusion transport, is slower than the binding rate of the analyte 
to the receptor. This gives rise to a local depletion zone of analyte concentrations in the vicinity of 
the sensor surface. The resulting concentration gradient can cause a miss-interpretation of the 
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binding data using pseudo-first order reactions which often underestimates the association rate 
constant. Mass transport effects are usually accompanied by a sigmoidal association profile [44] 
instead of a standard exponential isotherm. Analogously, during the dissociation under mass transfer 
limit, the analyte concentration over the sensor does not completely fall to zero due to rebinding of 
the analyte to the free receptors, thus decelerating the dissociation rate.  
 There are two ways to mitigate mass transfer limitations. The first solution is to increase the flow 
rate in order to increase the analyte flux to the sensor surface, but more reagents are consumed. 
Another preferable answer is to decrease the surface capacity or levels of the immobilized receptors 
which in turn reduces the demand for the analyte and minimizes the concentration gradients within 
the flow channel [45]. When the mass transport is unavoidable by properly experimental design, it 
can be eventually modeled in data analysis. 
 Non-specific binding is one of the problematic issues responsible for the deviation from the 
simple model. Several successful approaches have been exploited to create anti-biofouling surfaces 
using hydrophilic and bioinert polymers, suppressing non-specific protein adsorption [46]. On the 
other hand, the problem of steric hindrance can be overcome by employing a low capacity surface or 
by optimizing immobilization strategies for better orientation of the surface receptors.  
1.3 Current tools for real-time monitoring of protein binding 
kinetics 
As mentioned earlier, there have been a variety of biophysical methods exploited to characterize 
protein interactions. All cannot be discussed in this study; however, special attention has been paid 
to the current techniques specifically developed to probe protein-binding kinetics in a real-time 
manner, since these techniques offer more specific information on molecular interactions. After 
presenting the classical methods currently used in biological laboratories, we will then present the 
alternative tools that have been lately developed based on new technologies.  
1.3.1 Classical methods (solution-based assays) 
The most simple and straightforward way to measure the rate of interactions involves mixing two 
reagent solutions and observing the subsequent changes.  This bench top operation is typically 
carried out manually by mixing various concentrations of one reagent with a fixed concentration of 
its binding partner in the different cuvettes (observation cells). The detection is subsequently made 
by following the spectrophotometric changes (e.g., absorbance, light scattering, fluorescence 
polarization, nuclear spin relaxation and chemical shifts, electron spin resonance or x-ray diffraction 
[47]). For fast reactions, the speed of mixing and the observation rate are the key limitations because 
it is difficult to precisely measure the initial stage of the reactions [48], due to the time wasted for 
replacing cuvettes in and out from the detector.     
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 To tackle this issue, Hartridge and Roughton developed the continuous flow apparatus in 
1923, which was suited for kinetic studies of rapid reactions in real-time with a millisecond time 
resolution [49]. The principle of this early method is based on rapid mixing of two sample solutions 
in a mixing chamber and then the mixture flows continuously through an observation tube. The 
progress of the reaction is monitored (e.g., by adsorption or fluorescence photometry) at a fixed 
observation point in the observation tube. However, this procedure is laborious and it requires 
copious amounts of materials.  
 Later, the continuous flow was replaced by the stopped-flow technique which appeared to be 
more versatile and economical. In the stop-flow configuration, the solutions are delivered to a 
mixing chamber via two syringes that are driven by a pneumatic or stepper-motors. The solutions 
are rapidly mixed and directed to an observation cell. The flow can be abruptly stopped for a desired 
period of time when a stopping syringe is filled and it hits the stopping block, generating a back 
pressure (Figure 1.10).  
 After the reagents are mixed, numerous real-time observation techniques can be implemented to 
monitor the rate of reactions including absorbance (UV/IR), fluorescence spectroscopy [50, 51], 
nuclear magnetic resonance (NMR) [52], and electron paramagnetic resonance (EPR) [53]. Stopped-
flow method has been effectively employed for elucidating the reaction kinetics of biochemical 
processes, such as enzymatic reactions [54], protein folding [55], and ligand binding [56, 57].             
A number of stopped-flow instruments have now been commercialized, including Bio-Logic-Science 
Instruments SA (Claix, France) and Hi-tech Scientific (Salisbury, UK), to name a few.  
   
 
 
Figure 1.10 Schematic diagram of a basic stopped-flow apparatus (from [58]). 
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 While the stopped-flow technique can be coupled with a wide range of the detection methods, a 
few hundred microliters of the sample volume are generally consumed to fill the observation cell. 
This is a main shortcoming for bioanalysis of the samples that are limited in volume and expensive 
to obtain, particularly in proteomics research. Therefore, a strong need for cost-benefit alternative 
technologies, which provide the real-time kinetic monitoring capability while minimizing sample 
consumption, is essential. 
1.3.2 Alternative technologies (surface-based assays) 
1.3.2.1  Biosensors – affinity-based sensors 
A biosensor is a surface-based analytical device that integrates a biological sensing element (e.g., 
enzymes, aptamers, or antibodies) onto a physical transducer (e.g., optical, mechanical, or 
electrochemical). The transducer converts the molecular recognition events into a measurable 
electrical signal, which correlates the presence or the amount of biological substances, such as 
proteins, deposited on the sensing layer (Figure 1.11). Biosensor technologies have gained enormous 
attention in recent years to compete or even surpass the classical analytical methods in terms of 
analysis time, cost, and sensitivity. Other advantages of biosensors over the conventional methods 
include low reagent consumption, high-throughput [59], and multiplexing capability [60].  
   
 
 
Figure 1.11 A general schematic representation of a biosensor. 
 
 Applications of biosensors have been tremendously extended along with the advancements in 
biosensor development, for example, to clinical diagnosis and biomedicine, environmental 
monitoring, and defense against bioterrorism [61, 62]. For kinetic analysis, biosensors offer a user-
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friendly and effective technological platform for real-time observations of the binding events of 
protein-protein interactions [63]. Recent advances in micro- and nanotechnologies (e.g., 
incorporation of microfluidics or nanomaterials to biosensors) have led to the development of 
biosensors for in vitro diagnostics and in vivo studies [64]. This new frontier of a multidisciplinary 
approach offers great promise in translating standardized laboratory routines to point-of-care clinical 
applications or a “bench-to-bedside” in the near future. 
  Biosensors are usually differentiated and categorized according to their bio-recognition elements 
(catalytic and affinity-based) or according to their transduction scheme. Over the last few decades, 
the affinity-based biosensors, exploiting the specific recognition of a free target analyte by an 
immobilized receptor on a solid surface, have been a key solution in characterizing biological 
interactions in vitro. These methods reveal the affinity and kinetic information of protein-ligand 
interactions [65]. The affinity biosensor solid-state device which couples immunochemical reactions 
(antigen-antibody complex) to a transducer is termed as an immunosensor. 
 As far as the sensing strategies are concerned, the immunosensors can be broadly classified into 
label-free and labeled-based methods. To be more explicit, in our context we simply define the 
label-free configuration as when the native protein targets are used without labeling intervention 
whereas if the target molecule is tagged with e.g., a fluorescent molecule (fluorophore), it is referred 
as fluorescence-based. In the following section, we present up-to-date label-free and fluorescence-
based techniques that are available for real-time detection of protein binding kinetics along with 
their strengths and weaknesses. In this context, we focus on fluorescence-based methods rather than 
other label-based techniques (e.g., radioactivity or chemiluminescence) because fluorescence labeling 
has been a common method extensively used in proteomics applications over the last decades owing 
to its sensitivity and versatility.   
1.3.2.2  Label-free technologies 
The surface plasmon resonance (SPR) is currently a standard commercialized technology routinely 
used in the field of pharmaceutical and life sciences. SPR has come to the forefront of optical 
sensing to quantify protein binding kinetics in real-time without label requirement [66, 67]. It detects 
a change in refractive index when the biosensing molecules (e.g., antibodies) immobilized on the 
transducer (thin metal film) bind with their specific targets. Details of SPR principle are provided in 
Chapter 4. SPR devices have addressed the demand for protein array-based sensing with the advent 
of the SPR imaging (SPRi) technology (Figure 1.12), permitting multiple assay spots to be screened 
simultaneously via a CCD camera [68, 69].  
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Figure 1.12 Schematic representation of an SPR imaging apparatus (adapted from [70]). 
 
 In practice, measuring the interactions of low-molecular weight analytes, such as hormones, 
antibiotics, and chemical drug-fragments, with the SPR instrument is limited in terms of sensitivity. 
Furthermore, if the reaction is too fast (i.e., with high association rate), the obtained kinetic 
information is not reliable due to the strong effects of mass transfer [71]. So far, SPR has merely 
been accessible through the use of high-cost dedicated sensor surfaces and specialized 
instrumentation with sophisticated optical components, which in turn increases overall running and 
maintenance costs and also restricts its application. 
 There have been several attempts to reduce the instrumental costs through the development of 
inexpensive sensor chips and portable SPR systems [72], but little success has been met [61].  Until 
now, typical users, however, prefer using high-end machines which offer more benefits in terms of 
well-optimized fluidic handling and the user-friendly commercialized software for data analysis. 
Other examples of label-free optical biosensors, including optical waveguide lightmode spectroscopy 
(OWLS) [73, 74], nanoplasmonic sensors [75, 76], and surface enhanced Raman spectroscopy 
(SERS) [77], have been extensively utilized for real-time monitoring of molecular interactions with 
the bioactive surfaces.  
 OWLS is a new sensing technology relying on the use of the evanescent field of guided light to 
probe the binding reactions in the vicinity of the waveguide layer (Figure 1.13a). The advantage of 
optical waveguides over SPR technology is the freedom in sensor design aimed at increasing the 
penetration depth of the guided waves into the sample volume to detect relatively large biomolecules 
[78]. This property is limited for SPR system exhibiting a shorter propagation length because the 
penetration depth is merely controlled by the material properties [79]. In addition, more information 
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can be gathered using OWLS since both the thickness and the refractive index of the adsorbed layer 
can be simultaneously determined [73]. The main drawback of OWLS setup arises from its rotating 
sensor configuration which therefore hampers the sensor miniaturization. 
 Nanoplasmonic biosensors (e.g., nanohole arrays) operating with a simple collinear transmission 
or reflection illumination geometry [80], necessitate neither bulky prism-coupling instruments nor 
sensor moving parts which in turn open up the opportunities for sensor miniaturization and low-
cost production. They improve the sensor signal-to-noise ratio through engineered nanostructures 
such that biomolecular interactions occur in a region of high field strength. The combination of 
plasmonic sensing and fluid transport has led to the miniaturized biosensor system with the 
possibility to exploit the flow-through sensing format to improve the sensor response time as 
compared to the traditional flow-over method (Figure 1.13b) [75]. However, the chip fabrication of 
nanoplasmonic sensors are expensive and burdensome due to the need of nanopatterning 
techniques [81].  
 
 
Figure 1.13 (a) Optical setup of an OWLS instrument (from [73]). (b) Flow-through nanoplasmonic 
sensing  (adapted from [75]). 
 
 Another ultrasensitive optical method with minimal background interference is SERS. This 
technique provides limit of detection down to single molecule level by taking advantage of 
electromagnetic enhancement induced by the localized surface plasmon resonance (LSPR) on noble 
metal nanostructures and the chemical enhancement [82]. Apart from its intrinsic sensitivity, SERS 
allows structural and conformational studies of biological components and it is ideal for multiplexed 
detection and discrimination of target molecules. However, the utility of this powerful technique has 
been impaired due to the fact that most SERS substrates are expensive and complex to prepare. In 
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addition, the signal amplified specific locations, or hotspots, are randomly dispersed on the 
substrate, hence reproducibility and reliable detection are often difficult to achieve [83].  
 In the last decade, there has been growing interest in emerging electrochemical assays for protein 
detection due to their low-cost, simplicity, and sensitivity as compared to the optical based 
instrumentation [84]. In principle, the surface-bound affinity complex is associated with a change in 
the electrical properties (e.g., current, potential or conductivity) of the reactive layer immobilized on 
the electrode surface. Label-free electrochemical impedance detection provides possibility to 
examine binding kinetics of molecules between electrolytes and the electrode surface; for example, 
small molecules binding to their target proteins (kinases Abl1 and p38-) [85]. Lately, nanoparticles 
and carbon nanotubes (CNTs) have been introduced in electrochemical biosensor devices to 
improve the electrochemical responses [86, 87].  
 While being sensitive with a label-free operation capability, the electrochemical-based assays rely 
on electron transfer reactions with electroactive species whereas most clinically relevant biological 
compounds are not electrochemically active. As a result, a combination of enzymatic reactions to 
generate an electroactive product is highly needed [88]. Furthermore, the biospecifically bound 
complex on the electrochemical transducer that shields the surface can cause the interference in 
electron transfer, resulting in diminished electrical signals [89].   
 Among semiconductor-based biosensors, ion-sensitive field-effect transistor (IS-FET) and 
nanowire based field-effect transistor (NW-FET) have attracted much attention in scientific 
community as new effective and high-throughput approaches in electrical biosensing technology. 
Due to their extreme miniaturization capability, they are very well-suited for use in micro-total-
analysis-systems (µ-TAS). Their sensing principle is based on the change in the drain-source current 
upon binding of the analyte to the gate electrode modified with biological receptors. Many studies 
on IS-FET and NW-FET for real-time detection of various kinds of biological entities, such as 
DNA, proteins, enzymes, and cells, have been previously reported [90-94].  
 When applying FET-type biosensors for clinical diagnosis, presence of the Debye screening 
length is of importance since the biomolecular recognitions takes place within this distance (Figure 
1.14). As a result, to improve the FET sensitivity, sample desalting is often required prior to analyte 
detection. Realizing the sensing events under physiological conditions (at high ionic strength) 
typically decreases the sensing performances, which in turn limits their universal applicability [95, 
96].  
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Figure 1.14 (a) Schematic of the Si-NW FET biosensor setup used for kinetic analysis of protein 
interactions (from [90]). (b) Schematic depicting the impact of Debye screening length (D) on the 
biomolecular sensing. Increasing the ionic strength of the buffer solution leads to the reduction of 
the D, thus minimizing device sensitivity (from [96]). 
 
 Other promising candidates for label-free detection are mechanical biosensors, owing to their 
high sensitivity, fast response, and high dynamic range [97]. Quartz crystal microbalance (QCM) is a 
mass sensor widely employed to characterize biological interactions by continuously measuring 
changes in the mass adsorbed on the oscillating crystal surface. While QCM measurement is 
applicable in liquid environments with sensitivity in the nanogram range [98], it requires large sample 
volumes and is not suitable for high-throughput assays. Other prominent mechanical biosensors are 
microelectromechanical systems (MEMS). Analyte binding to a microcantilever is detected by 
measuring the bending of the cantilever induced by the surface stress (static mode) or by measuring 
the change in mechanical resonant frequency due to the additional mass on the cantilever (dynamic 
mode) (Figure 1.15). MEMS affinity biosensors have been demonstrated for reliable real-time 
monitoring of biomolecular interactions of C reactive protein (CRP) antigen-antibody complexes 
[99], and immunoassay of prostate-specific antigen (PSA) [100].  
 While MEMS biosensors have enabled real-time analyte monitoring with fast analysis time, the 
damping effects in liquid environment, causing a low quality factor and thus lowering the sensitivity, 
are the major caveat in the dynamic-mode operation [101]. Dip-and-dry technique has been 
practically employed to measure bound target molecules on the cantilever surface. This method 
however does not allow real-time measurements and thus limits gaining insights into the actual 
kinetics of biochemical reactions in physiological fluid media [102]. Consequently, real-time 
biomolecular sensing with liquid-phase measurement using MEMS devices has been barely reported. 
One way to circumvent the damping problem of the resonators in liquid was proposed by the 
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Manalis group [103] by integrating the suspended fluidic system within hollow cantilevers while 
leaving the channel exterior in a gas phase or vacuum.  
 
 
 
Figure 1.15 Schematic representation of the microcantilever-based biosensor (a) and its operation 
modes: static (b) and dynamic (c) modes (from [104]). 
 
 Although the aforementioned techniques have revolutionizing impacts on the large-scale studies 
of protein-protein interactions with label-free sensing capability, each technique has its own 
advantages and drawbacks. As a result, none of them are fully satisfactory. Another approach to 
study protein binding kinetics lies on fluorescence-based methods thanks to their high sensitivity 
and versatility.  
1.3.2.3  Fluorescence-based methods 
Fluorescence-based biophysical technologies are robust and common methods extensively used in 
proteomics to characterize protein interactions [105]. They appear to be well-suited to complex 
matrix analyses, such as serum, plasma, or tissues. This is owing to their capability to specifically 
recognize only the analyte, which is fluorescently-tagged, without interference by highly nonspecific 
binding from the background. These techniques enable quantitative and semi-quantitative detection 
by relating the generated signal to the amount of the analyte captured. As opposed to the label-free 
SPR detection, the analytical methods merging a labelling technique are independent on the 
molecular weight of the analyte and, thereby, offer considerably higher sensitivity, down to single 
molecule identification [106]. Regarding clinical applications, labels such as radioactive isotopes and 
fluorophores have already been widely employed in immunoassays [107]. 
 Concerning new developments, the total-internal-reflection fluorescence (TIRF) microscopy is a 
powerful analytical tool capable of real-time visualization of reversible interactions of fluorescent 
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species on the surface with single-fluorophore sensitivity. TIRF imaging confines the illuminated 
volume to excite the fluorophores in an aqueous environment very close to a solid surface (within 
100 nm), thus minimizing the background fluorescence and in turn improving the signal-to-noise 
ratio [108, 109].  
 The surface-selective illumination feature of TIRF has been often employed in combination with 
fluorescence polarization (FP) and fluorescence correlation spectroscopy (FCS) to measure the 
affinities and reveal the binding kinetics of ligand-receptor interactions; for instance, fluorescently 
labeled IgG association with mouse receptor FcgammaRII, and human estrogen receptors 
interaction with their specific ligands [110, 111]. Furthermore, the extraction of kinetic parameters 
of fluorescently labeled cell-membrane-derived liposomes upon binding to the surface-immobilized 
antibody fragments has been successfully demonstrated using TIRF setup [112]. The conjugation of 
TIRF fluorescence microscopy with protein microarrays and a CCD camera also provides a 
potential means of recording an abundance of binding kinetics in parallel with spatially resolved 
fluorescence images [113], facilitating the growth of handheld device development (Figure 1.16). 
 
 
Figure 1.16 A TIRF setup mounted on an inverted microscope and coupled with the light source 
amenable to produce the evanescent wave needed for TIRF (from [113]). A microarray slide is 
placed above the microscope objective and multiple binding reactions can be simultaneously 
monitored via an EM-CCD camera.  
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 Another fluorescence-based technique enabling real-time measurement of biomolecular 
recognition events is Förster resonance energy transfer (FRET). FRET provides not only kinetic 
information of the binding partners but also on the conformation changes within complexes. The 
FRET process involves the energy transfer from an excited fluorescent donor to an adjacent 
fluorescent receptor molecule via an induced dipole-dipole interaction. The ability of FRET-based 
approach was noticeable in the work of Li et al. [114], in which the binding kinetics of proteins with 
SNARE complex was determined with a single-molecule resolution. In addition, measuring protein 
interactions in living cells with high spatial resolution assays using FRET measurements has been 
demonstrated [115].  
 These single-molecule fluorescence-based techniques, however, pose several challenges. Firstly, 
the concentration of fluorescent species should be low enough to maintain low background 
fluorescence. The highest tolerable concentration is in the range of 10 nM, which becomes a hurdle 
for single-molecule kinetic study of many biomolecular interactions which occur at higher 
concentrations [116]. Secondly, the resulting signal is often small due to low excitation intensities of 
these techniques. Therefore, careful control experiments should be carried out for achieving reliable 
interpretation of the binding results [117]. To address these issues, a nanostructured device, the zero-
mode waveguide, has been developed by H. Craighead and W.W. Webb to enable single-molecule 
analysis in FCS at high fluorophore concentrations [118].   
1.3.2.4  Fluorescence-enhanced label-free sensors 
One of the interesting advantages of fluorescence technologies is to increase the binding signal 
inherently produced from the label-free based biosensors. For instance, fluorescence detection 
coupled with fiber-optic biosensors (Figure 1.17) is one of most prominent technologies for 
quantitative measurement of the biomolecular interactions, whereby the bound fluorophore-labeled 
target adjacent to the fiber surface is excited by the localized evanescence wave. In contrast, the 
background signal of the unbound fluorescence-labeled molecule outside the evanescence field does 
not significantly contribute to the total measured fluorescence signal. It has been shown that this 
method was capable of real-time kinetic measurement of antibody-antigen interactions, such as 
IgG/anti-mouse IgG and PSA/anti-PSA [119, 120].     
  Additionally, biosensor sensitivity can be enriched by several orders of magnitude through the 
emergence of the highly sensitive surface plasmon-enhanced fluorescence spectroscopy (SPFS) 
[121], allowing the analysis of samples carrying tremendously low analyte concentration. This 
concept generally offers a way to amplify the signal. Figure 1.18 depicts an optical set-up of surface 
plasmon resonance biosensor (SPR) combined with fluorescence spectroscopy detection (SPFS). 
The fluorophores are chosen in such a way that their adsorption bands match the excitation 
wavelength of the laser. The fluorescence signal emitted from the sensor surface is measured in real-
time by a photomultiplier or a CCD camera. 
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Figure 1.17 Illustration of sandwich immunoassays using fluorescence detection coupled fiber-optic 
biosensor (from [119]). 
 
 
 
Figure 1.18 An optical biosensor set-up for the combination of angular modulation of surface 
plasmon resonance (SPR) and surface plasmon fluorescence spectroscopy (SPFS) (from [121]).  
 
 The enhanced intensity of the electromagnetic field associated with the coupling to surface 
plasmons leads to an efficient excitation of surface-confined fluorophore molecules, which is 
directly translated into a stronger fluorescence signal related to the interfacial binding events. 
Comparing with TIRF, the enhanced evanescent field displays a profoundly increased signal 
intensity [122]. Although the fluorescence quenching near the metal surface may pose complications 
to the SPFS-fluorescence signal [123], this can be overcome by using well-defined dielectric films. 
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SPFS have found numerous applications in kinetic analysis of binding events between the antibody 
and its surface-anchored antigen [124, 125]. 
 Furthermore, Episentec has newly developed an add-on tool, called the label-enhanced SPR 
technology, breaking the performance barriers of the conventional SPR. This new technology aims 
to enhance the sensitivity and selectivity together with the capability to analyze small molecules and 
fast kinetic reactions by using EpisentecTM dye labels [126]. This concept essentially erases the 
limitations of both label-free and labeled-based methods in terms of the sensitivity by taking 
advantage of strongly absorbing dyes, and the capability to probe preceding immobilization steps 
and obtain a full shape of kinetic sensorgrams. 
 Since labeling can possibly alter the binding behaviors of the investigated species, care must be 
taken to validate and select appropriate labels in any particular application [127]. The pitfalls of the 
necessity of labeling (i.e., cost, laboriousness, and possibly changed biological activities) are therefore 
compensated by the high sensitivity, thus achieving low limit of detection, when fluorescence is 
incorporated. These aforementioned examples have clearly proved that the label-based techniques 
are still up-to-date and readily applicable for investigating binding kinetics of ligand-receptor 
interactions in complement with the label-free techniques to bring on the biologically meaningful 
information.   
 As mentioned above, numerous techniques have been successfully employed to characterize the 
interactions of proteins that express in soluble form or “soluble proteins”. On the other hand, 
“membrane proteins”, proteins that interact with biological membranes, are far more challenging to 
characterize than soluble proteins due to their hydrophobic nature and the difficulties in purifying 
these proteins for analysis [128]. For detailed biochemical investigation of membrane proteins, it is 
essential to incorporate the purified proteins into a lipid bilayer, known as reconstitution, in order to 
retain their native structure and activity which results in “proteoliposomes” [129]. It was reported 
that the proteoliposomes could be captured to the designed specific BIAcore chips and their binding 
kinetics were investigated in vitro using conventional surface plasmon resonance platforms [130]. 
Several groups have attempted to develop newer SPR technologies which allow membrane proteins 
to be presented in their native or near-native environments. This includes nanopore SPR sensors 
wherein membrane proteins can be integrated in free-standing lipid bilayers [131]. This approach 
enables the study of ligand binding to membrane proteins on both sides of the bilayer. Recently, 
surface plasmon resonance microscopy (SPRM) has been demonstrated for the measurement of 
binding kinetics of membrane proteins in single living cells [132].  
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1.4 Challenges in affinity-based biosensor development and the 
need for alternative answers 
Affinity-based biosensors have been rapidly expanding in the field of research through the 
development of novel methodologies and efficient means of signal transduction (i.e., optical, 
electrochemical, and mass sensitive methods) to investigate a variety of biomolecular interactions. 
They have found particular utility in monitoring diseases, proteomics, drug discovery and diagnosis. 
In clinical applications, end-users are in need for reliable, robust and fully integrated biosensor 
systems for analyzing complex clinical or biological specimens (such as bloods, urines, tissues). 
Ultimate affinity-based biosensors should offer highly desired characteristics including ease of use 
(for non-technical personnel), rapidity, and high throughput at an affordable cost.  
 Rapid continuous monitoring of biological entities using robust and highly miniaturized signal 
transducer elements has been an essential driving force toward point-of-care applications. Real-time 
bioaffinity monitors unquestionably provide detailed information about the biomolecular 
interactions regarding their affinity and kinetics as opposed to end-point affinity assays. This feature 
is well-suited for drug development industry especially in pharmacokinetics evaluation, and for 
assessment of drug efficiency for patients with personalized medicine [133], thus promoting optimal 
clinical outcomes and public health. In addition, it can be particularly useful for rapid on-site 
monitoring of infectious diseases and their progression in order to treat them more quickly and 
efficiently [134]. This is particular important for critical care at the emergency room where accurate 
and rapid results are required. Despite clinical needs, transforming biosensors from centralized 
laboratories to clinical applications at the bedside has remained a critical bottleneck in biosensor 
development. This is mostly caused by persistent challenges in sample preparation associated with 
the matrix effects as well as system integration [135]. Despite numerous attempts over the past 
decades, no obvious success has been realized through commercialization of affinity-based 
biosensors for specific applications in the biomedical market.   
 Traditional affinity-based biosensors have harnessed labels or label-free methods to meet the 
requirements of a particular application. Each method has its individual strengths and weaknesses. 
An SPR-based affinity biosensor is rapidly becoming the method of choice to study a broad range of 
biomolecule interactions in real-time without the need of labeling. However, this technique is mainly 
used in research laboratories due to bulky and sophisticated optical instrumentations as well as high 
cost of the operation and maintenance, which have limited this prevailing technology to few 
facilities. There is thus the clear need for alternative platform with improved sensor performances in 
terms of robustness, portability, and cost-effectiveness for use in point-of-care locations or home-
based testing. This alternative technology is expected to increase the likelihood of translating highly 
standardized laboratories toward decentralized and resource-poor settings.    
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1.5 Conclusion 
In this chapter, we have highlighted that kinetic studies of biomolecular interactions, particularly 
protein-protein recognitions, are central to understanding their cellular functions, offering the 
possibility to develop new and efficient therapies to treat protein-based diseases (e.g., Alzheimer’s 
disease and cancers). We have detailed the basic protein structures and forces involved in their 
interactions. A number of analytical methods have been harnessed to elucidate specific protein-
protein interactions, which can be classified into solution-based (homogeneous) and surface-based 
(heterogeneous) approaches. In addition, we have described the methodology to determine affinity 
and kinetic constants of protein-protein interactions with surface-based assays, which encompasses 
equilibrium and kinetic analyses.   
 Particular attention has been placed on the current tools that have been employed to probe 
protein binding kinetics in real-time. Classical methods relying on solution-based assays have long 
been used to study rapid protein reactions. However, high reagent consumption has rendered this 
technology less convenient for the analysis of rare biological samples with limited volume. We have 
presented the alternative tools which have been newly developed, based on affinity biosensor 
technology. A variety of biosensing modalities, including label-free, fluorescence-based, and 
fluorescence-enhanced label-free technologies, have been utilized to probe biorecognition events 
and allow the extraction of kinetic parameters. Despite a great number of available techniques, the 
selection of a proper analytical tool depends on the requirements of a given application.   
 Affinity-based biosensors have found important utility in clinical arena, such as diseases 
monitoring, drug discovery and personalized medicine. In order to fulfill the clinical needs, 
considerable efforts should be directed toward the development of cheap, robust, and integrated 
affinity biosensor systems, ideally suited for point-of-care settings. Biosensors with fast continuous 
monitoring of biologically important species have been a key to clinical success by providing viable 
solutions to the patients in a rapid and efficient way. Among numerous prevailing affinity-based 
biosensors, SPR is a highly mature technology and its main hallmark lies on the capability to probe 
kinetic reactions of biomolecular interactions in real-time. However, the requirement of expensive 
and sophisticated optical apparatus inherent to this technique has limited its versatility and 
accessibility especially for field use, thus illustrating the need for an alternative biosensor platform.   
 In this PhD framework, we propose fluorescence-based nanofluidic biosensors as a promising 
alternative to conventional SPR technique. The key objective of this study is to keep the merit of 
SPR biosensing (real-time detection with kinetic constant extraction), while providing additional 
benefits such as low-cost, device miniaturization, high sensitivity regardless of analyte mass, and 
high-throughout. It is anticipated that this alternative tool will open up the opportunity for the 
development of point-of-care diagnostic devices with true clinical outcomes. The basic introduction 
of nanofluidics and our innovative platform will be provided in the following chapter.  
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Chapter 2     
                                                   
Nanofluidic: Miniaturized systems as an 
alternative answer for kinetic study 
 
This chapter gives an introduction to the field of nanofluidics, the technology used throughout this 
work as an alternative tool for kinetic studies. We introduce the concept of the extended nanospace 
- a new dimension that bridges the gap between current nano- and microtechnologies, followed by 
the leading applications of nanofluidic systems, such as bioseperation, pre-concentration, and single-
molecule analysis. We present current achievements of biosensing and kinetic studies using 
nanofluidic devices and some issues related to the realization and the use of nanofluidic biosensors. 
In addition, particular emphasis is placed on the concept and unique features of our approach to 
accomplish real-time kinetic studies. Finally, the interplay of mass transport and surface reaction in 
surface-based biosensors are described along with specific dimensionless numbers used as figures of 
merit, which are crucial indicators to define the operational regime of our biosensor system. 
2.1 Introduction to nanofluidics 
2.1.1 What is nanofluidics? 
Over the last decades, there has been growing desire to use miniaturized systems in order to tackle 
fundamental physical and biological questions. Inspired from the great success of commercial 
integrated microelectronic circuits in the 1960s, microfluidic technology has emerged in the early 
1980s as part of the development of biochips and microelectro-mechanical systems (MEMS) [1]. 
Microfluidics allows the control and manipulation of fluids on a small scale with operational lengths 
in the 1-100 µm range. It has recently attracted significant attention due to its unique features with a 
“sample-in”, “answer-out” capability [2]. The striking qualities of microfluidics include small device 
footprint, reduced sample and reagent volume, enhanced analytical performances as compared to 
macroscale systems, facile integration and automation, and high throughput analysis. These features 
have led to tremendous applications offered by microfluidics ranging from biomedical arena, such as 
drug delivery, chemical and biochemical sensors, micromixers and microseparators, to non-
biomedical applications, such as water purification and design of batteries and fuel cells.   
 On the other hand, nanofluidics is generally defined as the study and application of fluid flows 
in nanometer-sized systems with a length scale of 1-100 nm in at least one dimension [3]. The typical 
length scales of micro- and nanofluidics are shown in Figure 2.1. Nanofluidics has appeared not as 
an extension or advancement of the existing microfluidic systems, but rather as an unprecedented 
route for discovering a new range of phenomena that do not exist at the microscale [4]. 
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Figure 2.1 Length scales of microfluidics, nanofluidics, and relevant biological objects (adapted 
from [5-7]). 
   
 Indeed, nanofluidics is a highly motivating area but it is not entirely a new field of research. It 
has already been addressed in the past. For example, natural nanoporous materials (e.g., zeolite), 
membranes or gels have been used as porous catalysts in petroleum industries [8] and mimic natural 
molecular filters [9], such as renal filtration system in our body [10]. However, uncontrollable 
structure geometries and sizes of such classical nanopores/membranes have limited our 
understanding of these systems.  
 Recent advances in micro- and nanotechnologies have made possible the fabrication of well-
defined, deterministic networks of nanochannels/pores whose dimensions are close to the biological 
objects, such as DNA strands or antibodies [11]. The captivating effects inherent to nanofluidic 
devices have opened a new window not only to explore and identify fundamental phenomena of 
biological systems which have been previously inaccessible, but also for practical chemical and 
biological analysis. At this length scale, the enhanced electric fields obtained at low voltages can be 
applied to concentrate molecules, separate biological components, as well as enable DNA 
sequencing and single biomolecule detection. Due to the enormous potential of nanofluidics for a 
wide range of applications, it has been noticeable as a remarkable tool for biophysicists.   
 Nanofluidic devices can be classified according to their degree of confinement (i.e., the number 
of dimensions that are not confined to the nanometer scale). For example, 1D channel has one 
dimension in micro/macro scale while the other two dimensions in the nanoscale. As a result, the 
aspect ratio (AR) between the height and the width of the cross-section is a figure of merit of 
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nanochannels (Figure 2.2). A large number of technological choices, mainly based on top-down 
approaches, are now available for nanochannel fabrication, depending on the device geometries and 
desired applications [12]. Square or circular nanochannels (1D), offering ultimate confinement in 
two dimensions, usually have near-unity AR and are complicated and expensive to fabricate since 
they necessitate the use of dedicated tools, such as nanopatterning techniques (e.g., electron beam 
lithography (EBL), focused ion beam (FIB)). However, 1D nanochannels can also simply be 
obtained through the realization of porous membranes using alternative fabrication techniques such 
as anodization [13]. On the other hand, low aspect ratio planar nanochannels that offer 
nanometer-scale confinement in only one dimension (channel height) and often referred as 2D 
nanoslits, are easy to fabricate using standard lithography tools. Finally, the fabrication of high 
aspect ratio (HAR) 2D vertical nanochannels with nanometer-sized width is more delicate since it is 
usually carried out by deep reactive ion etching and deposition approach or edge lithography, and 
spacer technique [14, 15]. HAR nanochannels are commonly made in an array format which leads to 
a high level of integration and a high throughput [16].  
 
 
 
Figure 2.2 Different classes of nanochannel geometries according to their aspect ratios between the 
height and the width of the cross-section (adapted from [11, 16-18]). 
 
 Due to the multidisciplinary approach of the nanofluidic realm, there are many other disciplines 
involved in the realization, the understanding and the use of nanofluidic devices (Figure 2.3). 
Throughout this work, we have used scientific and engineering approaches and disciplines, such as 
surface chemistry, physics of fluids, and micro/nanoengineering, to achieve the goal of our study.  
2.1 Introduction to nanofluidics 
 42 
 
 
Figure 2.3 Classical disciplines of science and engineering related to nanofluidics (adapted from 
[19]). 
 
2.1.2 Extended nanospace – a new gap between nano-and microdevices 
The 101-103 nm length scale, referred as the “extended nanospace”, bridges the gap between 
conventional nano-objects (1-10 nm, e.g., carbon nanotubes) and microfluidic devices (1-1000 µm) 
(Figure 2.4). The fluidic properties and chemical reactions in such transient space have not been well 
explored due to the lack of fundamental research tools.  
 Kitamori’s group proposed and developed the methodologies, relying on nanofabrication, fluidic 
control, surface modification, and detection methods, to study unique phenomena (e.g., related to 
liquid properties) occurring in the extended nanospace [20]. They demonstrated novel applications 
of the extended nanofluidic systems which are unachievable using microfluidics [21]. While 
microfluidics accommodates the sub-nanoliter to nanoliter-scale volume within the analytical space, 
the smaller analytical volume and unique characteristics of the extended nanochannel are desirable 
for the analysis of ultra-low-volume samples (e.g., individual cells) in a range of attoliter to femtoliter 
[22]. 
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Figure 2.4 The extended nanospace bridging the gap between the nano- and microtechnologies 
(from[23]).  
  
2.1.3 Main applications of nanofluidics 
2.1.3.1  Biomolecule separation and sieving  
Bionanotechnology - the emerging field of biological manipulation at the nanoscale, is one of the 
most inspiring areas in life sciences nowadays as it has found important applications in 
bioengineering, biotechnology, and medicine. One of the promising applications of chip-based 
nanofluidic systems is biomolecule separation.  
 In the last decade, various innovative nanofluidic sieves and filters have been developed to 
accomplish more efficient bioseparation as compared to the traditional gel separation, in terms of 
separation speed and resolution [24, 25]. With recent advances in micro- and nanofabrication 
technologies, the development of patterned regular sieving and filtering nanostructures with diverse 
well-defined pore sizes and tailored surface functionality becomes feasible. This allows researchers 
to elucidate the detailed biophysical phenomena of molecular dynamics in a controllable fashion, as 
opposed to their counterparts (i.e., gel electrophoresis) wherein disordered porous gel media is 
present as molecular sieving matrixes.  
 Fu and coworkers [26] demonstrated that physiologically relevant macromolecules (e.g., protein, 
DNA) could be separated in a nanofluidic filter array system under continuous-flow conditions via 
different sieving regimes, including Ogston sieving, entropic trapping, and electrostatic sieving 
(Figure 2.5). Briefly, the device consisted of a periodic array of deep passages and shallow nanoslits, 
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of which the molecule traveled through upon an application of diagonal electric field. The molecules 
jumped from a deep channel to another through the nanoslits at different rates, depending on their 
molecular properties and sieving regimes. Interestingly, this continuous-flow permits to collect 
purified biomolecules for downstream biosensing and detection, thus being suitable for an 
integrated bioanalytical system [27].  
  
 
 
Figure 2.5 Three different sieving mechanisms in nanofluidic separation devices (from [26]).  
 
  Ogston sieving and entropic tapping separate the biomolecules based on their size. Ogston 
sieving relies on the process in which the biomolecules are smaller than the size of the channels and 
the sieving process occurs via steric repulsion by the walls of the nanofluidic channels. On the other 
hand, when the size of the nanochannel gap is smaller than the radius of gyration of a flexible 
biomolecule being separated, there is a developed entropic barrier which induces molecular trapping 
at the entrance of the nanochannel, referred as entropy trapping. A longer DNA has a higher overall 
mobility or escape probability from the confined channel, leading to a shorter trapping time [28].  
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  Electrostatic sieving separates the biomolecules based on their charge. At low ionic strengths, 
when the Debye length within the charged nanochannel becomes comparable to the channel depth 
[29], electrostatic interactions of the molecule and the electrical double layer (EDL) become 
dominant, and the nanochannel is perm-selective (preferentially allowing transport of ions with one 
polarity over another) [22]. This means that the separation of biomolecules can be based on their 
charge density (or pI values) and pH conditions of the buffer. For instance, co-ions (negatively 
charged proteins) are prohibited from entering the negatively charged nanochannel due to 
electrostatic repulsions while permitting counter-ions to pass through [30].  
2.1.3.2  Pre-concentration of biomolecules 
The major problem in proteomics concerns the complexity of the biomolecule samples, such as 
saliva or blood serum, which contain diversities of proteins of various concentration ranges [31]. 
This issue is recognized as a key bottleneck in early diagnosis from the detection of trace amounts 
(nM-pM range) of proteins, such as biomarkers, present in body fluids [32]. To address this 
problem, one should concentrate these low-abundance molecules, particularly when their levels are 
much below the detection limit of biosensors. However, there is no equivalent amplification 
technique, such as polymerase chain reaction (PCR), available for proteins and peptides.  
 Nanofluidic concentrators have gained a significant place in scientific communities as an 
effective protein pre-concentration tool. Several pre-concentration schemes are currently available 
using such devices. One of the outstanding mechanisms is electrokinetic trapping. Wang et al. [33] 
have used a nanofilter (40 nm in thickness) as an ion-selective membrane to concentrate proteins, 
based on electrokinetic trapping and nonlinear electroosmotic flow near a microchannel-
nanochannel junction. When applying an electric field across the nanochannel, an unbalanced ionic 
transport between counter-ions and co-ions induces ion concentration polarization (ICP) [34]. 
This causes the depletion of ions at the anodic side because charged biomolecules are repelled from 
the nanochannel whereas ions are enriched at the cathode side [35] (Figure 2.6a). Such anodic 
repulsion force can be balanced with the electroosmotic flow through the microchannel in order to 
continuously trap biomolecules coming from the reservoir at the vicinity of the depletion region 
(Figure 2.6b). Based on this approach, a pre-concentration factor of more than a million fold has 
been achieved, nearly identical to the PCR technique used for nucleic acid amplification.  
 In addition, Liao and Chou [36] have proposed an alternative pre-concentration method, based 
on molecular traps and dams, for protein enrichment in nanofluidic channels using electrodeless 
dielectrophoresis (DEP) in physiological conditions. The underlying principle lies in the use of 
nano-sized constrictions to enhance the electric field and associated field gradients which results in a 
highly efficient protein pre-concentration at the constriction region, more than 105 fold faster than 
the trapping effects described previously.    
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Figure 2.6 (a) A schematic diagram showing ion concentration distributions when an electric field is 
applied across a perm-selective nanostructure, creating ion depletion zone at the anodic side and ion 
enrichment zone at the cathode side (from [37]). A nanofluidic protein pre-concentration device 
developed by Wang et al. based on ion concentration polarization effects (from [33]): (b) Schematic 
and mechanisms of biomolecule pre-concentration near the microchannel-nanochannel junction; (c) 
A fluorescence image of trapped proteins after applying the electric field for 100 min.   
 
 The binding kinetics of immunoreactions is inherently controlled by several factors, such as the 
target concentration, the affinity (𝐾𝐷) of antigen-antibody pairs, and the quality of antibodies used. 
When the concentration of target molecules falls below the 𝐾𝐷 (which is the case of common 
disease biomarkers), the binding kinetics is limited by the diffusion and is thus extremely slow: this 
results in noisy signal. To tackle this issue and enhance the dynamic range and sensitivity of 
immunosensors, nanofluidic pre-concentration devices can be conveniently and directly associated 
to a biosensor within microfluidic channels [38]. Wang and Han [39] demonstrated the utility of the 
nanofluidic pre-concentrator to effectively enhance the binding events in a bead-based immunoassay 
by increasing the local concentration of the sample prior to binding, thus improving the sensitivity 
and reaction kinetics (Figure 2.7).  
 Aside from their potential use to enhance protein binding kinetics, nanofluidic-based pre-
concentrators have been used to increase enzyme activities in low-level enzyme assays [40]. 
Furthermore, Swami et al. [41] have used dielectric constriction-based DEP and a nanostructured 
edge sensor embedded at the bottom of the constriction with immobilized DNA capture probes to 
simultaneously carry out DNA pre-concentration, hybridization, and real-time sensing. They 
demonstrated a 10 fold enhancement of DNA hybridization kinetics due to a localized amplification 
of DNA concentration at high field-focusing nanoconstrictions. 
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Figure 2.7 Integration of a nanofluidic pre-concentrator with bead-based assays (from [39]). (a) 
Procedures of bead loading, pre-concentration, and sensing. The samples were concentrated on the 
antibody-coated beads located in front of the nanochannels, enhancing the binding events. (b) 
Binding curves of the bead-based immunoassay with and without pre-concentration. After 30 min 
on-site pre-concentration, the detection limit was lessen from 50 pM to 100 fM range (500 fold).  
 
2.1.3.3  Single-molecule analysis – the benefits of nanoconfinement 
As the channel dimensions are scaled down, fewer molecules are present inside the volume given by 
the nanofabricated fluid-filled channels. Smaller illumination probe volume improves the spatial 
resolution and signal-to-noise ratios of the sensing schemes [42, 43]. Similar to TIRF or two-photon 
excited fluorescence, confining the molecules in a nanochannel is a simple way to decrease the 
observation volume. Confinement of molecules in nano- and submicrometer (a height less than 1 
µm) channels have allowed fundamental studies, such as molecular dynamics and transport [44-46], 
as well as high-resolution visualization and analysis of biopolymers (e.g., DNA molecules) at a single-
molecule level [47, 48]. These studies reveal the properties of the individual molecule as opposed to 
the classical ensemble experiments, thus giving a deeper insight into the biophysical mechanisms. 
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 When the dimensions of the channel are comparable with the radius of gyration of an enclosed 
macromolecule, the physio-chemical properties of the molecule is significantly altered due to the 
confinement effect. This arises from the prohibited conformation changes within a confined 
channel, which are not observed for a free molecule in solution [44]. When a DNA molecule is 
confined to a one-dimensional nanochannel, DNA elongation is energetically more favorable than 
its naturally coiled configuration [17]. Uniform stretching of a DNA molecule in the nanochannel 
leads to enormous biological implications.  
  Tegenfeldt and colleagues [49] exploited a direct optical imaging approach to measure the 
contour length (end-to-end distance) of a single-molecule genomic DNA (>1 million bp) confined 
in 100-nm wide channels (Figure 2.8). They demonstrated that the measurement of the polymer 
extension was in accordance with the de Gennes’s theory, wherein DNA extension in the 
nanochannel scaled linearly with the contour length. The authors also showed that the measurement 
of DNA extension with a standard deviation of 130 nm was achieved by means of statistical analysis. 
Using similar one-dimensional nanochannels, the same group was able to localize bound proteins on 
a DNA molecule elongated in a nanochannel [50]. These studies pave a new road for single-
molecule studies of protein-DNA interactions and relevant biochemical reactions within confined 
spaces.    
 
 
 
Figure 2.8 (a) Schematic illustration of a micro/nanofluidic device used for single-molecule analysis. 
The nanochannel arrays with 100 nm in width and 200 nm in depth were imprinted on fused silica 
wafers. DNA molecules were guided into the nanochannels by electrophoresis. (b) A captured digital 
image showing the -ladder DNA molecules elongated in the imprinted nanochannel array (from 
[49]).  
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 DNA linearization offered by nanoconfinement has also emerged as a groundbreaking tool for 
physical genome mapping [51, 52] - the process of which the relative positions of genes along a 
chromosome are identified without sequencing the entire chromosome. Since the genetic 
information is stored in a linear fashion along the DNA strand, it is therefore difficult to analyze 
such information using the native folded structure of DNA. Nanoconfinement offers an access to 
this genetic information which reveals genome variation, genetic mutations, and replication 
dynamics [53].  
2.2 Biosensing with nanofluidics 
As highlighted above, the potential of nanofluidic domain has led to a wide variety of applications, 
enabling biomolecular separation and concentration, DNA manipulation, and single molecule 
analysis. Herein, we present another possibility offered from nanofluidics as an extraordinary tool 
for biosensing applications. This section covers some of the current achievements related to 
nanofluidic-based biosensors, as well as kinetic studies of biomolecular interaction with nanofluidics. 
2.2.1 Current nanofluidic-based biosensors 
Performances of miniaturized biosensors are often limited by inefficient analyte transport to the 
bioactive layer due to the presence of the surface diffusion layer [54]. This poses the difficulty for 
low-abundant analyte detection. The development of chip-based nanofluidic systems for 
biomolecule detection has recently received intense interest in the biosensor community. 
Downsizing the fluidic channel to nanoscale considerably accelerates the diffusion-controlled 
reactions and dramatically increases the signal-to-noise ratio for optical signals [55]. Once again, this 
is attributed to unique features offered by nanometer-scale channels, such as the molecular 
confinement effect and extremely large surface-to-volume ratios. Miniaturization of biochemical 
reactions into the nanospace benefits from faster reactions, higher binding efficiency, and further 
reduced amount of reagents as compared to conventional microchips and standard ELISA wells.  
 For biomolecular sensing, there are currently two main detection schemes integrated in 
nanofluidic systems: electrical and optical detections (e.g., fluorescence). While electrical detection is 
inexpensive and compatible with miniaturized systems, optical methods are more straightforward 
and they provide direct visual evidence. Both sensing schemes have been evolved to complement 
each other for the detection of a wide range of biomolecular species in nanofluidic systems.  
 A number of studies have proven the capability of solid-state nanopores as a sensitive 
biomolecular sensor, owing to their ability to probe single molecules within tunable pore size as 
opposed to biological (-hemolysis) protein nanopores [56, 57]. Various receptors can be specifically 
anchored inside the nanopore for electrical sensing of proteins and long biopolymers, such as His-
tagged proteins [58] (Figure 2.9a) and single-stranded DNA (ssDNA) [59]. In principle, when ions 
and macromolecules translocate through a nanoscopic opening, the ionic current blockages are 
observed [60], producing transient changes of the ionic current. On a similar concept, Saleh et al. 
[61] developed an on-chip artificial nanopore to detect the interaction of antibody-antigen pairs
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using functionalized synthetic colloids and resistive pulse technique (Figure 2.9b). Although this 
approach relied on end-point analysis, it appeared to be more rapid and inexpensive compared to 
the SPR technique.  
 
 
 
Figure 2.9 Nanopore-based single-molecule detection. (a) Gold-coated solid-state (SiN) nanopores 
functionalized with NTA receptor (green) thiols for stochastic sensing of His-tagged proteins (red) 
(from [58]). Charged analyte molecules were electrokinetically driven through the pore and being 
detected by transient blockades in the ion current. (b) On-chip artificial pore integrated-PDMS 
microfluidic device for detection of antigen-antibody binding (from [61]). Pressure was used to drive 
the particles through the pore and the current was measured using a four-point technique.   
 
 Apart from measuring the transient changes of ionic current when a single molecule passes 
through a nanoscopic opening, causing a partial or complete occlusion of a pore (steric influence), 
the binding of analyte to the nanopore wall also induces the modification of the surface charge 
(electrostatic influence), leading to current modulations across the channel [62]. Due to the 
proximity between the nanochannel dimension and the Debye length, surface charges play a 
significant role in controlling ionic concentrations inside the channel to maintain electroneutrality, 
especially in a low electrolyte concentration regime. Under these conditions, nanochannel 
conductance is proportional to the surface charge density while insensitive to the bulk ionic 
concentration and channel height [63]. Therefore, any adsorption of biomolecules with different 
surface functionalities on the channel surfaces can modulate its surface charge, and thus the 
nanochannel conductance. On the contrary, as the electrolyte concentration increases, the 
nanochannel conductance is governed by the change of channel geometry induced by the 
occupation of the macromolecule. Karnik et al. [64] demonstrated that both regimes were of 
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importance for probing biological reactions and surface modifications within the confined channel 
(Figure 2.10). They coated the entire nanochannel surface (30 nm thick) with biotin, and measured 
subsequent binding of the charged streptavidin partner by reading the change of nanochannel 
conductivity.  
 
 
 
Figure 2.10 (a) An optical image of a nanochannel device with 120 µm long, 3.5 µm wide and 30 nm 
thick nanochannels that enabled conductance measurements. (b) A diagram depicting the effect of 
biomolecule modifications on the nanochannel conductance for two different regimes: surface 
charge-governed and geometry-governed regimes. Immobilization of biomolecules caused an 
increase in conductance at low ionic concentrations while a decrease in conductance was observed at 
high ionic concentrations due to the modified channel geometry upon molecule binding (from [64]).  
  
 Nanochannel structures have also offered numerous advantages in fluorescence microscopy 
thanks to the confinement of the measurement volume. High sensitivity single-molecule detection 
was achieved in submicrometer-sized fluidic channels, with a significant reduction of the 
observation volumes (two orders of magnitude) as compared to the conventional optical method 
[42, 65]. This leads to increased signal-to-noise ratios for single-molecule sensing at higher target 
concentration.  
 Among other inspiring optical detection modalities used for nanofluidic devices, there has been 
significant progress in emerging surface enhanced Raman spectroscopy (SERS) in nanofluidic 
biosensors. Chou et al. [66] presented a novel nanofluidic biosensor using SERS to detect -amyloid 
peptide (A), a biomarker for Alzheimer’s diseases. The device consisted of a microchannel and a 
nanochannel (40 nm deep) in the middle (Figure 2.11a). This method notably improved the 
sensitivity of SERS by localizing nanoparticles (60 nm in diameter) and simultaneously concentrating 
the target analyte near the entrance of the nanochannel. Using the similar approach, Choi et al. [67] 
detected and structural probed A aggregates at ultra-low concentration (10 fM) (Figure 2.11b). This 
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study is potentially useful to understand the molecular mechanism behind Alzheimer’s diseases at 
the early stages. 
 
 
Figure 2.11 Schematic diagrams of the nanofluidic biosensor-based SERS used for -amyloid 
peptide detection. (a) Gold nanoparticles were trapped at the micro/nanofluidic junction and the 
target molecules were concurrently concentrated (from [66]). (b) A aggregates concentrated near 
the SERS-active surface where gold nanoparticles were initially immobilized (from [67]). 
 
2.2.2 Kinetics of biomolecular interactions in nanofluidics  
Another interesting potential of nanofluidic systems arising from nanoconfinement effect is the 
study of reaction kinetics. Herein, we particularly focus on nanofluidic biosensor platforms 
(excluding the measurements carried out in free solution) that serve as an analytical means for 
kinetic analysis of biomolecular interactions. 
 As mentioned earlier, the performance of miniaturized biosensor systems (e.g., microarrays) are 
often restricted by diffusion transport of the target analytes to the sensing elements, thus limiting 
binding kinetics and increasing the time required to reach equilibrium. Several microfluidic-based 
techniques have been demonstrated to overcome the diffusion-limited mass transport of typical 
biological reactions, such as the use of high convective flow [68], flow confinement [69], mixing [70], 
electrothermal stirring [71], flow-through format using nanoporous membranes [72], and magnetic 
particle-enhanced target delivery [73]. However, the simplest and an efficient way to enhance the 
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binding assay is to further shrink the channel height, giving that the convective flow is applied. 
Nanometer-sized channels can force target molecules to be extremely close to their binding 
partner on the surface. Consequently, the analyte diffusive transport is dramatically boosted 
over such a short distance and the binding reactions occur very efficiently in nano-confined 
channels.  
 For instance, Schoch et al. [74] utilized 50 nm deep nanofluidic channels, whose internal surfaces 
were coated with specific binding partners, to study surface binding reactions (Figure 2.12). Low 
analyte concentrations were driven through the nanochannel by means of pressure-driven flow and 
the reactions were electrically monitored. They demonstrated that by confining the target molecules 
within nanochannels under continuous-flow conditions, the binding kinetics could be prominently 
enhanced and thus the response time to detect specific target molecules could be reduced by a factor 
of  54, as compared to previously reported pure diffusion-limited reactions [64]. Indeed, due to the 
small height of the nanochannels, the diffusion of molecules to the channel walls became very 
efficient even at the relatively high flow speed (23 mm/s). Consequently, all the molecules that 
entered the channel became bound to the binding partners. They reported the response time of 
approximately 1-2 h at 1 nM analyte concentration.   
 
 
 
Figure 2.12 (a) A photograph of the chip (12 × 25 mm), consisting of two microchannels connected 
by nanochannels, used in reaction kinetic studies. (b) An SEM image depicting two microchannels 
and nanochannels (50 nm deep, 5.5 µm long). (c) A cartoon drawing of the channel coated with 
specific binding partners and the binding of target molecules can be sensed by the change in 
nanochannel conductance (adapted from [74]). 
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 Another example showing significant nanoconfinement effects on reaction kinetics was 
demonstrated in a recent work by Wang et al [75]. Briefly, they investigated enzyme kinetic reactions 
under continuous-flow conditions using size-tunable nanofluidic devices in combination with 
electrochemical sensing (Figure 2.13). They proposed an efficient way to covalently immobilize 
glucose oxidase enzymes (GOx) on polycarbonate-based nanochannels with the depth ranging from 
50 to 140 nm. Glucose substrates were electrokinetically introduced through the channel, and 
hydrogen peroxide products were detected by the change in steady-state electrochemical current 
responses. As compared with bulk-solution systems, the specific enzyme activity increased by a 
factor of 4. Moreover, the catalytic constant (𝑘𝑐𝑎𝑡) increased with decreasing the channel height, 
providing that the flow rate was kept the same. This suggested that faster reaction rates, hence 
higher conversion efficiencies could be expected in the smaller nanochannels. This was due to the 
fact that the substrate required shorter diffusion times to reach the immobilized enzyme in a smaller 
nanochannel space. These studies provide important insight in biological reactions occurring in 
confined spaces such as membranes, or in the crowded cellular milieu, which may be different from 
those occurred in bulk solutions. 
   
 
 
Figure 2.13 (a) Schematic diagram depicting the nanochannel fabrication and covalent attachment 
of enzyme on the nanochannel surface. (b) The concept of the nanofluidic device coupled with 
electrochemical sensing for enzyme reaction kinetic studies (from [75]). 
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2.3 Issues related to nanofluidic sensing 
While nanofluidic systems have led to significant advances in biomolecule separation/pre-
concentration and biophysical studies of single molecules, surprisingly there have been a few studies 
that exploited nanochannels as biosensing systems, especially for ultra-fast real-time kinetic studies 
of protein interactions. This is due to several challenges that need to be overcome when combining 
biological requirements (e.g., preservation of the biological activity and localized surface 
modification) with the constraints imposed by manufacturing technology at the nanoscale (e.g., chip 
assembly). In this section, we intend to provide some issues faced by researchers in this field along 
with conceivable solutions, which ultimately would allow one to fully benefit from the merit of 
nanofluidics as an effective sensing system. 
2.3.1 Integration of biofunctional layers  
When combining biosensors with nanofluidics, several aspects have to be taken into account. One 
of them concerns the integration of the biosensitive layer into nanofluidic channels. Here, we focus 
on the nanochannels that are fabricated by top-down approach and the assembly of nanofluidic 
device is achieved by sealing with another substrate. Traditional biosensors involve grafting of one 
interacting partner (receptor) onto the active sensor which is usually achieved in an open-top 
manner, by immersing the entire open substrate into a specific solution containing biomolecules of 
interest. Nevertheless, once dealing with enclosed fluidic systems, immobilization inside the 
channels becomes a technical hurdle due to inaccessibility from the outside world. From a practical 
point of view, there are two strategies to integrate biosensing elements in the nanochannels: pre-
bonding and post-bonding functionalization [76]. 
  In-situ or post-bonding functionalization relies on the biomolecule grafting after the 
nanochannels are sealed. This process is carried out by sequential delivery of biomolecules carrying 
specific functional groups which interact with the channel surface [74]. However, one of the main 
restrictions inherent to this approach is the inability to localize probe molecules on a specific region 
of the channel walls, and more importantly it does not allow grafting multiple types of biomolecules 
in the same channel, thereby preventing the use of nanofluidic devices as multiplexed biosensors. 
Although several methods can be exploited for local surface modifications in enclosed fluidic 
channels (e.g., electron beam induced graft-polymerization [77], photochemical reaction [78, 79], 
diffusion-limited patterning (DLP) [80]), the fact that they require multiple reagent exchanges and 
washing steps make these procedures burdensome and time-consuming. This is inherently attributed 
to very small flows imposed by high-resistance nanofluidic channels. 
 Pre-bonding functionalization approach seems to be more desired to locally immobilize one 
or more interacting partners inside previously etched nanofluidic channels with the possibility of 
batch processing. In this case, several available open-top surface patterning techniques [81], such as 
spotting and dip-pen lithography [82], can be applied. However, the presence of biomolecules in the 
channels precludes the ordinary sealing techniques, such as thermal-fusion bonding and anodic 
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bonding, to be performed. This is due to irreversible denaturation of the biomolecules upon heat 
treatment, UV/plasma exposure, or harsh chemical treatment, required during system assembly. 
Therefore, mild sealing methods dedicated to nanofluidic channels, which preserve the bioactivity of 
the sensing layer and concomitantly give reasonably high bonding strengths, are central for fruitful 
advancements of nanofluidic biosensors. 
2.3.2 Sealing process 
Low temperature bonding technology is considered to be very beneficial for nanofluidic channels, 
which would make possible the integration of biosensing elements prior to sealing without the use 
of high temperatures or a vacuum. Xu et al. [83] proposed a low-temperature (200 ºC) direct bonding 
of fused-silica glass nanofluidic chips via a two-step plasma surface activation. The process consisted 
of an oxygen plasma treatment followed by a nitrogen microwave radical activation on two 
substrates bearing nanochannels and microchannels, respectively. Another strategy to address the 
technical challenge in nanofluidic bonding is the use of one-step plasma treatment through the 
surface activation process by O2/CF4 gas mixtures [84]. This process permitted the bonding of 
fused-silica glass at room temperature (Figure 2.14). While both methods enable nanofluidic channel 
bonding at low temperature, exposure to plasma could potentially damage pre-immobilized 
molecules, such as antibodies or chemical groups, on the surfaces.  
 
 
Figure 2.14 Schematic diagrams of the room-temperature bonding process of fused-silica glass 
nanofluidic chips based on a one-step surface activation using an O2/CF4 plasma treatment (from 
[84]). 
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 Lately, Shirai et al. [21] developed another low-temperature bonding procedure for glass-glass 
sealing at 100 ºC. They utilized a vacuum ultraviolet (VUV) light to partially pattern functional 
groups on a plain substrate through a photomask for subsequent in-situ protein immobilization. At 
the same time, UV light rendered the surface activated for bonding with another plasma-activated 
substrate bearing nanofluidic networks. With this technique, they were able to pattern antibody on 
the inner surface of the nanochannel by pressure-driven flow and demonstrate selective molecular 
capture using nanofluidic-based immunoassay. 
 Apart from glass-glass bonding, PDMS-sealing, relying on the activation of the surface chemical 
group, is very popular in the microfluidic realm. However, so far it has not been employed to seal 
pre-biofunctionalized nanochannels due to elastomeric deformation of the PDMS. Recent work 
reported a novel bonding method applicable for nanometer-sized channels using polysilsesquioxane 
(PSQ) as an adhesive polymer layer combined with an asymmetric oxygen plasma treatment [85]. In 
this way, a selective surface functionalization could be accomplished prior to chip encapsulation as 
only the PSQ-coated substrate was activated but not the pre-functionalized nanochannel surface. 
Therefore, the biofunctionality of the grafted molecules could be fully preserved. The assembly 
procedure of our nanofluidic biosensor device was also based on a similar sealing approach.  
2.3.3 Detectability and response time 
As highlighted earlier, miniaturization of the analytical space into the nanoscale offers tremendous 
advantages for chemical and biochemical processes, such as shorter analysis time and decreased 
sample volume. Conversely, detection becomes challenging when low sample concentrations are 
present within such small detection volumes. Considering the detection volume with the dimensions 
of 100 ×100 ×100 nm3, less than a single molecule is present at a sample concentration of 1 µM. 
This means that the sophisticated detection technology with single molecule sensitivity is 
compulsory.  
 Optical detection modality is considered as a non-invasive, sensitive technique enabling in-situ 
single molecule detection. Several promising optical detection schemes include laser-induced 
fluorescence (LIF) [86], confocal fluorescence microscopy [87] and total internal reflection 
fluorescence microscopy (TIRFM) [88]. While highly sensitive detection techniques are essential for 
probing molecules within nanofluidic channels, the absolute detection efficiency (the number of 
detected molecules over the total number of introduced molecules) can be expected inside the 
nanospace which is unattainable in microfluidic chips. This unique detection property is proven by 
LIF technique because a typical spot size of the laser beam (1 µm in diameter) is much bigger than 
the size of the nanochannel [23]. Consequently, all molecules occupying the nanochannel volume 
can be sensed (Figure 2.15).  
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Figure 2.15 Improved detection efficiency in analytical nanospace (from [20]). 
 
 Another issue related to biosensing in nanofluidic channels lies on sensor response times. This 
problem seems to be contradictory to the goal of nanofluidic approach as an ultra-fast biosensor. As 
a direct proof, we underline the work reported by Schoch [74], where the total response time of 
about 1-2 h was established for the reactions in nanofluidic channels. Indeed, they grafted the entire 
nanochannel walls with specific probe molecules and the sensor response was made by integrating 
over a relatively large surface area (the whole channel length), thus they did not take full advantage 
of a locally enhanced reaction rate.  
 In fact, the binding rates on a single large sensing surface at low target concentrations tend to be 
restricted by mass transport of the target molecules to the sensor surface as seen in the case of 
typical SPR biosensors, which in turn has a direct impact on the total response time of the sensor. 
This is because most of target molecules are captured near the entrance of the flow channel and the 
concentration of target molecules is depleted downstream. As a result, the target capture at 
downstream regions is delayed, thus slowing down the overall capture rate of the whole sensor, 
especially when the whole sensor surface is integrated for detection. It was reported that  arrays of 
spaced smaller sensors (i.e., microarray spots [89]) led to a higher fractional occupancy of the 
immobilized probes and faster equilibrium times as compared to a single large sensor with the same 
overall sensing surface area [90]. Therefore, the localized selective surface modification is envisaged 
as an effective way to realize fast-response nanofluidic sensors.   
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 On the other hand, the response time can be limited by other factors, such as non-specific 
binding effects on the channel wall outside the analysis region due to an extremely high surface-to-
volume-ratio, especially when shrinking down the channel size. Hence, a proper channel surface 
passivation (e.g., surface pretreatment with bovine serum albumin (BSA)) is recommended to 
prevent sample loss.  
2.3.4 Fluid handling 
Frequently used fluid handling systems in nanofluidic devices are electrokinetic method, capillary 
filling and pressure-driven flow [91]. Electrokinetic methods, such as electroosmotic pump, are 
favorable to drive the fluid flow in nanofluidic channels because the external electric field required 
to generate flows does not depend on the channel height. However, there are still some limitations 
inherent to an electroosmotic pump for general analytical applications because it is highly sensitive 
to the surface charges and any contaminants. While capillary filling is another simple way to 
introduce liquid into the nanochannels [92], it poses a great difficulty when it comes to a more 
complex fluid manipulation where multiple steps of reagent exchange (e.g., sample injection, rinsing) 
are required.  
 With all these constraints, pressure-driven flow remains a key solution which allows a precise 
fluidic handling beneficial for widespread uses in analytical and chemical applications. However, as 
the flow resistance dramatically increases in nanofluidic channels, pumping of fluid in nanochannels 
using pressure-driven flow becomes impractical due to a huge pressure drop. In fact, the flow 
velocity induced by pressure-driven flow in such a narrow channel is slow; giving that the flow 
velocity is directly proportional to the square of the channel height.  
 To tackle the issue raised by pressure-driven flow in nanofluidic systems, Tsukahara et al. [93] 
developed a novel air-pressure-based nanofluidic control system, which consisted of a Y-shaped 
extended nanochannel and U-shaped microchannels on a fused-silica substrate (Figure 2.16). The 
liquid flow and mixing of different aqueous solutions could be precisely controlled by applying an air 
pressure into a sample solution. While fluidic handling presents a bottleneck if the chip contains 
only a single nanochannel due to tedious washing cycles, the flanking U-shaped microchannels 
integrated in this chip design facilitate rapid interchange of different reagents. This liquid handling 
interface noticeably shows a great potential for effective biosensing in the nanospace. 
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Figure 2.16 A pressure-driven nanofluidic control system (from [94]). 
 
2.4 Concept and contributions of our approach 
In this study, we utilized nanofluidic systems as a novel and cost-effective biosensor platform which 
enabled monitoring of reaction kinetics associated with biomolecule interactions with spatial time-
resolved resolution. Our approach relied on the combination of biofunctionalized uniaxial-
confined planar nanochannels, or nanoslits, and fluorescence microscopy to elucidate protein-
protein interactions in physiological media. By confining the reaction volume into sub-µm thick 
channels with localized sensing elements, fluorescence conjugated biomolecules could be rapidly 
detected in real-time without cumbersome washing steps using a conventional fluorescence 
microscope, thus increasing the accessibility for classical biochemical or life science research 
laboratories where sophisticated and expensive analytical tools (e.g., SPR, QCM, TIRF) are limited.   
 Figure 2.17 depicts the schematic diagram of our fluorescence-based nanofluidic biosensors used 
for kinetic studies. We locally immobilized probe biomolecules on the gold patch located at the 
bottom of the nanochannels prior to chip encapsulation. Such local surface modification 
consequently allowed us to benefit from inherently locally enhanced reaction kinetics. The 
biofunctionalized nanofluidic chip was sealed with a cover glass coated with a transparent adhesive 
material via asymmetric plasma treatment at room temperature, hence allowing the optical 
visualization and at the same time preserving the bio-functionality of the preceding grafted 
biomolecules. Once the chip was sealed, we passivated the remaining channel bottom area and roof 
with the protein-resistant functionalities. The fluorescently-labeled analytes were driven though the 
nanoslits by means of pressure-driven flow and the signals associated with analyte adsorption and 
desorption on/from the sensor surface were detected in real-time under a fluorescence microscope 
coupled with a CCD camera.  
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Figure 2.17  A schematic diagram of our fluorescence-based nanoslit biosensor concept. 
 
 Our proposed method permits enhancement of immuno-reaction kinetics with a maximized 
binding efficiency (virtually 100%) on a seconds time scale thanks to the well-known molecular 
confinement between the flowing target molecules and the surface-immobilized receptors. This is 
attributed to a dramatically decrease in the diffusion length for the molecule to travel across the 
channel in the vertical direction, thereby boosting the collision frequency between the analyte 
molecules and the sensing element located at the bottom of the channel. Therefore, conducting 
immunoassays in a confined-nanospace enhances the binding rates and reduces the time required for 
equilibrium to be reached. Furthermore, drastic reduction of the diffusion length drives the 
transport toward reaction-limited regime, being ideal conditions for kinetic analysis. 
 From a molecular point of view, if we compare the depth of the nanoslits being 450 nm with the 
diffusion distance of the target molecule when traveling over a 50 µm long sensing layer, the 
traveling time, 𝑡, required for a molecule to pass by the sensing layer can be calculated as 0.25 s, 
giving a linear flow velocity being 200 µm/s. The length over which the molecule has to travel as it 
diffuses to the probe-immobilized region during such time scale, 𝐿, can be calculated to be 2.2 µm, 
by equation 𝐿 =  √𝐷𝑡, where the diffusion coefficient (𝐷) of an IgG is 10 µm2/s. The calculated 
diffusion length is significantly higher ( 5x) than the depth of the nanoslits. This implies that all 
molecules entering the nanochannel will certainly be captured by their interacting partners 
grafted on the sensor surface without loss, as opposed to the typical microfluidic immunoassays 
wherein a relatively high fraction of the analytes just passes over the sensor without being captured 
and thus lost for detection. In our case, the target molecules in the sample volume are exploited 
more efficiently.  
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Figure 2.18 Comparisons between nanoslit and microfluidic sensing schemes (not to scale) and the 
depletion regions formed upon binding reactions between the flowing target analytes and the probe-
immobilized sensor located at the bottom of the channel. The color map presents the concentration 
of the target analyte from high (red) to low concentrations (blue).  
 
 As can be seen from Figure 2.18, when the target analytes react with the sensor, the depletion 
region (the concentration gradient layer) expands across the entire channel height of the nanoslits, 
contrary to the reaction in microfluidic chips with the same sensor size wherein the depletion zone 
forms very close to the sensing layer. Accordingly, with an optimized flow velocity, and sensor 
length, our device can operate in a full collection regime (which will be explained in details in the 
following section), hence eventually suitable for ultrafast molecular filtering based on molecular 
affinity [95]. However, it is worth mentioning here that the analyzed sensing area in our case should 
be smaller than the diffusion length in order to obtain accurate kinetic data. The typical sample 
volume in nanoslits is in the pL range, i.e., 4 orders of magnitude smaller than the sample volume of 
conventional microfluidic biosensor formats [96]. From the two advantages: high capture efficiency 
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and reduced volume, our platform is particularly suitable to the analysis of ultra-small and low-
volume samples, e.g., the contents of a few cells. 
 In addition, real-time fluorescence detection of the conjugated biomolecule interaction with the 
capture region within nanoslits offers the ability to extract kinetic constants. This is attributed to a 
considerable reduction of the sample volume during observation, leading to negligible levels of 
fluorescence background. This characteristic inherent to our device allows us to directly probe the 
sensing surface by correlating the binding fluorescence signal directly to the amount of bound 
targets, without the need of reagent wash and without using complicated and expensive setups, such 
as SPR, TIRFM, or QCM. Fluorescence microscopy also offers the possibility to carry out spatially 
resolved measurements where each camera pixel represents an independent measurement of the 
reaction kinetics. Hence, in addition to the high sensitivity with no analyte mass dependence 
inherent to this detection technique, a large sampling area over a number of pixels ensures reduced 
statistical errors [97]. On the other hand, because the fluorescent background level is proportional to 
the channel height, sub-micrometer channels offer signal-to-noise ratios of at least 100 on a large 
scale of dissociation constants 𝐾𝐷, from the pM to the sub-µM range, that concerns most molecules 
of interests. 
 In contrast to the reaction volume (µm scale) in conventional microfluidic formats exhibiting a 
high level of fluorescence background, a greatly reduced analytical space of the extended-
nanochannel (nm scale) with a comparatively lower fluorescence background leads to another 
golden feature of our platform. This involves the capability to carry out full kinetic assays generating 
full kinetic sensorgrams (association and dissociation curves) in one single-experiment through 
reversed-buffer flow operations. This procedure is literally impractical in typical microfluidic formats 
because we need to pause the experiment after completion of the association phase in order to load 
a fresh buffer solution in the same inlet and then reset the experiment for the dissociation process. 
These procedures in turn prevent continuous monitoring of association and dissociation processes 
in a single-experiment.  
 Indeed, in contrast to microfluidic formats, our device operates with an absolute molecular 
interaction, and as a result there is a clear boundary between the regions where the analyte 
concentration drops from maximum to zero (the depleted region). Hence, the liquid downstream 
the sensor is virtually analyte free and the dissociation study can be performed directly after 
completion of the association phase by reversing the fluid flow within the nanochannel instead of 
injecting a new buffer solution at the inlet. As opposed to microfluidic chips where a large number 
of target molecules still remains in the detection volume, our device does not necessitate washing 
steps to remove the background fluorescence signal, which results in a simplified protocol and 
reduced total analysis times. 
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 The advantages and unique features of our biofunctionalized nanoslit can be summarized as 
follows: 
 cost-effective and simple operation with ultra-low reagent consumption  
 compatible with any conventional fluorescence microscope, thus suitable for use in 
classical biochemical laboratories 
 enhance the reactions kinetics with high capture efficiency and optimized response time 
due to a drastically reduced diffusion length 
 operate in a full collection regime without sample loss, thus beneficial for analysis of 
low-volume and rare/expensive samples 
 enable real-time monitoring of biomolecule interactions with kinetic constant extraction, 
similar to SPR and QCM setups, and provide the possibility to study protein interactions 
with a wide range of binding affinities, regardless of the analyte mass 
 allow localized sensing with a high spatial resolution and reduced statistical errors (high 
precision) via a CCD-based fluorescence imaging system 
 increase the signal-to-noise ratio of optical signals due to a significantly reduced 
detection volume as compared to microfluidic chip formats 
 achieve full kinetic sensorgrams (association and dissociation curves) in a single- 
experiment using a simplified reversed-flow protocol, which is not attainable in 
conventional microfluidic immunoassays 
 
2.5 Diffusion, convection and reactions in surface-based biosensors 
To explore sensor binding kinetics and understand how our system behaves, it is desirable to know 
the physics of mass transport and surface reactions that come into play in surface-based biosensors 
embedded in micro/nanofluidic systems. In many situations, surface-based biosensors rely on mass 
transport of target molecules to the receptor on the sensor surface. Hence, there are multiple 
competing physical processes that need to be considered in order to reveal the operational regime of 
a given biosensor system. In general, target molecules are transported with convective flows and 
they are randomly diffused in the solution. Free target molecules have the possibility to bind to their 
interacting partners on the surface and the bound molecules may unbind from the surface and 
return to solution. As different biosensor systems exhibit diverse characteristic parameters, Squires 
and coworkers [98] developed elegant and intuitive rules of thumb for one to qualitatively determine 
the behavioral regime of a system wherein convection, diffusion and surface reactions all 
simultaneously take place.   
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2.5.1 Model system description 
The biosensor model described here involves a two-dimensional channel of height 𝐻 and width 𝑊 
(Figure 2.19). Solution containing target molecules with concentration 𝐶0, and diffusion coefficient 
𝐷, is introduced through the channel with a volumetric flow rate 𝑄. At the bottom of the channel, a 
sensor of width 𝑊𝑠 and length 𝐿𝑠 is functionalized with receptors of a density 𝑏𝑚. Target molecules 
only bind specifically to the receptor on the surface with typical binding constants 𝑘𝑎 and 𝑘𝑑 , but do 
not bind to the channel surface outside the sensing area. As the channel width is much larger than 
the height, the target concentration is assumed to be uniform across the channel (in 𝐻 direction).  
 
 
 
Figure 2.19 A schematic cartoon of the model biosensor system used to describe analyte transport 
and surface reactions.  
 
2.5.2 Dimensionless numbers 
Fluid physics of a typical surface-based biosensor system, operating under continuous-flow 
conditions, are governed by a competition between wide varieties of physical phenomena as 
mentioned above. Dimensionless numbers indicate the relative importance of such competing 
effects, and they can be simply determined without complex computations. Their values are very 
useful to identify in which regime a system operates (e.g., absolute collection versus rapid collection 
or transport-limited versus reaction-limited regimes).    
2.5.2.1  The Reynolds number 
Fluid flows through a micro-/nanofluidic channel can be characterized by the dimensionless 
Reynolds number which is conventionally defined as the ratio of inertial forces to viscous forces as: 
𝑅𝑒 =  
𝑖𝑛𝑒𝑟𝑡𝑖𝑎 𝑓𝑜𝑟𝑐𝑒
𝑣𝑖𝑠𝑐𝑜𝑢𝑠 𝑓𝑜𝑟𝑐𝑒
=
𝜌𝑈𝑚𝑙
𝜇
,                                                       (2.1) 
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where  is the fluid density (kg.m-3), 𝜇 is the fluid viscosity (Pa.s) and 𝑈𝑚 is the average velocity of 
the flow (m.s-1). 𝑙 is the relevant length scale (m) which is equal to 4𝐴/𝑃, where 𝐴 is the cross 
sectional area of the channel and 𝑃 is the wetted perimeter of the channel. It is well known that the 
laminar flow occurs at low Reynolds number (𝑅𝑒 <2000) [99] where viscous forces are dominant 
whereas the turbulence flow occurs at higher Reynolds number.  
2.5.2.2 The Peclet number   
The transport regime of target molecules to the sensor is determined by both diffusive transport – 
the random movement of target molecules within the channel, and convective transport – the 
movement of target molecules in the direction of the fluid flow. The Peclet number represents the 
rate ratio of the convective transport to the diffusive transport as [100]: 
𝑃𝑒𝐻 =  
𝑐𝑜𝑛𝑣𝑒𝑛𝑡𝑖𝑜𝑛 𝑟𝑎𝑡𝑒
𝑑𝑖𝑓𝑓𝑢𝑠𝑖𝑜𝑛 𝑟𝑎𝑡𝑒
=  
𝑈𝑚𝐻
𝐷
                                             (2.2. ) 
 In other words, the Peclet number compares the rate at which a molecule diffuses across the 
channel with the rate at which it is conveyed downstream past the sensor with the same distance. 
When 𝑷𝒆𝑯 ≪ 𝟏, diffusion is the dominant mass transport. This implies that convection is slow 
enough that all molecules have sufficient time to diffuse to the surface and being grabbed by the 
sensor. This occurs under extremely slow flows or small channel heights. On the other hand, when 
𝑷𝒆𝑯 ≫ 𝟏, the convective transport wins. Under these considerably high flows or high fluidic 
channels, the molecules do not have enough time to diffuse to the sensor. Consequently, merely a 
small fraction of target molecules very close to the sensor has chance to react to the bioactive 
surface while the rest of the molecules are practically swept downstream due to the reduced 
residence time. Therefore, the biosensor loses its sensing efficiency. This is the case of typical 
microfluidic formats like SPR. From a practical point of view, the Peclet number for optimal 
biosensors should not be neither too high that the molecules do not have adequate residence time to 
bind to the sensor which in turn requires a larger amount of target to reach detectable levels, nor too 
low that it slows down the binding process, leading to long response times [101].  
2.5.2.3 The Damköhler number – interplay of mass transport and reactions 
When combining surface chemical reactions with mass transport, the Damköhler number is another 
dimensionless parameter which expresses the relative importance of these two phenomena as: 
𝐷𝑎 =  
𝑟𝑒𝑎𝑐𝑡𝑖𝑜𝑛 𝑟𝑎𝑡𝑒
𝑑𝑖𝑓𝑓𝑢𝑠𝑖𝑜𝑛 𝑟𝑎𝑡𝑒
=  
𝑘𝑎𝑏𝑚𝐻
𝐷
                                              (2.3) 
 The effects of analyte diffusive transport and reaction rates dictate the binding kinetic regimes of 
a system. When the rate of target diffusion to the sensor surface is much slower than the intrinsic 
reaction rate on the surface, 𝑫𝒂 ≫ 𝟏, then mass transport is rate limiting. Conversely, when the 
reaction rate is much slower than the transport rate, 𝑫𝒂 ≪ 𝟏, binding kinetics are reaction-
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limited. Consequently, the time required for a sensor to reach equilibrium is strongly dependent on 
the dimensionless number 𝐷𝑎. Under mass transport-limited conditions, the concentration of the 
bound complex grows linearly in time and the sensor exhibits long equilibrium times, demanding 
large amounts of target sample [102]. Furthermore, the measurement becomes problematic for the 
determination of kinetic parameters because the estimated kinetic constants will be the rates at 
which analytes are transported to the sensor surface, rather than the real intrinsic reaction rate 
constants of the binding reactions. On the other hand, if the system falls into reaction-limited 
regime, the analyte concentration above the sensor is nearly identical to the bulk concentration and 
the bound complex concentration reaches equilibrium with an exponential growth. Under these 
conditions, the reaction kinetics can be solved analytically in Langmuir model. To push the reactions 
toward reaction-limited regimes, the channel height and grafting density of the receptor can be 
simply modified whereas the on-rate and diffusivity are inherent to given antigen-antibody pairs.  
2.5.3 Phase diagram of mass transport 
Now we consider mass transport scenario in the model system described above, assuming that the 
sensor acts as an ideal perfect collector. This means that any molecule that diffuses to the sensor 
will bind instantaneously upon confronting the surface receptor. As the target molecules are 
collected by the sensor embedded on the channel floor, the diffusion layer with a concentration 
gradient forms above the reactive surface. The Peclet number and the sensor length, 𝜆 =  𝐿𝑠/𝐻, are 
the key parameters that characterize mass transport behaviors and the concentration profiles in the 
flow channel.   
 In the case where there is no bulk fluid flow, the diffusion region grows indefinitely into the 
channel with a size   √𝐷𝑡. When applying extremely small fluid flows, 𝑃𝑒𝐻 ≪ 1, 𝑄 ≪ 𝐷𝑊, the 
sensor collects all target molecules delivered by the flow and the depletion zone expands across the 
channel height (𝛿 ≫ 𝐻) until the convention balances its progression. At a steady state where the 
target convective flux 𝐽𝑐 = 𝐶0𝑄 is equal to the target diffusive flux 𝐽𝐷 = 𝐷𝐶0𝐻𝑊/𝛿, this 
equilibrium gives the depletion zone with a thickness 𝛿~𝐷𝐻𝑊/𝑄. On the other hand, if the 
diffusive transport cannot compete the target delivery by convection, a thin depletion zone forms 
above the sensor surface.  In this case, the depletion zone has a thickness 𝛿 ~ (
𝐿
𝑃𝑒𝑠
)
1/3
, where 𝑃𝑒𝑠 
is the shear Peclet number related to the sensor length, 𝑃𝑒𝑠 = 6𝜆
2𝑃𝑒𝐻. 𝑃𝑒𝑠 describes whether the 
depletion region is thicker (𝑃𝑒𝑠 ≪ 1) or thinner (𝑃𝑒𝑠 ≫ 1) than the sensor.  
 The analyte retention or the fraction of the analytes that are collected by the sensor for a 
variety of 𝑃𝑒𝐻 and 𝜆 is shown in Figure 2.20a. We can observe that for a sufficiently low 𝑃𝑒𝐻, and 
large enough sensor 𝜆, the incoming target molecules are completely collected. This corresponds to 
the full collection regime in region (i) in the mass transport phase diagram of the model biosensor 
system (Figure 2.20b). We designed the nanoslit biosensors used throughout this study to follow this 
full collection regime according to the values of experimental parameters. More details of 
dimensionless number computations for our biosensor system will be described in Chapter 4. Figure 
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2.20c-i show the steady state concentration profiles for different values of 𝑃𝑒𝐻 and 𝜆, corresponding 
to the stars in the phase diagram. In full collection regime, it can be observed that the depletion zone 
forms across the channel height (c,d,f). On the other hand, in region (ii) where both 𝑃𝑒𝐻 and 𝜆 are 
sufficiently high, the developed depletion layer is thin relative to both the sensor length and the 
channel height (e,g,i). In the case of small sensors, 𝐿 ≪ 𝐻 (e.g., nanowires), the depletion zone is 
thinner than the channel height but it is thicker than the sensor itself (h), corresponding to region 
(iii). Finally, region (iv) has not yet been studied. 
 
 
 
Figure 2.20 (a) Retention or collected fraction of the target analyte by the sensor for a variety of 
sensor lengths and the Peclet numbers, under convection-diffusion transports (b) A mass transport 
phase diagram of the model biosensor system. The embedded sensor is assumed to be a perfect 
collector in which the target molecules instantaneously bind to the surface upon encountering it.   
(c-i) Steady state concentration profiles in the flow channels, corresponding to the stars in different 
regions of the phase diagram. The color bar represents the concentration of the target analyte and 
the white arrow represents the direction of the fluid flow (adapted from [98]). 
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 Computation of these dimensionless numbers is central to determine mass transport behaviors 
and kinetic regimes of our biosensor system. It thus provides a better understanding of how our 
device behaves under given experimental assay parameters. Furthermore, this analysis allows us to 
devise the biosensor design in order to aim for specific applications by considering numerous 
constraints from real-world assay conditions, such as the sample volume availability, signal-to-noise 
ratios of the sensing system, and total analysis times [103]. For example, high capture efficiency is 
desirable for finite sample volumes (e.g., individual cells, small-plug samples) and when a fast assay is 
less important because a reasonably slow flow velocity should be used to elevate diffusive transports. 
On the other hand, if the sample availability is not the main constraint (e.g., urine samples), a higher 
flow rate is applicable in order to speed up the reactions at the expense of inefficient analyte capture 
and lower signal. 
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2.6 Conclusion 
In this chapter, we have introduced the field of nanofluidics which has been used throughout this 
PhD work as an alternative analytical tool for kinetic studies. Nanofluidics, in essence, has opened 
new research avenues to discover and elucidate a variety of biophysical phenomena which have not 
been previously accessible at the microscale. This is attributed to the unique characteristics inherent 
to the nanoconfined space, including molecular confinement effects and extremely high surface-to-
volume ratios. Furthermore, we have introduced the extended nanospace – the 101-103 nm length 
scale that has bridged the gap between conventional nano- and microtechnologies. The main 
applications of nanofluidics including biomolecule separation, pre-concentration, and single-
molecule analysis have been presented, which have highlighted the real potential of the nanofluidic 
realm.  
 A literature review related to biosensing in nanofluidics, primarily based on electrical and optical 
detection schemes, has been provided. Particular emphasis has been placed on kinetic studies of 
biomolecular interactions in the nanofluidic system. The molecular confinement offered by 
nanofluidic channels renders these devices extremely promising to direct the transport of target 
molecules toward the immobilized receptors on the surface, which in turn enhances the reaction 
kinetics and speeds up the time taken to reach equilibrium. In addition, we have assessed different 
issues related to nanofluidic biosensing which have impeded researchers in this field to fully benefit 
from the potential of nanofluidics as an effective biosensor. To address these challenges, we have 
introduced our alternative concept relying on a combination of biofunctionalized extended nanoslits 
and a conventional fluorescence microscope, enabling real-time kinetic monitoring of protein-
protein interactions. The underlying principles of our device and its unique features have been 
highlighted, which have guaranteed the versatility of our cost-effective platform to carry out kinetic 
experiments with advantages of simplicity and optimized sensor performances in terms of the target 
capture efficiency and response times.  
 Finally, the interplay of target molecule transport and surface reaction involved in surface-based 
biosensors has been introduced along with the important dimensionless numbers. The Peclet 
number and Damköhler number are the key indicators that define mass transport behaviors and 
surface reaction occurring in the nanoslits, and their values are of importance to determine in which 
regime our biosensor system operates (e.g., full target collection, reaction-limited regime). In order to 
validate our device concept stated above, we have fabricated nanofluidic biosensor devices and will 
be presented in the following chapter.  
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Chapter 3     
                                                   
Fabrication and implementation of the 
nanofluidic biosensor platform 
 
The aim of this chapter is to present the nanofluidic biosensor platform including its design and 
implementation, from the fabrication of the chip to its biofunctionalization and packaging. After 
introducing design considerations and after detailing the microfabrication process used to realize the 
silicon-based nanofluidic chip, we describe the surface modification protocol carried out on the 
open nanofluidic device for the construction of the biorecognition element. The chip encapsulation 
and device assembly/packaging are then presented as well as the experimental setups for 
fluorescence observations and pressure-driven flow control. Finally, we calibrate the fluid flow 
within the nanochannels by correlating the applied pressure with the flow velocity through analysis 
of fluorescent bead displacement, a step necessary for subsequent kinetic assays. 
3.1 Device design and conception 
The nanofluidic biosensor platform developed through this work aims to provide a tool for the 
binding kinetics studies of biomolecular interactions while offering the well-known advantages of 
reduced sample volume and enhanced speed of analysis inherent to miniaturized systems. Proper 
device design is of critical importance for robust and high performance biosensors. Different criteria 
are guided by the initial requirements: for instance, ease of fabrication, facile fluidic manipulation 
and compatibility with optical fluorescence detection. Importantly, in order to simplify and optimize 
the biofunctionalization process that leads to the grafting of probe molecules onto the nanochannel 
surfaces, part of this process is carried out in open chip configuration and the nanochannel 
encapsulation thus needs to be compatible with the presence of active biomolecules. The major 
characteristics of our devices are described below. 
 Hybrid silicon/ hard-PDMS coated cover glass  
The choice of the materials constituting the sensor is important in the device design. It depends on 
the operating conditions and the targeted application. Silicon was chosen as a candidate material for 
the device substrate. Contrary to polymer-based fluidic systems, silicon allows the fabrication of 
well-defined nanochannels with a wider range of aspect ratios and without the risk of deformation 
[1]. What is more, the compatibility of silicon-based microfabrication processes with the deposition 
and patterning of metal layers [2] makes silicon an advisable choice for biosensing applications, 
particularly for further selective grafting of biomolecules via gold-thiol surface chemistry. However, 
silicon is not optically transparent, and thus may pose a complication for nanofluidic applications 
with optical observation.  
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 To obtain optically transparent devices, the silicon substrate baring micro- nanochannels were 
encapsulated with a cover glass (Figure 3.1). In order to create a permanent seal between the silicon 
chip and the cover glass, we used a polymer as an adhesive. Hard-Polydimethylsiloxane (h-PDMS) 
was chosen for its chemical composition and properties close to the ones of PDMS (a material of 
choice for microfluidic applications) but with a relatively higher Young’s modulus, thus preventing 
the risk of collapse for nanofluidic devices [3].  
 This hybrid silicon-polymer coated glass system not only offers the possibility to observe 
the biomolecular interactions inside the nanochannels through a cover glass using a bench-
top fluorescence microscope, but it is also compatible with the chip pre-encapsulation 
biofunctionalization since only a mild asymmetric plasma-activation is required for the 
encapsulation process, which will be described in detail in the chip encapsulation section.   
 
 
 
Figure 3.1 Photograph of the fabricated nanofluidic device. 
 
 Device footprint and geometrical considerations 
We have chosen a device footprint of 16 mm × 16 mm that resulted in 16 fabricated fluidic chips 
per 100 mm wafer (Figure 3.2). We found that this was a good compromise between the size and the 
fragility of the device during fabrication and the fluidic manipulation. The channel geometry was 
determined by the desired applications: in the scope of this work, we decided to fabricate a two-
dimensional nanochannel (or nanoslit), where only one dimension (the channel depth) is confined to 
the nanoscale to offer reduction of the diffusion length with a sensor patterned within the 
nanochannel and to simplify the fabrication process (since we could use standard photolithography 
to define the channel width and length).  
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Figure 3.2 Design of the fluidic device with a footprint of 16 mm × 16 mm, corresponding to the 
density of 16 chips per wafer. A chip consists of a set of 6 parallel 450 nm deep, 500 µm long and 50 
µm wide nanochannels (green) bridging two 5 µm deep, 400 µm wide microchannels (purple). Three 
100 nm thick square gold patches with the dimensions of 50 µm × 50 µm (black) are located at the 
bottom of each nanochannel for localized probe grafting.  
 
 Concerning the depth of the nanoslits, we wanted to create channels as thin as possible 
to take advantage of the nanoconfinement effect for biomolecular sensing with reduced 
fluorescence background and minimized reagent consumption but also deep enough to 
allow the use of positive pressure with precise flow control by means of a pressure 
microcontroller. Importantly, we needed to achieve a flow velocity appropriate for kinetic study, 
and for this aim we had to decrease the fluidic resistance of the system. It is known that as the 
height of a channel decreases, it is troublesome to move the liquid using pressure gradients. Since 
the flow velocity is highly controlled by the total resistance of the nanochannels, we decided to 
connect small channels for analysis with larger channels for bulk transport [4].  
 The device consisted of 6 parallel nanochannels with 450 nm in depth, 500 µm in length and 50 
µm in width with the inter-distance of 50 µm. We designed the nanochannel length and width to fit 
the field of view of a CCD camera upon fluorescence observation with the use of a 20X objective. 
The aspect ratio (height over width) being limited by the collapsing risk of the channels during chip 
bonding was chosen to be in the range of 1/100. These nanochannels were connected to two 5 µm 
deep, 400 µm wide microchannels. Both microchannels served for analyte transportation and facile 
reagent exchange during in-situ surface functionalization as well as for reversed-buffer flow 
operation upon complex dissociation process. At the bottom of each nanochannel, three gold 
patches (50 µm wide, 50 µm long and 100 nm thick) were locally deposited and served as the sensor 
surface for kinetic study of protein-protein interactions.  
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3.2 Fabrication process 
The core fabrication of the nanofluidic chips is based on bulk machining and consists of several 
standard photolithography steps, thermal oxidation and metal deposition, as summarized in the 
fabrication chart (Table 3.1). The details of each process step are provided in the following part.  
Table 3.1 Process chart for nanofluidic device fabrication 
 
Fabrication process of the nanofluidic device on a silicon substrate 
Step Process Remarks 
1 Substrate preparation 100 mm p-type silicon wafer  
525 µm thick 
2 Nanochannel fabrication: 
2.1) First photolithography 
2.2) RIE etching 
 
Define the nanochannel layout 
Create the nanochannels (550 nm) 
3 Microchannel fabrication: 
3.1) Second photolithography 
 
3.2) RIE etching 
 
Define the microchannel patterns 
on the same substrate 
Create the microchannels (5 µm) 
4 Thermal oxidation 200 nm thin oxide layer 
5 Gold deposition Evaporation Cr/Au (5/100 nm) 
6 Lamination Front side wafer protection  
7 Inlet/outlet drilling Sandblasting machine 
8 Dicing 16 individual chips 
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3.2.1 Nano- and microchannel fabrication 
The device was fabricated on a 100 mm P-type 525 µm thick silicon wafer (BT Electronics, France) 
using a standard photolithography to define the nano/microchannel structures. First, the silicon 
wafer was immersed in a piranha solution (H2SO4/H2O2; 1:1 v/v) for 2 min, followed by a 5% HF 
solution for 30 s to remove the native oxide layer carrying all impurities. The wafer was again 
cleaned in the piranha solution for 2 min, thoroughly rinsed with deionized water before 
dehydration in a 200 ºC oven for 10 min.  
 Before deposition of the photoresist, the silicon wafer was treated with an adhesion promoter 
(hexamethyldisilazane, HMDS) through vapor deposition to ensure good adhesion of the 
photoresist to the silicon wafer. The HMDS-activated wafer was spin-coated with the positive ECI 
3012 photoresist (AZ Electronic materials) and soft-baked to remove excess solvents and activate 
the photo-initiators in the resist, resulting in a 2.6 µm thick resist layer. In order to define the 
nanochannel patterns, the wafer was exposed to ultraviolet light (12.5 s at 20 mW/cm2) through a 
nanochannel-defined chromium mask using a vacuum contact mode (MA 150, Karl Suss Inc.), and 
then developed.  
 Using the patterned photoresist as a mask, 
the 550 ± 20 nm deep nanochannels were 
created on the silicon substrate using a reactive 
ion etching (RIE) technique, producing 
controllable anisotropic vertical profiles with a 
smooth bottom surface of the trenches. We 
used a profilometer (KLA-Tencor) to measure 
the channel depth. 
 After the photoresist dissolution, similar 
photolithography and etching steps were 
repeated to create microchannels on the same 
silicon wafer. However, instead of using a RIE 
technique, a deep reactive ion etching (DRIE) 
or Bosch process was employed to excavate 
deeper channels, which were 5± 0.4 µm deep 
microchannels in our case. This resulted in anisotropic sidewalls that exhibit scalloping or ripple 
(Figure 3.3).  
 
 
 
Figure 3.3 An SEM image of a microchannel 
connected to a nanoslit fabricated on a silicon 
substrate using a reactive ion etching technique.  
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3.2.2 Thermal oxidation and gold deposition 
To facilitate chip encapsulation and aqueous liquid filling, we performed thermal oxidation on the 
etched silicon wafer to render the chip surface hydrophilic by the formation of a thin oxide layer 
(200 nm). The obtained silicon dioxide thickness was controlled using an ellipsometer. The 
roughness of the bottom of the nanochannl after thermal oxidation was measured by contact mode 
atomic force microscopy to be approximately 1.3 nm. The smoothness of the bottom surface 
and channel sidewalls was crucial for our application since any surface defects could induce 
undesirable non-specific adsorption of biomolecules and non-uniform flow, thus 
diminishing the device performances.  
 After the thermal oxidation, gold patches were 
patterned at the bottom of the nanochannel by 
means of a photolithography process. Briefly, a 
negative resist (AZ-NLOF 2035, MicroChemicals) 
was spun onto the thermally-oxidized silicon 
wafer, UV-insolated (MA150, 7.5 s at 20 mW/cm2) 
and developed to create the gold patch structures. 
A 5 nm layer of chromium (Cr) and a 100 nm layer 
of gold (Au) were deposited using both standard 
thermal evaporation and lift-off techniques.  
 The metal film was allowed to recrystallize by 
thermal annealing at 250 C under an N2H2 
atmosphere for 20 min in order to reduce the 
stress built up at the metal-substrate interface and 
improve the metal adhesion on the underlying 
layer. The roughness of the gold surface after piranha cleaning was measured to be 1.2 nm. The 
gold roughness has a substantial influence on the surface modification of the biosensing 
element, thus on the sensing properties of the sensor. The SEM image of deposited gold layer 
at the bottom of the nanoslit is shown in Figure 3.4. 
3.2.3 Lamination and inlet/outlet hole opening  
To facilitate liquid injection into the fluidic chips, it was necessary to drill millimeter diameter holes 
on the silicon substrate, which served as inlet/outlet ports for the devices.  Prior to drilling, a dry 
photoresist (PH2050) was laminated on the silicon substrate using a Shipley laminator (The Rohm 
and Haas Electronic Material, Italy) at room temperature followed by lamination at 110 ºC. The 
purpose of this lamination step was to protect the wafer during inlet/outlet hole opening. The holes 
were drilled using a sandblasting machine (Micro Blaster, Comco Inc.) equipped with aluminum 
oxide particles. The dry photoresist was stripped out by immersing the wafer in an acetone bath with 
the aid of sonication.  
 
Figure 3.4 An SEM image of a 100 nm thick 
gold film deposited at the bottom of the 
nanoslit. 
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 The wafer was then protected with the photoresist and finally diced into individual chips. The 
cleanroom fabrication process and the SEM picture of nanoslits are illustrated in Figure 3.5 and 
Figure 3.6, respectively. The detailed experimental conditions of the fabrication processes are 
provided in the Appendix A.  
 
Figure 3.5 Fabrication procedure of the nanofluidic devices. (a) A 100 mm p-type silicon wafer was 
used as a device substrate. (b) The nanochannels were etched on a silicon wafer using RIE 
technique. (c) The microchannels were created on the same wafer by DRIE technique. (d) Thermal 
oxidation was employed to form a thin oxide layer on the silicon wafer. (e) A 5/100 nm Cr/Au layer 
was patterned at the bottom of the nanochannels using photolithography and lift-off processes. (f) 
Inlet/outlet holes (1 mm in diameter) were drilled using a sandblaster.  
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Figure 3.6  SEM image of the device having a series of parallel nanoslits linked to a microchannel. 
 
3.3 Biointerface 
Construction of a biointerface is a key ingredient in designing surface-based biosensors and has a 
compelling influence on the biosensor performances, in particular, sensitivity, specificity and 
selectivity of detection. To study kinetics of protein-protein interactions, one requires the 
immobilization of the receptor probes onto a suitable sensor surface. During this immobilization 
process, the receptors need to retain their binding activity and they should be stable over the 
course of the assay. The main characteristics of desirable biosensing elements are listed below. 
1) The surface coverage should be optimum. On the one hand, the surface grafting density of 
the receptors should be sufficient to ensure the signal strength and thus the sensor 
sensitivity. On the other hand, too high a probe density induces steric hindrance upon 
analyte binding, leading to deviations from the Langmuir-like binding behavior, which is not 
advisable for kinetic studies [5, 6]. 
2) The orientation of the biomolecules should favor the accessibility of the analyte from the 
solution phase with sufficient binding sites [7]. 
3) Non-specific adsorption should be minimized to avoid false positive-signals and a 
misleading interpretation of the results [8]. 
4) Importantly, the surface functionalization method should be compatible with the 
nano/microfluidic device materials and fabrication steps (for example, chip encapsulation). 
In our case, we also wanted the surface functionalization scheme to be applicable to SPR 
setup in order to conduct kinetics experiments with this standard tool for comparison 
means. 
  
Fabrication and implementation of the nanofluidic biosensor platform 
 
 85 
 Currently, various immobilization methods including physical adsorption, covalent coupling, and 
self-assembled monolayer have been established for the immobilization of biomolecules (receptors) 
onto the transducing surfaces [9]. The choice of surface chemistry strategies is governed by 
numerous factors such as stability and functionality of biomolecules, assay format, analyte of 
interest, detection scheme, and application.   
 The aim of the study discussed in this section was to implement surface grafting of protein 
receptors on the nanofluidic device for kinetic studies of protein-protein interactions. The 
functionalization protocol used to graft the probe molecules onto the gold sensors embedded in the 
nanofluidic channels was carried out partially on the open-top devices prior to chip encapsulation 
and in-situ bio-functionalization after chip sealing (see Chapter 4). Practically, the devices need to be 
dried before sealing and as a result the biorecognition elements immobilized on the sensor surface 
should sustain such bonding condition as part of the device fabrication.   
3.3.1 Biological model 
Two representative protein-receptor pairs of different affinities, streptavidin-biotin (high 
affinity) and mouse IgG/anti-mouse IgG (moderate affinity), were chosen to demonstrate 
the capability of our devices to determine kinetic parameters.  
 Biotin is a small water-soluble vitamin (244 Da) also known as vitamin H. Streptavidin is a 60 
kDa tetrameric glycoprotein purified from the bacterium Streptomyces avidinii. Streptavidin-biotin 
binding is one of the strongest non-covalent bonds known with a dissociation constant (𝐾𝐷) in the 
range of 10-14 - 10-16 M [10, 11].  Due to this very strong interaction, streptavidin-biotin shows a very 
high resistance to denaturation induced by changes in pH, temperature or exposure to denaturing 
agents [12]. Binding kinetics of streptavidin-biotin interaction was investigated in our study since 
monitoring this high affinity recognition with the standard SPR method has not yet been addressed. 
Figure 3.7a depicts a 3D molecular structure of the tetrameric streptavidin-biotin complex.   
 On the other hand, an IgG/anti-IgG pair was chosen as a generic candidate model for other 
varieties of protein-ligand interactions. Immunoglobulin G (IgG) is a type of antibody with a 150 
kDa molecular weight, created and released by plasma B cells. Figure 3.7b illustrates a 3D structure 
of a monoclonal immunoglobulin. Biotinylated anti-IgG are commercially available and can be 
simply linked to the sensor surface via a streptavidin-biotin bridge. The dissociation constant (𝐾𝐷) of 
anti-IgG/IgG binding is in the range of 10-9 M [13, 14].  
3.3 Biointerface 
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Figure 3.7 3D molecular structures of the tetrameric streptavidin-biotin complex (a) and of a 
monoclonal immunoglobulin (IgG) (b) (from RCSB Protein Data Bank).  
 
3.3.2 Surface chemistry 
We selected gold as a sensor surface for the immobilization of probe receptors. The first 
advantage of using a gold surface in this study is mainly to permit the same grafting protocol to be 
implemented onto our nanofluidic biosensor platform as well as on the SPR platform to conduct 
kinetics studies with both techniques for comparison purposes; gold is the main read-out format in 
SPR assay [15]. The popularity of using gold in the field of biosensors arises from its inert nature, 
and its compatibility with semiconductor manufacturing processes. It can be deposited onto the 
silicon substrate by evaporation which is applicable to our device fabrication. The most ordinary 
feature of gold is to allow facile and reproducible immobilization of thiol-containing biomolecules 
using a self-assembled monolayer via strong gold-sulfur linkage [16].  
 Concerning a choice of surface chemistry protocol, a self-assembled monolayer (SAM) of 
thiol molecules was employed for receptor immobilization on the gold sensor. SAM offers 
several advantages in biosensor applications due to its tremendous flexibility to design the 
headgroup of SAM with various functional groups. Accordingly, hydrophobic/hydrophilic surfaces 
can be achieved depending on specific requirements [17]. Attachment of antibodies on the sensor 
via SAM chemistry also prevents direct contact of proteins with the surface and provides well-
oriented immobilized antibodies, which in turn ameliorates the binding efficiency toward target 
analytes, owing to enhanced accessibility of the binding sites [18].  
 In this study, SAMs were composed of two thiol species, 1) hydroxyl-terminated thiol or a 
spacer and 2) biotinylated thiol. The first thiol compound reduced the surface density of functional 
groups, and thus minimized steric hindrance and suppressed non-specific adsorption of unappealing 
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proteins. The second thiol species contained biotin functional headgroups used for kinetic study of 
streptavidin-biotin interaction as well as for subsequent immobilization of biotinylated receptor 
molecules through streptavidin-biotin linkage [19].  
 Optimization of the mixing ratio between these two compounds allows better control of 
immobilized surface probe densities on the sensor surface [20], which is a requisite parameter for 
kinetic studies. For the streptavidin-biotin interaction model, 1% of biotinylated thiol (BAT) was 
used to obtain an optimum surface density of immobilized biotin and to avoid the problem of steric 
hindrance upon binding which could change their kinetic binding behaviors. On the other hand, 
10% biotinylated thiol was employed in the second model of mouse IgG/anti-mouse IgG 
interaction, providing the maximum density of immobilized streptavidin molecules for subsequent 
anchoring of the biotinylated anti-mouse IgG receptor [21, 22] (Figure 3.8). This immobilization 
step, based on SAM formation, was carried out prior to chip encapsulation since it required several 
hours of incubation (12 h), and due to the fact that the immobilized biotin molecules could retain 
their functionality upon chip dehydration prior to encapsulation.  
 
 
 
Figure 3.8 Schematic illustrations (not to scale) of two surface functionalization architectures on 
gold sensors used for protein kinetic study in nanoslits. (a) Model I streptavidin-biotin interaction on 
1% biotinylated thiol modified surface; (b) Model II mouse anti-rabbit IgG/anti-mouse IgG 
interaction via biotin-streptavidin linkage on 10% biotinylated thiol modified surface. Hydroxyl-
terminated thiol compound acts as a spacer to reduce non-specific adsorption of proteins on gold 
surfaces.  
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 After biotin is bound to the gold surface through alkyl chain of thiol molecules, it still possesses 
the binding affinity toward streptavidin, allowing highly rigid and well-ordered streptavidin 
immobilization [20]. We used fluorescently labeled streptavidin in our study to monitor its kinetic 
reaction with surface immobilized biotin in the first model as well as to offer the first fluorescence 
detection point, revealing successful streptavidin immobilization for further modification in the 
second model.   
 Since streptavidin has four biotin-binding sites located on two opposite sides of is tetrameric 
structure, another layer of any biotinylated protein can thus be built on top of it. In our case, 
biotinylated anti-IgG was chosen as the receptor layer for the detection of fluorescent IgG 
molecules. The aforementioned surface functionalization steps (i.e., streptavidin and biotinylated 
anti-IgG) were performed in a flow manner once the fluidic chip was sealed. For fluorescence 
imaging purposes, two different dyes with non-overlapping emission spectra were employed in order 
to distinguish between the immobilization of streptavidin and the subsequent binding study between 
the non-fluorescent immobilized receptors and the fluorescently labeled IgG analytes. In this case, 
streptavidin was conjugated with a green fluorescence dye (Alexa Fluor 488) while the IgG target 
analyte was conjugated with a far-red fluorescent dye (Alexa Fluor 647). 
 This surface chemistry concept not only offers widespread use of biotinylated proteins as 
receptors for targeting other specific analytes, but also leads to minimized non-specific adsorption 
while preserving bio-functionality of biomolecules with well-oriented receptors on the surface, 
beneficial for optimal target-probe interaction.   
3.3.3 Open-top surface functionalization 
Prior to implementing the surface functionalization protocol into the closed-nanofluidic devices, 
where the fluidic-like environment could complicate the functionality of the sensor and the device 
manipulation, we decided to assess the modification protocol using the open-top chip fashion and 
fluorescence imaging.  
 To this end, we utilized the unclosed silicon chip with embedded gold sensors as a device 
substrate for surface functionalization verification. Since the device consisted of both gold surfaces 
for selective patterning of biomolecules (receptors) and silicon dioxide surfaces on the remaining 
areas (Figure 3.9), it was compulsory to passivate the silicon dioxide surface with protein-blocking 
reagents to circumvent potential non-specific adsorption of other biomolecules, which could reduce 
the device sensitivity.   
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Figure 3.9 Simplified cartoon schematic depicting the device surfaces, consisting of the gold patch 
and silicon dioxide surface used in this experiment. The gold patch acts as the sensing layer for 
biomolecule immobilization via gold-thiol chemistry. The remaining silicon dioxide areas of the chip 
were passivated with blocking agents.  
 
 The role of blocking agents is mainly to reduce nonspecific adsorption of protein on the silicon 
dioxide areas, thus reducing interference background and improving signal-to-noise ratio without 
altering or obscuring the analyte binding onto the surface-immobilized receptors. Many blocking 
strategies have been reported to suppress non-specific adsorption on various surfaces. For instance, 
covalent attachment of poly(ethylene glycol) (PEG) creates non-fouling hydrophilic surfaces, 
resisting non-specific adsorption [23]. This method has also been implemented in microchannels 
[24].  
 In contrast to covalent modification, the adsorption strategy is one of the promising approaches 
relying solely on intermolecular interactions (van der Waals forces, hydrophobic interaction etc.) 
between the coating agents and the substrate surface [25].  The most commonly used coating agent 
is bovine serum albumin (BSA). BSA is a small protein which tends to bind to all surfaces including 
hydrophobic and hydrophilic surfaces [26], contributing to its widespread use in biosensor 
applications [27, 28]. BSA has been demonstrated to reduce background due to non-specific 
adsorption on PDMS microchannels in ELISA assay [29]. In this study, BSA was used to 
passivate the device surface (silicon dioxide) for open-top functionalization experiment as 
well as to passivate the h-PDMS roof of the enclosed fluidic devices (this will be discussed 
in the next section). 
  In all experimental conditions, the BSA passivation step was accomplished after the 
formation of the SAM layer on gold surfaces. Three different modified gold surfaces were 
studied; (1) bare gold surface, (2) 100% hydroxyl-terminated modified (MUOH) surface, and (3) 
10% biotin-modified (BAT) surface. For each surface modification scheme, the silicon dioxide 
surface of each chip was subsequently either BSA-passivated or not. As a result, there were six 
different samples for functionalization investigation in this experiment. The materials used 
throughout these experiments are given in the Appendix B. 
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 Briefly, piranha cleaned substrates were immersed in different solutions of thiols (0.5 mM in 
ethanol) for > 12 h to form SAMs on the gold surfaces. For the passivation step, a 2 mg/ml BSA 
solution was dropped onto the substrates and the surfaces were incubated for 30 min. The chips 
were afterwards rinsed with DI water and dried. A 100 nM Alexa Fluor 488 streptavidin solution 
prepared in PBS buffer was drop-casted onto the substrates to allow the interaction between 
streptavidin in the solution and the surface immobilized biotins for 30 min. The substrates were kept 
in the dark at room temperature throughout the experiment. The chips were rinsed with PBS buffer 
to remove any excess streptavidin molecules and they were observed under the fluorescence 
microscope using the same imaging parameters for all substrates (Table 3.2).  
Table 3.2 Fluorescence images of the chips after different surface treatments 
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Figure 3.10 Plot of increased fluorescence intensities after streptavidin immobilization on gold 
sensor and silicon dioxide (areas outside sensor) of different treated gold surfaces. 
 
 From Figure 3.10, some conclusions could be drawn regarding the passivation approach and the 
functionality of the surface modification protocol on the various treated-surfaces as listed below. 
 Streptavidin mostly non-specifically adsorbed on the bare gold surface and some 
adsorbed on the silicon dioxide surface. Pre-treated BSA surfaces effectively prevented 
these non-specific adsorptions.   
 There was no significant non-specific adsorption of streptavidin on hydroxyl-thiol 
modified gold surfaces for both cases: the BSA treated surface and non-BSA treated 
surface. This was attributed to the ability of the hydrophilic hydroxyl group located on 
the gold surface to block undesirable adsorption.   
 Streptavidin specifically bound to the 10% biotin treated gold surface. However, it was 
observed that streptavidin could bind more on the 10% biotin treated surface without 
BSA passivation. This suggested that some BSA molecules also adsorbed on the gold 
area which partially blocked further binding of streptavidin molecules.   
 Although, use of BSA passivation could partially block the binding sites on the biotinylated 
surface for subsequent streptavidin immobilization, adequate streptavidin binding signal on the gold 
sensor over background signal on the silicon dioxide surface was achieved, which is suitable for 
highly sensitive bio-analysis in nanochannels.  
3.4 Chip encapsulation 
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 These results obtained from open-top functionalization format partly validated our bio-
functionalization protocol. The validation of the full functionalization protocol was carried out using 
quartz crystal microbalance apparatus (see the Appendix C).  
3.4 Chip encapsulation 
Once the gold sensors at the bottom of the nanochannels were modified with biotinylated thiols in 
the open-top manner, the chip was encapsulated with an optically transparent substrate, enabling the 
fabrication of enclosed nanofluidic systems. The essential requirement of the chip encapsulation 
process is primarily its compatibility with low high-aspect ratio (1/100) nanochannels, without risk 
of collapse. Secondly, the bioactivity of the pre-immobilized receptors should be preserved. Lastly, 
the bonding method should ensure appropriate bonding strength and uniformity, suitable for 
pressure-driven injection (applied positive pressure in the range of 0-200 mbar).  
 The most widely used bonding techniques for nanofluidic fabrication includes fusion bonding 
and anodic bonding [30]. Nevertheless, involved heat treatment induces irreversible denaturation of 
pre-immobilized receptors on sensor surfaces. PDMS elastomer is commonly used to fabricate chip-
based microfluidic devices using lithography and replica molding. This is due to its desirable 
properties, including bio-compatibility and optical transparency, suitable to be used as a capping 
layer in microfluidic devices [31]. Replica molded PDMS can be irreversibly sealed on the glass 
substrates by oxygen plasma treatment and can withstand 30-50 psi of air pressure [32].  However, 
PDMS is impractical for the fabrication of nanofluidic devices with typical channel heights below 
one micron due to its deformability, leading to well-known roof collapse [33, 34].  
 A hard-PDMS, having similar properties and functionality to PDMS but harder (more cross-
linked polymer), is an alternative material which offers 4.5 times the Young’s modulus than that of 
standard PDMS [35]. The h-PDMS sealing approach has already been developed to fabricate 
nanofluidic channels [3, 36]. Due to its hardness, pressure-induced deformation in h-PDMS 
can be dramatically reduced, leading to successful chip encapsulation, particularly in 
nanoscale devices.  
 Therefore, an h-PDMS coated cover glass slide was employed in place of a regular PDMS to 
avoid channel collapse upon device sealing in this study. The lowest aspect ratio giving successful 
device sealing with h-PDMS was found to be 5×10-4 (500 nm deep and 1 mm wide channels).  
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 The detailed compositions for h-PDMS preparation are provided in the Appendix D. Briefly, 
the unreticulated h-PDMS mixture was spin-coated at 3000 rpm for 30 s onto a piranha-cleaned 
cover glass (0.13-1.16 mm thick, Menzel-Glaser) followed by 2 hours curing in an oven at 60 ºC, 
resulting in a 6 µm thick deposited polymer layer (Figure 3.11). This curing temperature was adapted 
from previous work [36] in order to reduce the surface roughness formed on h-PDMS coated cover 
glass upon baking. The surface roughness was very problematic in our case because of the high 
degree of non-specific adsorption of biomolecules onto the rough surfaces.  
 
 
 
Figure 3.11 Sketch of preparation procedures for the h-PDMS coated cover glass. 
 
 Unlike ordinary polymer sealing procedure wherein both surfaces (glass and polymer-coated 
substrate) are activated with oxygen plasma treatment to render them hydrophilic before bonding, 
our sealing approach relies on the activation of only h-PDMS coated cover glass but not the pre-
immobilized fluidic chip [37]. This process was performed under room temperature, thus keeping 
the bio-functionality of the pre-immobilized probes.  
 To this end, the h-PDMS cover glass was activated by oxygen plasma (120 s, 35 W, 0.5 mbar O2, 
PICO Plasma Cleaner, Electronic Diener) and immediately placed in contact with the biotin-
modified nanoslit chip to achieve a covalent bond (Figure 3.12). The chip was quickly baked in a 65 
ºC oven for 5 min to ensure good bonding.  
3.4 Chip encapsulation 
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Figure 3.12 Illustration of chip encapsulation process performed at room temperature. A h-PDMS 
coated cover glass was activated by means of oxygen plasma exposure and then brought into contact 
with a receptor pre-modified silicon chip to form a finished fluidic device. 
 
 A surface molecular mechanism of SiO2/h-PDMS bonding is considered similar to glass-PDMS 
bonding. Surface activation via oxygen plasma treatment alters the methyl moieties (Si-CH3) at the h-
PDMS surface to a hydrophilic silanol (Si-OH) surface structure. The measured water contact angle 
after plasma activation was less than 5 ºC, which was required for obtaining high bond strength [32]. 
It is well-known that oxidized PDMS based materials can recover their hydrophobicity upon 
exposure to air in a few hours or less. Therefore, as soon as the polymer surface was activated, the 
h-PDMS coated cover glass was immediately brought into conformal contact with the pre-
biofunctionalized chip. The reaction of silanol moieties on both surfaces creates a strong covalent 
siloxane (Si-O-Si) bond through a condensation process. The device encapsulation was preferably 
performed in a clean-room environment to avoid any dust or other contaminants, which would 
result in bonding failure. 
 After the encapsulation step, the chips were filled with a blocking solution (1% BSA in 10 mM 
PBS buffer with 0.02% Tween-20, pH 7.4) by capillary forces to prevent non-specific adsorption of 
proteins on the channel walls (h-PDMS roof surface and silicon dioxide bottom surface). It is noted 
that the BSA-filled nanofluidic devices could be stored in the dark at 4 ºC in which the sensor still 
remained active and stable for several weeks. A detergent such as Tween-20 is commonly added to 
the buffer or blocking solution to minimize background caused by nonspecifically bound materials 
in the assay [38].  
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3.5 Device assembly and fluidic configuration 
Fluid transport is a crucial issue in nanofluidic devices. In the scope of this work, positive pressure 
generated by a pressure controller (Fluigent) system was utilized throughout our experiments to 
pump the liquid or biological samples into the nanoslits. The pressure driven-flow method allows 
precise flow control and easy fluid handling, which is indispensable for immunoassay. Moreover, it is 
simple to implement and it is insensitive to surface contaminants, ionic strength and pH in contrast 
to electrokinetic flow.   
 In order to connect the nanofluidic device to the macro world for sample loading and injection, 
we have designed and constructed a dedicated fluidic interface. For the assembled devices to allow 
the bioanalysis to be performed in a controllable manner, several criteria were taken into account.   
 The chip holder should be compatible with a bench-top fluorescence microscope stage 
for optical observation on one side while permitting fluidic control on the other side.  
 
 Secondly, the disclosed fluidic assembly should be robust and perfectly sealed to sustain 
the application of the positive pressure, preventing the chip delamination and in 
consequence fluid leakage during manipulation and liquid injection.  
 
 Last but not least, it should allow the reversed buffer flow operation by switching from 
analyte to buffer solution without removing the fluidic setup for reagent exchange. In 
this way, both association and dissociation kinetics of protein interactions can be 
assessed in one single experiment and without an extra buffer loading step.     
  With this aim, a homemade dedicated fluidic support was created in the mechanical workshop at 
LAAS (Figure 3.13a). Three distinct parts were employed in the sample holder: a bottom support 
made of aluminum and bearing a defined-dimension gasket to host the fluidic chip (and to enable 
microscopy observations), a part bearing the reservoirs made of Teflon directly placed on top of the 
chip, and the fluidic connector in Teflon mounted on top of the reservoirs to close the entire 
system. O-rings and Teflon screws were employed at each interface to ensure a perfect sealing. The 
fluidic chip was placed upside-down in the gasket support.  
 The benefit of this fluidic setup is the significantly reduced dead-volume of expensive biological 
reagents, thus minimizing the sample consumption, as compared to the conventional microfluidic 
setup with lengthy tubing. Minimum reagent volume of less than 10 µL (which could be even 
less with an optimized setup) can be loaded into the dedicated reservoirs of our setup while 
hundreds of microliters are needed for a typical microfluidic device. 
3.5 Device assembly and fluidic configuration 
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Figure 3.13 (a) Schematic presentation of the chip holder compatible with pressure-induced flow. 
The fluidic chip is placed upside-down in its emplacement made in aluminum. (b) Diagram of fluidic 
configuration enabling reverse buffer flow operation in kinetic assay. The pressure controller is 
employed to induce the flow of biomolecules into nanoslit. The analyte solution is introduced from 
one inlet while another inlet is used for buffer injection, allowing the study of association and 
dissociation phases of immunoreactions in one single-experiment. 
 
 As far as the fluidic configuration is concerned, the chip included two microchannels used to 
introduce liquids and connect to the external fluid apparatus (air tubing and pressure generator) 
while parallel straight nanochannels served to conduct the binding kinetics of protein interactions. 
There were two inlets and two outlets situated at the end of each microchannel. In kinetic 
experiments, the sample and the buffer solutions were loaded in two opposite reservoirs. The first 
inlet empowered the delivery of the target analyte solution for the association phase whereas the 
buffer solution was injected from the opposite inlet for the complex dissociation (Figure 3.13b).  
 
 
 
Fabrication and implementation of the nanofluidic biosensor platform 
 
 97 
 Based on this configuration, the pressure could be applied to both inlets separately, and as a 
result the analyte solution could be replaced by the introduction of the fresh buffer solution by 
simply switching the automated pressure controller from one inlet to another one without having to 
remove the setup to refill it with the new solution. This operation is a key feature specific to our 
device in order to accomplish a full kinetic sensorgram in one single reagent loading, which 
is commonly impractical in the case of classical microfluidic formats. Indeed, in the present 
nanoslit configuration, a thin diffusion layer formed within the channel depth upon probe-target 
reaction and propagated along the channel length; there was thus a clear boundary between the 
analyte and the buffer, and so the pressure-driven flow could be conveniently used to switch 
between the two phases. 
3.6 Experimental setup 
Once the fluidic chip was assembled in the dedicated chip holder, it was directly placed onto the 
microscope stage. The experimental setup enabling fluorescence detection of protein binding 
kinetics inside nanoslits consisted of an inverted fluorescence microscope (IX70, Olympus) 
equipped with an iXonEM+885 EMCCD (1004×1002 active pixels, 8×8 µm2 pixel size) from 
Andor for fluorescence imaging, a white light source (Lumencore SOLA light engine, USA), and a 
pressure controller system (MFCS-8C Fluigent, France). This system allowed tunable positive 
pressure control over a range of 0-1 bar. The chip support containing the fluidic device was 
connected to the Fluigent using soft tubes (3mm OD, 1mm ID).  
 Fluorescence images were acquired with a LCPlanF1 20×/0.40 Ph1 objective (Olympus Optical, 
Japan) and appropriate filter sets (U-MWIB3 from Olympus and U-M41008 from Chroma). The 
exposure/acquisition time was set to 1 s and illumination of the sample was turned on only during 
the acquisition time using an external shutter triggered by the camera (Lambda SC, Shutter 
Instrument) to avoid photobleaching. Time-lapse fluorescence images were recorded using an 
Andor Solis imaging software. All measurements were carried out at room temperature. The 
photograph of the experimental setup used for kinetic assay in the nanoslits is demonstrated in 
Figure 3.14. 
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Figure 3.14 Experimental setup for performing kinetic study of protein interactions in nanofluidic 
devices. 
 
3.7 Flow calibration 
The pressure generator system was used in all experiments to induce liquid flow in the 
nanochannels. Since the reaction kinetics depends on the rate at which the analyte molecules are 
brought to the sensor, it was essential to know the flow velocity during the experiment. Flow 
velocity was one of the input parameters desired in the finite element simulation to predict the 
sensor responses. As a result, its accurate value was required to be able to compare the simulated 
data with our experimental assay. To this end, it was convenient to be able to relate the applied 
pressure to the flow velocity associated with the convective flow of surface-based immunoreaction 
performed in nanoslits. 
3.7.1 Materials and methods  
Flow calibration within the nanochannels was achieved by measuring the flow velocity of 
fluorescent beads for applied pressures (P) ranging from 25 to 100 mbar. 100 nm diameter 
fluorescein conjugated beads were diluted 105 times in 10 mM PBS buffer with 0.05% Tween-20. 
After proper degassing, the solution of beads was introduced into the BSA-passivated nanoslits. 
Various pressures were then applied at the inlets of the chip following two configurations: (i) using 
only one inlet where P1 = P; P2, P3 and P4 = 1 atm, and (ii) using two inlets where P1 = P2 = P; P3 and 
P4 = 1 atm.  
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 The displacement of the beads over time was visualized with the similar experimental setup as 
described above. Furthermore, a 40X (N.A. 0.6) and a 100X (N.A. 1.3) oil-immersion objective lens 
from Olympus were employed in this experiment. The minimum exposure time of 31.7 ms was 
achieved using a frame transfer to obtain a good resolution of bead movement, giving a cycle time 
of 32.7 ms. For a given applied pressure, the bead movements were captured during 16.4 s, 
corresponding to 500 video frames. The flow velocity of each bead was then calculated by dividing 
its traveling distance (𝑥) by the measurement time (𝑠). ImageJ software was used to measure the 
displacement distance of the beads and the average flow velocity was obtained using 10 different 
beads. 
3.7.2 Results and discussion 
The average flow velocities as a function of applied pressures (one and two inlets) are plotted in 
Figure 3.15 and show a linear relationship in both cases.  
 
 
 
Figure 3.15 The calibration curves showing the relationship between flow velocity in the 
nanochannels and the applied pressure induced by a pressure controller. The plots show a linear 
relationship in both cases: one inlet (P1=P, P2=P3=P4= 1 atm) and two inlets (P1=P2, P3=P4= 1 atm) 
connected to the pressure source. 
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 To confirm the flow velocities measured from bead measurement, the experimental values were 
compared with the theoretical values derived from pressure-driven flow in a rectangular channel 
(basic theory of mass transport in fluidic device can be seen in Chapter 5). Our device exhibited a 
rectangular cross section shape where the channel height was much lower than the channel width 
(𝐻 ≪ 𝑊). Hydrodynamic resistance (𝑅𝐻) is a function of channel geometry and fluid viscosity in the 
channel. The hydrodynamic resistance of a rectangular channel with a low aspect ratio can be 
calculated as [39]:  
𝑅𝐻 =  
12𝜇𝐿
𝑊𝐻3
,                                                                        (3.1) 
where 𝑊 is the width of the channel, 𝐻 is the height of the channel, 𝐿 is the channel length and 𝜇 is 
the fluid viscosity (water viscosity is 1.002 mPa.s at 20 ºC).  
 From Hagen–Poiseuille’s law, ∆𝑃 = 𝑄𝑅𝐻 , the fluid flow rate 𝑄 (m
3/s) in a flat rectangular 
channel can be approximated as: 
𝑄 =  
𝑊𝐻3
12𝜇𝐿
Δ𝑃,                                                                     (3.2) 
where ∆𝑃 is the pressure drop across the channel (𝑃𝑚𝑎𝑥 = 1 bar = 10
5 Pa). Mean flow velocity, 𝑈𝑚 
(m/s) can be simply derived by dividing the flow rate with the cross-sectional area as: 
𝑈𝑚 =
𝑄
𝑊𝐻
                                                                          (3.3) 
 To determine the flow velocity inside the nanochannels, the hydrodynamic resistance of the 
entire fluidic device was first calculated using equation 3.1 as 0.162 µm-3.Pa.s. Flow rates were then 
estimated from Hagen-Poiseuille’s law at different applied pressures across the channel. Finally, the 
flow velocity at the entrance of nanochannel can be estimated from equation 3.3. The flow velocities 
(µm/s) as a function of applied pressures (mbar) were compared between the experimental data 
obtained from bead analysis and the theoretical values as demonstrated in Figure 3.16.  
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Figure 3.16 The relationship of fluid flow velocity inside the nanochannels and applied pressure 
obtained from bead displacement analysis. The experimental data are linearly well-fitted with 
theoretical calculations based on pressure-driven flow in a rectangular cross-section channel. 
 
 Although the measured flow velocity is slightly higher than the mean velocity due to size 
exclusion, the experimental data fitted well with the theoretical calculation (R2 = 0.9993), exhibiting 
a linear relationship between the flow velocity and the applied pressure. It can be concluded that 
we could rely on the theoretical model to determine the flow velocity in our system and thus 
used as an input parameter in the finite element model to fit with the experimental data.  
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3.8 Conclusion 
In this chapter, we have described the design and the microfabrication process of the nanofluidic 
biosensor devices consisting of 2-D nanoslits connected to microchannels on a silicon substrate. We 
have chosen a gold surface as the choice of sensing material mainly for comparison purpose 
between our sensor platform and the SPR technique as well as for easy surface modification via 
gold-thiol chemistry. We have described the selected biointerface, based on self-assembled 
monolayers of mixed thiols, used as a generic approach to study protein-protein interactions. 
Streptavidin-biotin and IgG/anti-IgG interactions have been chosen as the representative biological 
models to validate our device capability for kinetic constant quantification using a conventional 
bench-top fluorescence microscope.  
 The grafting protocol of bio-receptors has been successfully implemented in nanoslits with an 
open-top modification manner combined with a surface passivation procedure using a well-known 
effective blocking agent: bovine serum albumin. The fluorescence characterization demonstrated 
high binding affinity between immobilized biotin probes against streptavidin target analyte in 
solution with low undesirable non-specific adsorption outside the sensor area, resulting in a high 
signal-to-noise ratio. This result validated our grafting strategy that was readily applicable for robust 
kinetic assays in nanofluidic devices (See Chapter 4). Furthermore, the bio-compatible chip 
encapsulation performed at room temperature environment has been established to preserve the 
bio-activity of pre-immobilized surface probes by means of oxygen plasma treatment on the h-
PDMS coated cover glass.  
 Concerning the world-to-chip fluid interface for nanofluidic devices, a home-made chip holder 
and fluidic connections have been realized, allowing low reagent consumption and, more 
importantly, the generation of a full kinetic sensorgram (association and dissociation assays) with 
single reagent loading via reversed-buffer flow fashion. We have presented the experimental setup 
on an inverted fluorescence microscope to visualize bio-recognition events in nanoslits during 
kinetic analysis. Finally, the flow calibration of the system showed a linear relationship between the 
applied pressure and the flow velocity inside the nanochannels. Good agreement between the 
theoretical model and the experimental data has enabled direct correlation of the applied pressure to 
the flow velocity, giving known hydrodynamic resistances of the fabricated fluidic devices. 
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Chapter 4     
                                                   
Real-time fluorescence detection of protein 
binding kinetics in nanofluidic biosensors 
 
In this chapter, we present an empirical validation of our platform capability for real-time kinetic 
analysis of protein-protein interactions with two dedicated biological models. The first model deals 
with high affinity interaction, namely streptavidin-biotin recognition pair. The assessment of bio-
functionalization and kinetic assay are demonstrated by means of fluorescence observations. The 
second binding model involves moderate affinity, mouse IgG/anti-mouse interaction, wherein in-
situ functionalization and kinetic measurement with a series of fluorescently labeled IgG 
concentrations are revealed. We then introduce the different data fitting approaches used along the 
course of this study to resolve kinetic parameters of bio-specific interactions. They include finite 
element modeling, analytical approach, and a commercial kinetic evaluation software package. 
Additionally, our biosensor performances are benchmarked with a mature technology, the SPR-
based biosensors, as well as with values found in the literature. Finally, we examine the operational 
range and detection limit of our system as well as the repeatability of the measurements for mouse 
IgG detection.  
4.1 Real-time kinetic measurement 
Real-time biomolecular analysis provides kinetic insight information of protein-ligand pairs of 
interest and allows the determination of distinct kinetic constants: the association and dissociation 
rates of the recognition molecules. Herein, real-time measurement of biomolecular interactions was 
conducted in the fabricated bio-functional nanofluidic devices, based on continuous analyte flow 
coupled with fluorescence detection, to determine rate constants of two dedicated biological 
systems. The underlying investigation aimed to validate our nanofluidic biosensor-based 
approach for kinetic analysis, similarly to the well-established label-free SPR technique, but 
offering a simpler and cost-effective analytical tool for wider community use.  
4.1.1 Streptavidin-biotin binding model 
4.1.1.1  Assessment of bio-functionalization 
Prior to performing the kinetic assays, it was desirable to ensure whether the immobilized biotin 
probes could preserve their bio-functionality after being subjected to open-top surface modification 
and asymmetric bonding protocol as described in Chapter 3. To this end, we investigated 
streptavidin-biotin reactions inside the closed biofunctional nanoslit based on pressure-driven flow.  
4.1 Real-time kinetic measurement 
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 To elucidate this specific biomolecular interaction, a 100 nM solution of Alexa Fluor 488 
conjugated streptavidin (ST-AF 488) diluted in 10 mM PBS buffer + 0.05% Tween-20 was delivered 
into the 10% biotinylated thiol modified channel loaded with a blocking buffer (1% BSA in 10 mM 
PBS buffer + 0.02% Tween-20, pH 7.4), at a constant flow velocity of 155 µm/s for 25 min (Figure 
4.1). 
 After rinsing with the buffer (10 mM PBS buffer + 0.05% Tween-20, pH 7.4) to remove excess 
streptavidin molecules from the channel and any non-specific adsorption on the surface, the 
fluorescence images were recorded. A significant increase in fluorescence intensity on the gold 
sensor patches containing pre-immobilized biotin molecules was observed, while the adjacent area 
on the channel wall (silicon dioxide) remained relatively low in fluorescence intensities (Figure 4.2), 
indicating minimal non-specific adsorption of analyte on the slit surface. 
 
Figure 4.1 Schematic presentation of the in-situ streptavidin functionalization. 
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Figure 4.2 A bar plot of fluorescence intensities measured on the gold sensors and channel walls 
(silicon dioxide) obtained from two different surface-treated nanoslit devices upon streptavidin 
injection. Fluorescence images of the 10% biotin modified nanoslit and the 0% biotin modified 
nanoslit (MUOH) after streptavidin introduction are shown in the insets.   
 
 A control experiment (no biotin) was also conducted on the hydroxyl-terminated thiol (a spacer) 
modified sensor surfaces (MUOH). No significant non-specific physical adsorption was observed 
after the washing step. This indicated the specific recognition between the pre-immobilized biotin 
and flowing streptavidin target molecules. The results therefore confirmed that the pre-modified 
probes maintained their bio-reactivity toward the specific targets after the chip 
encapsulation, providing a sensing capability with a remarkably high signal-to-noise ratio 
and diminished non-specific adsorption. 
4.1.1.2  Kinetic assay 
In the first experiment, we attempted to study the binding kinetics of flowing fluorescent 
streptavidin on the surface-immobilized biotin with 10% biotin content inside the nanoslits. Similar 
to the aforementioned experiment, a 100 nM solution of ST-AF 488 was driven by a positive 
pressure into the 10% biotinylated thiol modified channels. Using fluorescence time-lapse imaging, 
streptavidin binding events were now recorded in real-time.  
 The fluorescence time-lapse imaging of 100 nM ST-AF 488 binding onto the immobilized biotin 
patches is shown in Figure 4.3. A significant fluorescence signal on the first sensor patch could be 
distinguished within one minute or even less, and reached equilibrium after around 3 minutes, while 
the second and the third patches showed relatively dark regions (no or fewer binding events
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occurred), noted as a depletion zone. When driven streptavidin target molecules were moving 
extremely close to the surface-immobilized biotin, it literally guaranteed the optimal binding 
efficiency. As seen from the time-lapse fluorescence images, streptavidin molecules were effectively 
captured by the sensor patch with a very high signal-to-noise ratio (174 fold) and the binding 
reaction slowly propagated downstream along the flow direction.  
 
 
Figure 4.3 Time-lapse fluorescence images taken when a 100 nM solution of Alexa Fluor 488-
streptavidin was driven into the biotin-immobilized nanoslit by pressure-driven flow with a flow 
velocity of 155 µm/s.  
 
 This sensing characteristic could be confirmed by the plot of normalized fluorescence signals at 
different positions on the sensor patch (Figure 4.4), wherein the confronting front edge of the 
sensor reached the binding equilibrium before the middle and the back edge. The results suggested 
that all analyte molecules entering the nanochannel were bound to the biotin modified sensor and 
when the first sensor was saturated, the reaction moved forward to the next sensor patch and the 
depletion zone progressively disappeared.  
 Under these experimental conditions, we could observe full collection of the analyte by 
the sensor, demonstrating the high capturing efficiency of our nanoslit biosensors [1]. 
Contrary to typical biosensing formats where an excess amount of target analytes flows over the 
sensor to abolish the diffusion-limited reactions over the entire sensing area, locally immobilized 
probe layer embedded in the nanoscale-confined slits boosts the analyte-capturing speed without any 
unnecessary overconsumption of the target sample. 
Real-time fluorescence detection of protein binding kinetics in nanofluidic biosensors 
 
 109 
 
 
Figure 4.4 Plot of normalized fluorescence intensities as a function of time at different areas on the 
sensor patch. The data were obtained from 10×10 pixels (4×4 µm total feature size). The reactions 
that occurred at the front edge of the sensor reached equilibrium earlier than those measured at the 
middle and the back edge.  
 
 This sensor configuration, exhibiting ultimately high adsorption efficiency, is beyond doubt 
beneficial when a low detection limit is sought, under the constraint of limited-volume of rare 
sample presented. For a kinetic analysis point of view, however, kinetic data obtained from this 
experiment could not be correctly interpreted using a simple Langmuir binding model. This was 
attributed to the fact that the rate at which the analyte was transported to the sensor surface was 
slower as compared to the rate of the reaction of streptavidin-biotin interaction with an extremely 
high affinity; fast on-rate. In these conditions, the binding reaction was limited by mass transport of 
the analyte to the sensor. 
 Accordingly, we modified the surface probe density of biotin to 1% in order to minimize 
the mass transport effects and to work under conditions where reaction-limited regime was 
dominant. Lowering the surface probe density not only reduces steric hindrance effects but also 
avoids use of a high injection flow rate, which in turn enhances consumption of biological materials.  
 We then carried out kinetic experiments on the 1% biotin modified nanoslit. To do so, ST-AF 
488 solutions ranging in concentration from 10 nM to 100 nM were introduced at a constant flow 
velocity of 155 µm/s and allowed to bind with the biotin immobilized on sensor surfaces. The 
fluorescence images were recorded in real-time to monitor the association process of this specific 
binding event. Due to the very high binding affinity and exceptionally long dissociation time of the 
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streptavidin-biotin recognition system, four different devices were employed to measure the binding 
rates of streptavidin at each concentration. The results and the analysis of kinetic data are presented 
in the kinetic constant quantification section.  
4.1.2 Mouse IgG/anti-mouse IgG interaction model 
4.1.2.1  Post-sealing surface modification 
Following chip bonding, we conducted the in-situ surface functionalization to immobilize receptor 
molecules on the gold surface embedded in the nanoslits (Figure 4.5). First, we immobilized 
streptavidin onto the biotinylated SAM layer (10% biotin content) by introducing a 100 nM solution 
of ST-AF 488 at a constant flow velocity of 200 µm/s for 15-20 min until the saturation was 
achieved. After rinsing with the buffer, we subsequently immobilized the biotinylated anti-mouse 
IgG receptor on the sensor via streptavidin-biotin bridges by injecting a 100 nM solution of 
biotinylated goat anti-mouse IgG for 15-20 min and rinsing with the buffer solution for 10 min.  
 
 
 
Figure 4.5 Schematic presentation of post-sealing functionalization in the nanofluidic device. 
 
 This second step of surface modification after chip encapsulation allowed the kinetic 
study of mouse IgG/anti-mouse IgG binding model. It should be noted that the 
immobilization level of the receptor was unknown in the case of the nanoslit experiments 
since there was no fluorescence detecting point during the receptor functionalization step. 
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Nevertheless, a high concentration of receptor solution and a long injection time (15-20 min) were 
used during the receptor immobilization to ensure its saturation level on the streptavidin modified 
SAMs. Subsequently, the sensor was exposed to sufficient buffer washing in order to remove any 
excess receptor molecules. 
4.1.2.2  Kinetic assay 
After the sensor was functionalized with the desired receptors (anti-mouse IgG), we introduced the 
fluorescently labeled analyte solutions to the sensor embedded nanoslits in order to perform kinetic 
assay (Figure 4.6). Briefly, various concentrations of Alexa Fluor-647 conjugated mouse anti-rabbit 
IgG (mIgG-AF 647) target analyte (diluted in 10 mM PBS buffer + 0.05% Tween-20) ranging from 
0.46 to 15 nM were sequentially delivered to the anti-mouse modified sensor chip under continuous 
flow velocity of 200 µm/s. The bound complex was allowed to dissociate from the surface receptor 
by injecting pure buffer solution with the same flow velocity by means of reversed flow manner.  
 
 
 
Figure 4.6 Schematic presentation of the labeled target injection into the nanoslit during association 
phase.  
 
 The fluorescence images were recorded in real-time to monitor the association and dissociation 
processes inside the nanoslit. The association time was set at the same duration for all target 
concentrations, enabling a global analysis using the BIAevaluation software package (which will be 
discussed in the following part). The sensor surface was regenerated after each cycle by injecting a 
solution of 10 mM glycine-HCl pH 2.0 for a short period of time and rinsing thoroughly with buffer 
solution before the next analyte injection. Additionally, we further examined the non-specific 
interaction of an irrelevant target analyte (Alexa Fluor-660 goat anti-rabbit IgG) to the anti-mouse 
immobilized nanoslit. As expected in that case, no significant increase in fluorescence intensity was 
observed on the gold sensor.   
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 Figure 4.7 depicts real-time fluorescence images during the association and dissociation phases 
of analyte/immobilized receptor reactions. The fluorescence signal on the gold sensor patch 
progressively brightened up consequent to the introduction of the target analyte while maintaining 
fluorescence background in the channels at a relatively low level (high signal-to-noise ratio). 
Subsequently, the signal on the sensor gradually decreased upon buffer injection due to the 
dissociation of fluorescently labeled analytes from the sensor surface.   
 
 
 
Figure 4.7 Images taken by time-lapse fluorescence microscopy during association and dissociation 
time courses of 1.87 nM Alexa Fluor-647 mouse anti-rabbit target analyte binding on the anti-mouse 
IgG modified nanoslit. The dissociation phase was obtained by means of reversed-buffer flow 
manner. 
 
 As a matter of fact, the results showed the feasibility of our nanoslit biosensors for monitoring 
kinetic reactions (association and dissociation phases) in real-time using a conventional fluorescence 
microscope and a reversed-buffer flow procedure, without buffer loading and extra washing steps. 
This capability thus underlined a novel feature of the device. In other words, the full kinetics 
(binding and dissociation) of IgG/anti-IgG interaction could be assessed without necessity of pause 
the sample flux to load fresh buffer or to apply an additional washing step in order to discard 
background fluorescence in the channel.  
Real-time fluorescence detection of protein binding kinetics in nanofluidic biosensors 
 
 113 
 Such feature specific to nanometer scale channels was literally achieved thanks to the notable 
reduction of the fluorescence background in nanoslits, caused by the fluorescent molecules flowing 
above the sensor area and within the channel. Contrary to nanoslits, excessive background noise, 
arising from a greater observation volume in a micrometer thick channel inherent in ordinary 
microfluidic based immunoassay formats, often conceals the real binding signal from the sensing 
element, leading to a comparatively low signal-to-noise ratio. 
 Moreover, because we operated in full target capture, all upcoming molecules injected onto the 
sensor were consumed by the reaction and a diffusing layer (depleted layer) formed at the sensor 
site. This depleted layer constituted a clear boundary between regions where the concentration of 
analyte dropped from maximum to zero. Thus, the liquid downstream the sensor was virtually 
analyte free and the dissociation study could be simply implemented after completion of the 
association phase, by reserving the fluid flow within the nanochannel instead of injecting the new 
buffer in the inlet. This resulted in a simplified operating protocol and reduced time of analysis.  
 The unique characteristic of slit-like nanochannels allowed us to directly probe the sensing 
surface, enabling low-noise real-time kinetic studies without need of using complicated and 
expensive setups, such as SPR, TIRFM, or QCM. Beyond that, our nanoslit is prominently simple in 
fluidic design as compared to the typical microfluidic immunoassays, in which individual flow 
channels and valves are commonly required to induce sequential reagent exchanges for multi-step 
immunoassays [2, 3].   
4.2 Fluorescence data analysis 
The fluorescence images were analyzed using ImageJ (NIH Image). Raw SIF ANDOR format 
images were converted to 16-bit grayscale images. All regions of interest (ROIs) consisted of 10×10 
pixels (4×4 µm total feature size) selections within the captured images. The average fluorescence 
intensity of each ROI was taken as the average pixel value for that region along with the associated 
standard deviations (variance).  
 The fluorescence signal from the sensor was background subtracted and normalized to relative 
fluorescence intensity (see equations below). This normalization provided the means to compare the 
experimental binding assays with the simulated results from the finite element model. Kinetic 
sensorgrams were then obtained by plotting the relative fluorescence intensity from the selected 
regions of interest as a function of time.  
𝐼 (a.u. fluorescence intensity)  = 𝐼𝑠 − 𝐼𝑏                                         (4.1) 
𝐼𝑠𝑝 (a.u. fluorescence intensity) = 𝐼 − 𝐼𝑛𝑝                                         (4.2) 
                                                  𝐼𝑠𝑝,𝑛𝑜𝑟(0,1) =
𝐼𝑠𝑝−𝐼𝑠𝑝,𝑚𝑖𝑛
𝐼𝑠𝑝,𝑚𝑎𝑥−𝐼𝑠𝑝,𝑚𝑖𝑛
                                                   (4.3)
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 𝐼 is the net fluorescence intensity on the receptor-immobilized sensor (combinations of 
specific and non-specific binding) 
 𝐼𝑠  is the fluorescence intensity on the sensor 
 𝐼𝑏  is the fluorescence intensity of the background obtained from adjacent region outside 
the sensor 
 𝐼𝑠𝑝 is the fluorescence intensity of specific binding on the sensor 
 𝐼𝑛𝑝 is the fluorescence intensity of non-specific binding on the sensor (without receptor 
immobilization) 
 𝐼𝑠𝑝,𝑛𝑜𝑟  is the normalized specific binding fluorescence intensity 
 𝐼𝑠𝑝,𝑚𝑖𝑛  and 𝐼𝑠𝑝,𝑚𝑎𝑥  are the minimum and maximum fluorescence intensity of specific 
binding on the sensor, respectively. 
4.3 Kinetic constant quantification 
Here, we present three kinetic constant quantification approaches used throughout this work to 
deduce kinetic constants of two biological systems from the kinetic data obtained in nanofluidic 
biosensors. The basic principle of each technique along with governing kinetic equations and the 
fitted kinetic curves are described. The aim of using different fitting approaches for kinetic 
constant determination was to demonstrate the robustness and the utility of our kinetic data 
acquired in the nanoslits, being applied to a variety of existing fitting methods. The 
consistency between each model could essentially confirm the reliability of the extracted 
binding constants. To demonstrate the feasibility of our approach as the proof of concept for 
kinetic analysis, we assumed a 1:1 interaction for both protein-receptor pairs for the simplicity of the 
model.  
4.3.1 Finite element method (FEM) 
Finite element method (FEM) was primarily utilized to describe the behavior of our biosensor 
system and to predict the binding kinetics. As nanofluidic-based immunoassays delivered the target 
analyte onto the receptor surface in a continuous-flowing manner, one should consider the 
convection-diffusion equations for mass transport of analyte species in combination with the 
binding reactions between analytes and the surface immobilized receptors in the nanoslits.  
4.3.1.1  Model construction 
We constructed a 2D model in COMSOL 4.2a Multiphysics software to simulate the heterogeneous 
immunoreaction in a rectangular nanochannel. The model of a biosensor was built as a two-
dimensional geometry due to a reasonable assumption of laminar flow (Reynolds number ≪ 1) with 
a parabolic flow profile, expecting a minimum variation in concentration along the channel width 
(channel width ≫ channel height). Furthermore, it was also relevant to consider only a segment of 
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nanochannel excluding microchannel networks for reaction modeling because the binding was not 
sensitive to mass transport along the microchannels.  
 Generally, there were three main coupled physical processes involved in the computational 
immunoassay: (i) convection or transport of the analytes along the nanochannel, (ii) diffusion of the 
analytes in all directions, in which the analytes were allowed to diffuse perpendicular to the flow 
direction and be captured by the probes on the active area, and (iii) surface reactions described by a 
typical analyte-ligand binding with simple first-order kinetics. Our computational model was 
relatively similar to previous studies [4, 5].  
 A schematic of the heterogeneous immunoreaction in a nanofluidic channel is shown in Figure 
4.8. The dimensions of nanochannel were 450 nm in depth (𝐻) and 500 µm in length (𝐿). A 50 µm 
long sensor patch immobilizing capture ligands was located at the bottom center of the 
nanochannel. The sensor patch was assumed to be a square. Inlet and outlet were defined as the 
opening of nanochannel on the left boundary and at the end of the geometry on the right boundary, 
respectively. The analyte with concentration of 𝐶0 was pumped to the channel from the left inlet 
with a fluid flow velocity (𝑈𝑚) and they were transported along the channel length in 𝑥 direction by 
a convective flow. They diffused freely with diffusion coefficient (𝐷) and were captured by the 
immobilized probe on the sensor with surface probe density (𝑏𝑚). Kinetics of biospecific 
interactions were defined by their association (𝑘𝑎) and dissociation rate constants (𝑘𝑑).  
 
 
 
Figure 4.8 A 2-D model used in the finite element simulation of heterogeneous immunoreaction in 
a nanofluidic channel.  
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 The transport of analyte concentration in the bulk solution was given by the differential equation 
of convection and diffusion as:  
𝜕𝐶0
𝜕𝑡
+ ∇. (−𝐷∇𝐶0 + 𝐶0?⃗? ) = 0,                                                    (4.4) 
where 𝐶0, 𝐷 and ?⃗?   were the bulk concentration, the diffusion coefficient of reacting species, and 
the flow velocity vector, respectively. The initial condition (𝑡 = 0) set the bulk concentration 𝐶0 = 0.  
For laminar flow field, the Navier-Stokes equation for an incompressible fluid with no slip boundary 
conditions was applied. At the surface reaction, the binding between flowing analyte molecules and 
the immobilized ligand was assumed to follow a simple 1-1 interaction (Langmuir binding model). 
The reactions were governed by the association and dissociation rate constants of the analyte-ligand 
recognition as: 
𝜕𝐶𝑠
𝜕𝑡
= 𝑘𝑎𝐶0(𝑏𝑚 − 𝐶𝑠) − 𝑘𝑑𝐶𝑠,                                                  (4.5) 
where 𝐶𝑠 was the surface concentration of bound complex on the sensor. 𝑏𝑚 was the total effective 
surface probe concentration (total number of active binding sites) and the term (𝑏𝑚 − 𝐶𝑠) was 
defined as the free binding sites on the sensor. At the beginning of the reaction (𝑡 = 0), the 
concentration of bound analyte was zero (𝐶𝑠 = 0). For bulk boundary conditions at the reaction 
surface, the rate of reaction was balanced with the flux of the analyte as: 
?⃗? . (−𝐷∇𝐶0 + 𝐶0?⃗? ) =  −𝑘𝑎𝐶0(𝑏𝑚 − 𝐶𝑠) + 𝑘𝑑𝐶𝑠,                                      (4.6) 
where ?⃗?  was the unit normal vector to the surface. The left boundary was defined as an inflow 
boundary where the concentration at the inlet was set as 𝐶0, which was the initial bulk analyte 
concentration. The boundary for the outlet was set as the outflow boundary condition where 
?⃗? . (−𝐷∇𝐶0 + 𝐶0?⃗? ) = ?⃗? . 𝐶0?⃗?  and all other boundaries (the channel walls), except the reaction 
boundary at the sensor, was set to no flux boundary conditions where 𝑛⃗⃗⃗  . (−𝐷∇𝐶0 + 𝐶0?⃗? ) = 0.  
 Triangular mesh elements were generated for the non-linear solver calculation with a grid size of 
1 µm for the entire domain and a finer mesh of 0.1 µm at the sensor surface (smaller than the pixel 
size for data analysis), providing an acceptable simulation time with high accuracy. Since the model 
dealt with a 2D phenomenon (convection-diffusion domain) coupled to another 1D phenomenon 
occurring only at the sensor surface, the weak form partial differential equation (PDE) module was 
added.  
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4.3.1.2  Simulation parameters 
The simulation parameters used in the numerical computation of both biological models are 
summarized in Table 4.1.  
 Fluid properties (density and viscosity) of water were assumed for both models. The flow 
velocities were estimated from the theoretical calculation. Due to gold being the sensor surface, the 
probe grafting density could not be directly investigated from the fluorescence calibration method 
due to quenching or/and enhancement effects on the metal surface. The effective surface probe 
densities (𝑏𝑚) were then obtained from the analogous SPR measurements. These surface densities 
should reasonably represent what was on our nanoslit surface since the same surface 
functionalization protocol was performed on the similar sensor surface. Ultimately, regular surfaces 
such as glass or silicon dioxide can be employed as a sensor surface to enable the characterization of 
the actual immobilized probe density on our sensor. The ranges of association rate constant 𝑘𝑎 and 
dissociation rate constant 𝑘𝑑 were obtained from the values in the literature [6-8]. 
Table 4.1 Simulation parameters used in COMSOL modeling for streptavidin-biotin and 
mouse IgG/anti-mouse binding models. 
Parameter Description Streptavidin-biotin model Mouse IgG/anti-mouse 
model 
 Fluid density 1000 kg/m
3 1000 kg/m3 
𝝁 Fluid dynamic viscosity 10-3 Pa.s 10-3 Pa.s 
𝑪𝟎 Analyte bulk concentration 
1.0×10-5  to 1.0×10-4  
mol/m3 
 
(10-100 nM) 
0.46×10-6 to 1.5×10-5  
mol/m3 
 
(0.46-15 nM) 
D Diffusion coefficient 7.4×10-11 m2/s [9, 10] 1×10-11 m2/s [11, 12] 
𝒃𝒎 Surface probe density 4×10
-8 mol/m2 1×10-9 mol/m2 
𝒌𝒂 Association rate constant 
1.5×102 to 1.4×103 
m3/mol.s 
 
(1.5×105 to 1.4×106 M-1s-1) 
6.0×102 to 9.0×102 
m3/mol.s 
 
(6.0×105 to 9.0×105 M-1s-1) 
𝒌𝒅 Dissociation rate constant 8×10
-7 to 8×10-5 s-1 5.0×10-4 to 7.0×10-4 s-1 
𝑼𝒎 Flow velocity 155 µm/s 200 µm/s 
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 To obtain a full sensorgram including the association and dissociation phases, the solution 
containing analyte species was switched to the buffer solution at a user-defined time via a step 
function module. Figure 4.9 depicts plots of concentration fields above the binding surface inside a 
nanochannel during the association (a) and dissociation (b) phases of 1.8 nM mouse IgG/anti-IgG 
interaction. The depletion region was developed above the sensor and it continued across the full 
channel depth showing a high capturing efficiency of the target analyte in solution by the surface- 
immobilized probes. 
 
Figure 4.9 The simulated results depicting concentration of target molecules in the channel (color 
map) upon association (a) and dissociation (b) phases of mouse IgG (1.8 nM)/anti-IgG interaction. 
The depletion region can be seen across the nanoslit thickness.    
 
 The time dependent solver was employed to evaluate the surface concentration of adsorbed 
species (𝐶𝑠) as a function of time for different variable parameters. From the simulation results, 𝐶𝑠 
was calculated by integrating on the sensing length of interest (4 µm) but not the entire sensor 
length. The simulated kinetic curves at various target concentrations are shown in Figure 4.10.  
 Conceptually, this finite element-based computational model assumed that the immunoreaction 
followed a simple Langmuir 1:1 binding model. Moreover, non-specific adsorption on the channel 
walls and other interfering effects, including heterogeneity of the surface and steric hindrance, were 
not taken into account.   
 To minimize time-consuming tasks of the simulation user, we wrote a program in COMSOL 4.2 
linked MATLAB software to automatically command COMSOL parametric simulations through 
MATLAB. Different variable on/off rate parameters were defined and the simulated results were 
exported to MATLAB for data post-processing.  
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Figure 4.10 A plot of surface concentration of adsorbed species (𝐶𝑠) as a function of time at 
different analyte concentrations obtained from the finite element computation model. The 
association rate of 8×105 M-1s-1 and the dissociation rate of 6×10-4 s-1 associated with IgG/anti-IgG 
interaction were used as input parameters for the simulation.   
  
  Surface concentrations of the bound complex (𝐶𝑠) were normalized and used as a key parameter 
to correlate predicted sensor responses with relative fluorescence intensities from the experimental 
immunoassay obtained in nanoslits. Kinetic constants were then determined from the best fit 
between the experimental kinetic curves and the simulated sensorgrams by means of coefficient of 
determination (𝑅2). 𝑅2 is related to the ratio between the residual sum of squares (𝑆𝑆𝑟𝑒𝑠) and the 
total sum of squares (𝑆𝑆𝑡𝑜𝑡), as defined by 𝑅
2 = 1 − (
𝑆𝑆𝑟𝑒𝑠
𝑆𝑆𝑡𝑜𝑡
). The model fits the experimental data 
well when 𝑅2 is closer to 1. 
 In order to assess the operation regime of our nanofluidic-embedded biosensor, it was vital to 
estimate the Peclet number (𝑃𝑒𝐻) with respect to the channel height, the sensor size, and the 
Damköhler number (𝐷𝑎). As mentioned in Chapter 2, 𝑃𝑒𝐻 relates the rate of convection to the rate 
of diffusion, 𝑃𝑒𝐻 =
𝑈𝑚𝐻
𝐷
, where 𝑈𝑚 is the mean flow velocity, 𝐻 is the channel height, and 𝐷 is the 
diffusion coefficient. The sensor size is expressed as 𝜆 = 𝐿𝑠/𝐻, where 𝐿𝑠 is the sensor length (the 
whole sensor length or the length of 10 pixels used in data analysis).  
 The Peclet numbers of 0.9 and 9 were found in the case of streptavidin and mouse IgG, 
respectively. These numbers being close to the unity suggested that the time for the analyte to 
diffuse across the entire channel height was comparable to the time for the analyte to be transported 
over the sensor via convection. Theoretically, all analyte molecules in the channel should have the 
possibility to interact with probes on the sensor surface, and the system approaches the limit of full 
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collection when 𝑃𝑒𝐻 < 0.5 [13]. This displayed high sensing performances with enhanced analyte 
binding efficiency and short response time of our nanoslit system.  
 For both models, the sensor size (𝜆) can be calculated as 111 for the whole sensor length (50 
µm) and 8.9 in the case of 10 pixels data collection (4 µm). These dimensionless numbers again 
described our sensor falling into a “full collection” regime at sufficiently low 𝑃𝑒𝐻 and large enough 
sensor (𝜆) according to the earlier work [14]. 
 On the other hand, the Damköhler number (𝐷𝑎) is expressed as the ratio between the rate of 
reaction and the rate of diffusion, 𝐷𝑎 =
𝑘𝑎𝑏𝑚𝐻
𝐷
, where 𝑘𝑎 is the association rate constant (1×10
6     
M-1s-1 for streptavidin-biotin binding [15] and 4×105 M-1s-1 for anti-mouse/mouse IgG interaction 
[16]), and 𝑏𝑚 is the immobilized probe density (4×10
-8 mol/m2 for streptavidin-biotin model and 
1×10-9 mol/m2 for mouse IgG/anti-mouse IgG model). The calculated 𝐷𝑎 being smaller than one 
(0.24 for streptavidin-biotin and 0.018 for anti-mouse/mouse IgG) indicated that the kinetic 
reactions fell into a reaction-limited regime and were not diffusion-limited. 
 According to the calculated dimensionless numbers, our pressure-driven flow-based nanoslit 
biosensor was not limited by mass transport of analyte to the sensor, which could significantly 
reduce the sensor performances in terms of sensitivity, response time, and kinetic data accuracy. 
Therefore, a simple analytical solution, namely “well-mixed model”, in which the model does not 
account for analyte mass transfer to the biosensor, can be eventually employed to elaborate the 
binding constants of the biorecognition pairs.  
4.3.2 Analytical solution (well-mixed model) 
Based on our sensing configuration in nanofluidic devices, the analyte solution continuously flowed 
over the sensor surface and as a result the analyte concentration above the binding surface was 
constantly replenished with the new analyte solution, thus in turn alleviating any mass transfer 
problems. The kinetics of analyte-surface probe binding can consequently be described by means of 
a simple analytical solution by solving the kinetic rate equations, called “well-mixed model” [17] or 
“rapid mixing model” in some studies [18].  
 This model assumes that the kinetics is reaction rate-limited. The free analyte concentration 
being transported to the sensor surface remains uniform in space and constant in time as the binding 
reaction does not lead to any significant depletion of the analye molecules in solution. Giving a 
simple biomolecular first-order interaction, the binding of analyte to the sensor surface with the 
association rate constant 𝑘𝑎 and dissociation rate constant 𝑘𝑑 is given as: 
𝐶𝑠 =
𝑘𝑎𝑏𝑚𝐶0(1 − 𝑒
−(𝑘𝑎𝐶0+𝑘𝑑)𝑡)
𝑘𝑎𝐶0 + 𝑘𝑑
                                                  (4.7) 
 As mentioned in Chapter 1, the apparent time constant is defined by 𝐾𝑎𝑝𝑝 = 𝑘𝑎𝐶0 + 𝑘𝑑 , which 
can be derived by fitting the association phase of kinetic curves to equation 4.7. The time course of 
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the binding reaction during the association process is typically measured for several analyte 
concentrations. For each concentration, this apparent time constant is determined. The association 
rate constant can be estimated from a slope of the plot between 𝐾𝑎𝑝𝑝 and analyte concentration 
whereas the dissociation rate constant is separately determined from a single exponential decay. 
  It is important to note that this analytical model is only valid when the analyte transport does 
not influence the kinetics of binding and dissociation to and from the surface receptors. 
Nevertheless, if the mass transport is dominant in kinetic reactions and cannot be neglected, the 
binding kinetics need to account for transport using a two-compartment model described in a 
number of studies [19, 20]. However, it is not in the scope of this work.  
4.3.3 BIAevaluation software package 
BIAevaluation is a stand-alone commercial software package from Biacore AB, developed for the 
evaluation of the sensorgram collected from kinetic measurements of analte-surface probe 
interactions. The software supports several means of data evaluation.  
 The global analysis module simultaneously fits an entire set of association and dissociation 
curves at various target concentrations with one set of rate constants, ideally improving the 
robustness of the fitting procedure. The software can also fit the association and dissociation phases 
separately or fit the transient kinetics with equilibrium analysis by means of Scatchard analysis. 
Another additional module is called global-local fit where an individual sensorgram containing 
association and dissociation phases is separately fit for each analyte concentration. As a result, 
various sets of on- and off-rates corresponding to each analyte concentration are achieved. In this 
study, we used global analysis and global-local to fit the experimental kinetic data.  
 Contrary to the aforementioned fitting approaches, such as FEM and well-mixed models, where 
1:1 interaction can solely be assumed for data fitting, different kinetic modules are available in the 
BIAevaluation software for more complex interactions. Mass transfer limitation can also be included 
in a 1:1 binding model. Other more complex fit models available in BIAevaluation software include 
bivalent analyte, heterogeneous analyte (competition reaction), heterogeneous ligand (parallel 
reaction), and conformation change. More detailed information concerning this software can be 
found in the handbook [21]. 
 The quality of the fit can be evaluated by various aspects. For example, the residuals are used to 
visualize the difference between the fitted curves and the experimental data. Practically, the residual 
values should not exceed 10% of the maximum response of the fitted curve whereas higher values 
indicate an inaccurate fitting. The chi2 (𝜒2) value is a statistical parameter that measures the 
closeness of the fit. A good fit should have 𝜒2 in the same order of the noise magnitude in RU 
(normally <2). Values of 𝜒2 below 10 are often acceptable [22]. Standard error (SE) values are 
considered satisfactory if their values are within one order of magnitude of the rate constants.  
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 The data evaluation using this commercial software strongly requires highly skilled personnel to 
reliably interpret the kinetic data therefore this exquisite operation was addressed to Martine 
Pugnière who has expertise in SPR at the Institute de Recherche en Cancérologie de Montpellier 
(IRCM).  
4.3.4 Results and discussion 
4.3.4.1  Streptavidin-biotin binding model 
The relative sensor responses of streptavidin-biotin binding at various analyte concentrations fitted 
with the simulation model are shown in Figure 4.11a. It was observed that the experimental data of 
streptavidin binding at low concentration (10-50 nM) fitted the simulation data well with 𝑅2 in a 
range of 0.99. Nevertheless, the high concentration of streptavidin (100 nM) showed a relatively 
poor fit with the simulation results (𝑅2 = 0.95). This might be due to several reasons prominent at 
high analyte concentration including steric hindrance, heterogeneity of the surface, non-specific 
binding, and deviation from a 1:1 interaction model. To determine the binding affinity based on 
computational model, the association and dissociation rate constants at each concentration were 
extracted from the best fit of the predicted binding curves to the experimental data. 
 The average association rate constant (𝑘𝑎) was determined to be 7.1×10
5 M-1s-1 and the 
dissociation rate constant (𝑘𝑑) of 8.0×10
-7 s-1 was observed from the best fit for all concentrations.  
Additionally, a lower off-rate was also applied to the simulation model, but there was no change in 
sensor responses due to an extremely tight bond between streptavidin and biotin. As a result, the 
dissociation constant (𝐾𝐷) for streptavidin-biotin interaction can be estimated as 𝐾𝐷  1.1×10
-12 M. 
It should be noted that the dissociation phase was not experimentally studied, thus the dissociation 
constant of streptavidin-biotin was not determined directly from the experiments but rather its 
theoretical value found in the literature was used as an input parameter in the simulation to find the 
best fit for the association data.   
 The kinetic curves of streptavidin-biotin interaction were also fitted to equation 4.7 in the well-
mixed model, obtaining the apparent time constant for each analyte concentration. A replot of 
apparent time constants as a function of streptavidin concentrations is demonstrated in Figure 
4.11b. The apparent time constant increased with increasing analyte concentration. The plot gave a 
linear fit with a slope of 0.0003 and 𝑅2 of 0.9903. A derived slope of 0.0003 nM-1s-1 resulted in the 
association rate constant 𝑘𝑎 of 3.0×10
5 M-1s-1. The derived value of 𝑘𝑎 was in good agreement with 
the value extracted from our finite element model. 
 
 
Real-time fluorescence detection of protein binding kinetics in nanofluidic biosensors 
 
 123 
 
 
Figure 4.11 (a) Real-time sensor responses of streptavidin-biotin interaction measured in 
biofunctional nanoslits. Kinetic curves obtained from each concentration were attributed to the 
measurement from the different nanofluidic device (the error bars: standard errors). The sensor 
responses were normalized to the relative fluorescence intensity and fitted with the computation 
model, based on finite element method, and the well-mixed model assuming a simple Langmuir 1:1 
interaction. The black (___) and (----) lines represent the predicted curves from the best fit of finite 
element simulation and the well-mixed model, respectively. Due to a long response time, the binding 
curve of the lowest concentration of streptavidin (10 nM) is also plotted separately in the inset 
figure. (b) Plot of apparent rate constants (𝐾𝑎𝑝𝑝) determined from non-linear least-squares fit as a 
function of streptavidin concentration. The plot showed a linear trend with 𝑅2 value of 0.9903. 
 
4.3.4.2 Mouse IgG/anti-mouse IgG interaction model 
The resulting kinetic data of mouse IgG/anti-mouse IgG interaction obtained in the nanoslits were 
fitted with three different approaches as described previously: i) our developed finite element model, 
ii) the well-mixed model, and iii) global-local fitting by BIAevalulation 4.1.1 software.  
 The simulated kinetic curves at various rate constants were generated in COMSOL Multiphysics 
software and compared to the experimental kinetic data for each analyte concentration. The other 
parameters, such as the flow velocity, the channel geometry, and the surface probe density, were 
kept the same. 
 For this biological model, the full experimental sensorgram containing association and 
dissociation phases for each analyte concentration were simultaneously fitted to the simulated 
curves. It can be observed that our simulated kinetic model described the immunoreaction assay in 
nanoslits well as each experimental binding curve was fitted accurately (𝑅2 in a range of 0.99) 
(Figure 4.12). The average association rate constant (𝑘𝑎) was determined to be 8.0×10
5 M-1s-1 and a 
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dissociation rate constant (𝑘𝑑) of 6.2×10
-4 s-1 was achieved, giving an equilibrium dissociation 
constant 𝐾𝐷 of 0.77 nM. 
 
 
Figure 4.12 Extraction of kinetic constants for mouse IgG/anti-mouse IgG interaction. The 
experimental data of various mouse IgG concentrations (0.46, 0.93, 1.87 and 3.75 nM) () were 
plotted with the simulated curves (___) obtained from finite element computation model at different 
association and dissociation rate constants. The surface probe density and flow velocity were kept 
the same in all cases. The extracted rate constants were determined from the best fit of the predicted 
binding curves to the experimental data by means of coefficient of determination. 
 
 The effects of various flow velocities ranging from 200 to 600 µm/s (associated with the 𝑃𝑒𝐻 
numbers in the range of 9-27) on the binding kinetics were also investigated. However, the sensor 
responses did not show any significant differences, indicating no mass transport limitation as 
expected. Consequently, the experimental data were fitted to the ‘well-mixed’ analytical model using 
the non-linear least squares method (Figure 4.13a) and the apparent time constant (𝐾𝑎𝑝𝑝) was 
plotted as a function of analyte concentration, giving a good fit with 𝑅2 of 0.9959 (Figure 4.13b). 
Desorption of bound analyte molecules from the surface receptor was estimated using a first-order 
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exponential decay. This resulted in the association and dissociation rate constants of 6.0×105 M-1s-1 
and 5.5×10-4 s-1, respectively with 𝐾𝐷  being 0.92 nM. 
 Finally, the kinetic data were examined using a global-local analysis from BIAevaluation 
software. Comparable to our simulation, the best fit was found using a Langmuir 1:1 binding model 
giving residual versus time plots lower than 0.1 (Figure 4.13a). The average values of 𝑘𝑎 and 𝑘𝑑 were 
determined to be 12×105 M-1s-1 with SE of 2.0×104 and 5.0×10-4 s-1 with SE of 1.8×10-5, 
respectively. The value of 𝐾𝐷   can be calculated to be 0.42 nM.  
  
 
 
Figure 4.13 (a) Real-time sensor responses of mouse IgG/anti-mouse IgG interaction measured in 
the biofunctional nanoslit at various analyte concentrations ranging from 0.46 nM to 15 nM (the 
error bars: standard errors). The data were normalized to relative fluorescence intensity and fitted 
with three different models: (1) finite element simulation, (2) well-mixed model, and (3) global-local 
fitting by BIAevaluation software package with associated residual plots, assuming a simple 
Langmuir 1:1 interaction. The black (___), (----) and (……) lines represent the predicted curves 
from the best fit of finite element simulation, the well-mixed model, and global-local fitting, 
respectively. (b) Plot of apparent rate constants (𝐾𝑎𝑝𝑝) as a function of mouse IgG concentrations, 
showing a linear trend with 𝑅2 value of 0.9959.   
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 To summarize, the extracted binding constants measured from three different fitting 
approaches were shown to be in good agreement, supporting the validity of our finite 
element model for good quantitative description of the kinetic data and, more importantly, 
demonstrating that our kinetic data obtained in nanoslit biosensors could readily applied to 
various fitting methodologies. 
4.4 SPR benchmarking 
To further evaluate the feasibility of our platform for use in kinetic studies of biomolecular 
interactions, using the same preparation coated-gold surface as nanoslits, an analogous real-time 
kinetic measurement of mouse IgG/anti-mouse IgG interaction was conducted using a surface 
plasmon resonance (SPR) setup. BIACORE was used to study the binding kinetics of only mouse 
IgG/anti-mouse IgG interaction. The streptavidin-biotin interaction was not addressed because of 
the limitation of the apparatus. All SPR measurements and kinetic curve fitting were performed by 
our colleagues, Martine Pugnière and Corinne Henriquet, at IRCM.  
4.4.1 SPR principle 
The surface plasmon resonance (SPR) biosensor is a surface-based analytical tool used in qualitative 
and quantitative characterization of reversible interactions between flowing reactant and its binding 
partner immobilized on the sensor surface. The optical detection principle of SPR relies on the 
excitation of surface plasmons in the metal film with a beam of p-polarized light, based on the total 
internal reflection (TIR) at a well-defined angle of incidence, called the resonance angle. This 
process occurs at a glass/thin metal film/dielectric interface. The evanescent wave generated by 
plasmons is useful for the measurement within  300 nm (distance of one wavelength) from the 
sensor surface as it decays exponentially with distance from the interface [23].  
 The resonance angle is sensitive to the change in refractive index (RI) of the sample adjacent to 
the metal film (within the evanescent field above the sensor surface). Any adsorption or desorption 
of macromolecules on the sensor surface induces changes in refractive index, leading to a 
measurable shift in the resonance angle (Figure 4.14). Reviews of SPR biosensor including 
fundamental theory, different SPR configurations and its applications can be found in the literature 
[24, 25].  
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Figure 4.14 A typical Kretschmann SPR biosensor setup. The sensor chip containing receptors 
immobilized on the thin gold film is placed onto the prism. The sample solution is supplied to the 
sensor through the flow channel via an integrated microfluidic system. SPR detects the change in 
refractive index occurring adjacent to the surface from the reflected light. This change is dependent 
on the mass of biomolecules bound to the surface. The angle shift can be monitored in real-time 
upon binding progress as a plot of time-course of resonance signals (from [26]).   
 
 SPR can detect changes in refractive index in the vicinity of the surface upon biomolecule 
binding in real-time and these changes are typically measured in resonance units (RU), in which 1 
RU corresponds to  1 pg protein/mm2 [27]. The sensorgram (a plot of sensor responses or 
resonance units versus time) contains an abundant variety of information on the investigated 
biomolecular interactions including affinity, kinetics, and binding thermodynamics. 
4.4.2 Kinetic measurement  
The pre-surface functionalization protocol analogous to nanoslits was performed on specific gold 
substrates manufactured by GE Healthcare (SIA Kit-Au) and the experiments were conducted on a 
BIACORE 3000 instrument (Figure 4.15). Experimental details of the sensor preparation and 
receptor immobilization can be found in the Appendix E.   
 In this kinetic experiment, we optimized the level of immobilized ligand (260 RU) in order to 
obtain binding data that fitted well with the 1:1 interaction model. At high probe density, the surface 
heterogeneity problem induced by steric crowding was more pronounced and there was a high 
degree of bivalent binding due to the nature of the used polyclonal anti-mouse receptors (VH+VL), 
mixtures of antibodies in which each of them could recognize various parts of the same analyte 
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molecule. By reducing the grafting density of the receptors on the sensor, we could alleviate these 
problems leading to more binding with 1:1 Langmuir behaviors.  
 
 
 
Figure 4.15 A BIACORE 3000 SPR biosensor apparatus used in kinetic studies (from [28]). 
 
 Despite the use of polyclonal antibodies due to several constraints in finding the compatible 
protocol for both SPR and nanoslits, biotinylated anti-mouse Fc gamma specific could be ideally 
exploited in future work to avoid bivalent binding. This receptor only recognizes the Fc part of an 
antibody. 
 To conduct kinetic measurements, a continuous flow of 50 µL/min was applied throughout the 
experiments. The association and dissociation time were 180 s and 400 s, respectively. Five different 
concentrations of Alexa Fluor-647 conjugated monoclonal mouse anti-rabbit IgG (mIgG-AF 647) 
ranging from 1.6 to 26 nM were exploited to obtain kinetic sensorgrams. The regeneration steps 
were performed with a solution of 25 mM HCl for 36 s at each cycle. Furthermore, a 32 µg/ml 
solution of Alexa Fluor-660 conjugated goat anti-rabbit IgG (irrelevant analyte) was injected at a 
flow rate of 50 µL/min to verify non-specific binding. However, no significant binding signal was 
observed. The kinetic curves were finally evaluated and fitted using the BIAevaluation 4.1.1 
software. 
 The binding data was complemented by two types of reference experiments [29]. A blank-
surface reference was primarily used to correct the bulk effect or artifacts of refractive index change 
from the sample solution and non-specific binding. A blank-buffer reference was performed on a 
ligand surface with a buffer injection prior to analyte injection in order to correct for baseline drift. 
Unwanted parts of the sensorgrams, such as regeneration step, were removed, the baseline of sensor 
responses was adjusted to zero, and all spikes induced by buffer change were deleted. Global 
analysis was utilized to identify the binding model and quantify kinetic parameters. 
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 Figure 4.16 depicts the sensorgrams containing kinetic information of protein binding events at 
various target concentrations ranging from 1.6 nM to 26 nM. The best fit for the entire data was 
found with a 1:1 Langmuir binding model without influence of mass transport, giving 𝑘𝑎 and 𝑘𝑑 of 
7.3×105 M-1s-1 with SE of 3.0×103 and 1.9×10-4 s-1 with SE of 8.0×10-6, respectively, with 𝐾𝐷  being 
0.26 nM. 
 It is important to mention that the kinetic sensorgrams measured at higher analyte 
concentrations (> 26 nM) tended to deviate from the 1:1 interaction, due to the heterogeneity of our 
model (use of polyclonal antibody as surface receptors). In general, analyte concentrations for 
kinetic experiments should be in the range of the affinity constants (𝐾𝐷) of the interaction pairs to 
estimate the accurate results. In this SPR experiment, high analyte concentrations were included and 
a 1:1 interaction was utilized in the model fit for demonstration purpose only. 
 
 
 
Figure 4.16 Sensorgrams of Alexa Fluor-647 conjugated mouse IgG/anti-mouse IgG binding 
kinetics obtained from analogous SPR measurements with the corresponding residual plot. Kinetic 
curves were fitted with a 1:1 global analysis model from BIAevaluation software package (black line).  
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4.4.3 Binding kinetics at varying probe grafting density 
Optimal density of the immobilized probes on the sensor surface is critical to obtaining high quality 
kinetic data. A low surface density of ligand is preferable for accurate measurement of the 
binding kinetics of an interaction. An excess of ligand density can result in the data artifacts due 
to crowding effects, steric hindrance or aggregation on the surface [30]. Moreover, extensive amount 
of ligand density promotes weak non-specific interactions at high analyte concentration, impacting 
the observed binding kinetics and the resulting binding rates [29]. Yet, not enough ligand density 
inherently reduces the sensitivity of the measurement.  
 A high dependence of the binding kinetics of DNA-protein interaction and DNA hybridization 
on the probe surface density has previously been reported [31, 32], wherein the high probe density 
film resulted in slow kinetics of the target capture. For kinetic assay, it is usually recommended to 
use the minimum amount of surface immobilized ligand that generates an acceptable measurable 
response. This probe loading level could be as high as 300RU [33].  
 One way to assess the reliability and the accuracy of the measured binding rate constants is to 
conduct kinetic experiments with varying surface receptor densities. In this way, one could reveal 
obscuring effects such as heterogeneity and mass transfer on the binding kinetics. With this aim, the 
binding kinetics of mIgG-AF 647/anti-mouse IgG on the SPR setup with different immobilized 
probe densities (80RU and 800 RU) was performed. The experimental conditions (analyte 
concentration ranges, flow rate, etc.) were similar to the one described in the Appendix E except 
the exposure time of the gold sensor surface to the receptor (biotin-anti-mouse) solution. The 
estimated binding constants were compared with those obtained with the medium surface loading 
density (260 RU) in the foregoing experiment.  
 The kinetic sensorgrams of mIgG-AF 647/anti-mouse IgG for various surface probe densities 
are demonstrated in Figure 4.17. The data were globally fitted with 1:1 binding interaction without 
influence of mass transport. In spite of the fact that the kinetic curves of the immobilized sensor at 
low probe density exhibited higher noise level (lower signal-to-noise ratio), both kinetic curves were 
fitted well to a Langmuir model. 
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Figure 4.17 Kinetic sensorgrams of Alexa Fluor-647 conjugated mouse IgG/anti-mouse IgG 
interaction obtained from the SPR experiments at different immobilized surface probe densities (a) 
80 RU and (b) 800 RU. The data were both fitted to a simple Langmuir 1:1 interaction using global 
analysis. The experiment with a probe density of 80 RU yielded 𝑘𝑎 of 8.6×10
5 M-1s-1 and 𝑘𝑑 of 
1.0×10-4 s-1 while 𝑘𝑎 of 6.1×10
5 M-1s-1 and 𝑘𝑑 of 1.8×10
-4 s-1 were obtained from the measurement 
with a probe density of 800 RU. 
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 The kinetic constants and 𝜒2 values of mouse IgG/anti-mouse IgG interaction obtained at 
varying surface probe densities are summarized in Table 4.2. The estimated maximum response 
(𝑅𝑚𝑎𝑥) decreased which was proportional to the reduced ligand densities. The extracted kinetic 
constants and the affinity constants were shown to be consistent for all three measurements.  
 Based on these results, kinetic experiments were not dependent on the variation of the surface 
ligand density under our investigated experimental conditions. As a result, there were no involved 
experimental artifacts associated with mass transport limitation and steric hindrance. It is important 
to mention that when the surface grafting level of anti-mouse receptors increased up to 1520 RU, 
the kinetic data did not fit well with a simple 1:1 binding but rather fitted a bivalent model.  
  Good consistency of kinetic constants between different kinetic experiments at various 
probe grafting densities confirmed the accuracy of the determined rate constants of the 
investigated mouse IgG/anti-mouse binding model.  
Table 4.2 Summary of kinetic parameters of Alexa Fluor-647 conjugated mouse IgG/anti-
mouse IgG interaction obtained from SPR experiments at varying surface probe densities. 
Probe density 
(RU) 
𝒌𝒂 (M
-1s-1) 𝒌𝒅 (s
-1) 𝑹𝒎𝒂𝒙 (RU)  𝑲𝑫 (nM) 𝝌
𝟐 
80 8.60.1×105 1.10.1×10-4 12.9 0.122 0.393 
260 7.30.1×105 1.90.1×10-4 34.1 0.262 0.790 
800 6.10.1×105 1.80.1×10-4 72.6 0.297 2.82 
 
4.4.4 Effect of fluorescence labeling on protein binding kinetics 
To be able to compare the performance of our fluorescence-based nanofluidic biosensors with the 
label-free SPR technique, it was desirable to investigate the influence of fluorescence labeling on 
kinetic behaviors of biorecognition events.   
 How the presence of the fluorescent label alters the protein binding kinetics is a golden 
question that needs to answer to biosensor communities prior to applying our new platform for 
biomolecular interaction analysis. Sun Y.S. et al. reported that the equilibrium dissociation constants 
of the streptavidin-peptide reaction and antibody-antigen reaction changed significantly when the 
analytes were labeled with a Cy3 dye [34]. Fluorescent labeling may alter the binding behavior of the 
biomolecules of interest to some extent; this effect arising from the charge of the fluorescent labels 
could be minimized by a proper design of fluorescence tags [35].  
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 The influence of labeling on the binding affinity and kinetics could be negligible in some 
applications, considering that kinetic measuring of protein-ligand interactions by means of 
fluorescence detection has been demonstrated by numerous studies [36-38]. When working with 
fluorescently tagged biomolecules, care must be taken to validate their use in any specific 
application. 
 Here, the binding kinetics of unconjugated mouse IgG and fluorescently labeled mouse IgG 
(mIgG-AF 647) with the anti-mouse receptor immobilized surfaces were investigated using SPR 
apparatus. Both experiments were carried out under similar conditions, providing the same surface 
probe density of 800 RU and the same range of analyte concentrations varying from 1.6 nM to 26 
nM.  
 Figure 4.18 demonstrates the sensorgrams globally fitted with a 1:1 interaction without influence 
of mass transport. Both kinetic curve profiles appeared similar. However, the estimated maximum 
response (𝑅𝑚𝑎𝑥) was decreased 17% in the case of labeled analytes. The extracted kinetic parameters 
are summarized in Table 4.3. The equilibrium dissociation constant (𝐾𝐷) of mouse IgG with the 
anti-mouse IgG immobilized surface decreased by a factor of 2 when mouse IgG was labeled, 
primarily from a decrease in the association rate constant (𝑘𝑎). On the other hand, labeling had a 
minor consequence on the dissociation constant (𝑘𝑑).   
 Even though fluorescence labeling was shown to have an impact on the protein binding kinetics 
to a small extent, this influence could be considered negligible as the binding affinity of both 
experiments was still in the same order of magnitude. This experiment was essential to 
demonstrate that our nanofluidic biosensor platform exploiting fluorescence detection for 
protein binding kinetics studies combined with attentive experimental designs was valid to 
produce reliable kinetic data, enabling accurate determination of rate constants.  
 Furthermore, the competitive assay format [39], where a non-labeled analyte (cold analyte) and a 
labeled analogue analyte (hot analyte) compete for the same binding site on the sensor surface, is 
another possibility to completely remove any ambiguity raised from labeling. According to this 
format, indirect kinetic information of unlabeled analytes can be acquired and the interactions 
remain label-free. Nevertheless, the compatibility of this competitive assay format with our 
nanofluidic biosensor system needs to be verified. 
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Figure 4.18 Association and dissociation curves of Alexa Fluor-647 conjugated mouse IgG (a) and 
unconjugated mouse IgG (b) against anti-mouse IgG immobilized surface at different mouse IgG 
concentrations obtained from SPR experiments.  
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Table 4.3 Summary of kinetic parameters of unlabeled and labeled mouse IgG/anti-mouse 
IgG interactions obtained from SPR experiments. 
Target analyte 𝒌𝒂 (M
-1s-1) 𝒌𝒅 (s
-1) 𝑹𝒎𝒂𝒙 (RU)  𝑲𝑫 (nM) 𝝌
𝟐 
unlabeled mouse 
IgG 120.1×10
5 1.90.1×10-4 112 0.157 2.69 
Alexa Fluor 647-
labeled mouse 
IgG 
6.80.1×105 2.40.1×10-4 92.9 0.347 0.766 
    
4.5 Comparison of our sensor performances with the literature and 
SPR setup 
To shed light on the validity of our nanoslit biosensor platform for accurate quantification of 
binding kinetics of biomolecular interactions, the estimated binding rate constants of the two 
selected biological models were compared with those obtained from SPR measurement or/and with 
the values available in the literature. Since the kinetic measurement of streptavidin-biotin interaction 
was not possible to perform in the SPR-based instrument, the comparison of kinetic constants was 
accomplished merely between our platform and the literature. From Table 4.4, our nanoslit-based 
biosensor platform yielded kinetic constants of the streptavidin-biotin interaction that were within 
the range of values reported in the literature which primarily are solution-based assays.  
Table 4.4 Comparison of kinetic constants for streptavidin-biotin binding between our 
biofunctional nanofluidic platform and the literature. 
Biosensor platform 
Streptavidin-biotin 
binding 
Association rate 
𝒌𝒂 (M
-1s-1) 
Dissociation rate 
𝒌𝒅 (s
-1) 
Equilibrium 
dissociation constant 
𝑲𝑫 (M) 
Nanoslit biosensor 
- FEM model 
- Well-mixed 
model 
 
7.12.5×105 
3.00.3×105 
 
8.01.2×10-7 
N/A 
 
1.1×10-12 
Literature 
[8, 15, 40, 41] 
 
 
4.4×105 – 4.5×107 
 
2.4×10-6 
 
 10-13 
 
 Generally, the extracted kinetic parameters (𝐾𝐷) from surface-based biosensors should reflect 
the one in solution. However, these constants derived from immobilized ligand-based sensors are 
strongly affected by the state of the ligand on the sensor surface [42]. This causes the determined 
kinetic parameters to deviate from the assay in solution. In addition, the on-rate for biotin-
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streptavidin binding reported in the literature can be used as approximate values only. The on-rate 
of 7×107 M-1s-1 reported by Green N.M., et al. [43] is actually based on avidin-biotin interaction 
rather than streptavidin-biotin interaction. 
 It has been reported by Srisa-Art et al. [40] that the binding rate constants could be slightly 
different depending on the applied conditions of streptavidin-biotin system. Interestingly, the results 
obtained from X-ray crystallography data also showed that not every collision between streptavidin 
and biotin gave a productive binding because the exposed surface area of the four biotin binding 
sites on a tetrameric streptavidin represented only 2% of the total exposed area of a tetrameric 
streptavidin. All these factors could lessen the association rate into the range of 106 M-1s-1 and it was 
likely that the binding rate could be varied by 1 order of magnitude.  
 The very low equilibrium dissociation constant (𝐾𝐷  10
-14 M) of streptavidin-biotin binding is 
actually attributed to the extremely low 𝑘𝑑 due to its very strong non-covalent interaction; although 
the association rate constant can be in the same range as that of other analyte-ligand couples. Based 
on a simple concept of our work to demonstrate the ability of our platform, the theoretical 
value of dissociation rate constant was considered sufficient for being used in the kinetic 
model fitting of the streptavidin-biotin association reaction using a simple 1:1 interaction.  
 Table 4.5 summarizes the extracted kinetic parameters of mouse IgG/anti-mouse IgG 
interaction obtained from our biofunctional nanofluidic platform with different fitting approaches 
compared with those obtained from SPR and the literature. For this model, our nanofluidic-based 
biosensor was able to perform the association and dissociation phases consecutively, and as a result 
both on- and off-rate constants were experimentally derived. However, the values from the literature 
could be used as a rough guide to advocate our platform due to dissimilar experimental factors 
among various techniques: for instance, surface immobilization chemistry, sensor surface, and 
detection schemes. The analogue SPR experiment seemed to be the most well-suited comparison in 
which the experimental conditions were the most matching to those performed in our nanofluidic 
biosensor platform. 
 The resulting kinetic parameters determined from our platform were in good agreement 
with the SPR measurement and within the range of values in the literature, thus extending 
the validity of our platform for effective quantification of kinetic constants of protein-protein 
interactions. Our platform therefore displayed advantageous characteristic for bio-sensing 
and related applications. 
 
 
 
Real-time fluorescence detection of protein binding kinetics in nanofluidic biosensors 
 
 137 
Table 4.5 Comparison of kinetic constants for IgG/anti-IgG binding obtained from our 
biofunctional nanofluidic platform, SPR, and the literature. 
Biosensor platform 
Mouse IgG/anti-
mouse binding 
Association rate 
𝒌𝒂 (M
-1s-1) 
Dissociation rate 
𝒌𝒅 (s
-1) 
Equilibrium 
dissociation constant 
𝑲𝑫 (M) 
Nanoslit biosensor 
- FEM model 
- Well-mixed  
- Global local fit 
 
8.01.2×105 
6.00.3×105 
120.2×105 
 
6.20.3×10-4 
5.50.4×10-4 
5.00.2×10-4 
 
7.7×10-10 
9.2×10-10 
4.2×10-10 
SPR 
(Global analysis) 
 
7.30.1×105 1.90.1×10-4 2.6×10
-10 
Literature 
[16, 44, 45] 
2.5×105 – 1.3×106 
 
3.0×10-4 1.5×10-10-1.2×10-9 
    
4.6 Range of operation and detection limit  
The accurate determination of association and dissociation constants for the two couples of ligands 
presented here (streptavidin/biotin and mouse IgG/anti-mouse IgG) illustrated the various affinity 
strengths that could be studied with our system. Affinity studies usually require kinetic plots for 
several analyte concentrations ranging from 1/10 to 10 𝐾𝐷 in order to adequately extract kinetics 
constants. 
 Limitation of our technique in terms of working concentrations is given by the fluorescence 
signal to noise ratio, e.g., the fluorescence emitted by the analytes specifically interacting at the sensor 
surface vs. the fluorescence due to the molecules flowing in the fluidic channel. In reaction-limited 
regime at equilibrium, for concentrated (𝐶0 ≫ 𝐾𝐷) and diluted solutions (𝐶0 ≪ 𝐾𝐷), where analyte 
molecules bind all or a fraction of the receptor molecules, we respectively have: 
𝑆
𝑁
=
𝑏𝑚
𝐻 × 𝐶0
                                                                       (4.8) 
 
𝑆
𝑁
=
𝑏𝑚
𝐻 × 𝐾𝐷
                                                                     (4.9) 
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 Thus, the sampling volume reduction during observation translates into a decreased background 
with a signal to noise ratio inversely proportional to the channel height. Using the grafted probe 
density, 𝑏𝑚, obtained with the presented surface functionalization protocol for IgG grafting, the 
previous equations demonstrate that high enough 𝑆/𝑁 can be obtained with sub-micrometer 
channels (𝐻 <1µm) even for low affinity molecules, e.g., we can expect 𝑆/𝑁 of 100 in 100 nm deep 
channels for 𝐾𝐷 of 0.1 µM. In fact, the pM to the sub-µM range of 𝐾𝐷 can be addressed with the 
presented technique, which concerns most molecules of interests regardless of the analyte size. 
 Furthermore, to ensure that our device can be employed not only for investigating binding 
kinetics of protein-ligand interactions but also as a highly sensitive and rapid on-chip immunosensor, 
limit of detection (LOD) is another performance characteristic for validation. LOD is defined as 
the lowest concentration of an analyte in a sample that can be reliably detected by an 
analytical method, but not necessarily quantified [46].  
 It was demonstrated recently that the detection limit of surface-based sensors depended on the 
true affinity of the probe to its target when working under concentration-limited regime (low affinity 
probe), whereas it was rather dependent on the effective surface probe density and the sample 
volume under interrogation under ligand-depletion regime (high affinity probe) [47]. In our 
experiment, we simply employed the visual evaluation to experimentally determine the 
detection limit of our biosensor system. The basic concept of such evaluation is to analyze the 
samples with known concentrations and the detection limit is determined by establishing the 
minimum concentration at which the analyte can be reliably detected [46].  
 To this end, different concentrations of Alexa Fluor-647 mouse IgG target solutions were 
introduced to the anti-mouse-modified nanoslits and the fluorescence intensities were recorded.  
Fluorescence time-lapse images were acquired with a 40 (N.A. 0.6) objective, an exposure time of 
0.5 s, and a gain of 150. Each image was recorded with an accumulation of 10 and binning factor 
2×2. It should be noted that the obtained LOD strongly depended on the sensitivity of the camera 
in which the imaging parameters were adjusted, which in our case was to optimize this LOD. The 
changes in fluorescence intensity on the sensor associated with their standard errors upon the 
introduction of different target analyte concentrations are plotted as a function of time in Figure 
4.19.    
 No significant increase in fluorescence intensity was observed when an analyte-free buffer 
solution was injected, while an introduction of 1 pM resulted in a significant increase in fluorescence 
intensity after 30 min (𝑆/𝑁 3). With a sample volume of 10.5 nL, a mole detection limit can 
be determined as 10 zeptomole. Notably, increasing the analyte concentration to 10 pM, our 
sensor could easily detect the binding response signal within 5 min. 
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Figure 4.19 Fluorescence intensity changes with time upon the introduction of different 
concentrations of Alexa Fluor-647 mouse anti-rabbit IgG (mIgG-AF 647) target ranging from 0 pM 
(analyte-free buffer) to 100 pM on the anti-mouse IgG immobilized nanoslit (the error bars: 
standard errors). 
 
 The value of the detection limit obtained from our system for mouse IgG sensing is significantly 
better (100 times) than, or comparable to, existing microfluidic immunosensing formats [48-50]. 
Furthermore, the total immunoassay time (including injection, immobilization and detection steps) 
required for mouse IgG detection, based on streptavidin-biotin linkage for anti-mouse IgG grafting, 
was found to be approximately 40 min in our study while the traditional enzyme-linked 
immunosorbent assay (ELISA) takes hours to days to complete the whole assay.  Therefore, our 
approach also demonstrated a fast and sensitive immunosensing platform for protein detection with 
low reagent consumption (1000 times less than SPR setup), indicating a great potential in clinical 
diagnosis.   
4.7 Repeatability assay 
Repeatability is defined as the capability of a single sensor used repeatedly for a series of 
measurements under the same circumstances and the same analyte concentration to produce an 
identical result. In this study, the repeatability of the sensor responses was assessed by measuring the 
association and dissociation phases of mouse IgG/anti-mouse IgG for three consecutive 
experiments carried out on the same device under similar working conditions.  
 Each cycle of the measurement consisted of the injection of a 5 nM solution of mIgG-AF 647 
for 720 s during the association phase, followed by the introduction of a pure buffer solution for 
750 s to dissociate the surface bound analyte under an applied flow velocity of 200 µm/s. The
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sensor surface was subsequently regenerated by a short injection (10 s) of 10 mM solution of 
glycine-HCl, pH 2 and rinsed with the buffer solution prior to performing the next measurement 
cycle.  
 The fluorescence data of three measurements were obtained from the same sensor area (10×10 
pixels) on the gold patch and the normalized signals were plotted as a function of time as 
demonstrated in Figure 4.20. According to the time-course, association and dissociation of mouse 
IgG/anti-mouse interaction, our sensor exhibited an outstanding repeatability with the relative 
standard deviation (RSD) of the response being 2.28% (𝒏 =3), RSD = 100×standard 
deviation/average. Likewise, the results essentially revealed the reversibility and the stability of the 
surface-immobilized probe for multiple detection of its target analyte after being subjected to several 
regeneration cycles, which was a crucial characteristic of the biosensing elements for repeated use in 
kinetic applications. In this case, small deviation of the fluorescence signal results from measurement 
errors between experiments. The reported standard errors which originate from noise sources and 
fitting errors are still within the reproducibility of the data.      
  
 
 
Figure 4.20 Repeatability of the nanoslit biosensor for multiple sensing of 5 nM Alexa Fluor-647 
mouse anti-rabbit IgG (mIgG-AF 647). The plots represent the normalized fluorescence intensity as 
a function of time for three repeated experiments during kinetic assays on the same device (the error 
bars: standard errors).  
Real-time fluorescence detection of protein binding kinetics in nanofluidic biosensors 
 
 141 
4.8 Conclusion 
In this chapter, we have presented the experimental validation of our nanofluidic biosensor platform 
for real-time monitoring of binding kinetics of two biological systems with different affinity ranges 
(streptavidin-biotin and IgG/anti-IgG interactions) as well as the effective determination of the 
binding constants using different fitting methodologies.  
 To this end, special attention has been paid in the first part to assess the bio-functionality of the 
biotin receptor-immobilized in the closed-fluidic chip, initially performed by open-top 
immobilization combined with the biocompatible bonding procedure. Based on the results obtained 
from fluorescence imaging under pressure driven flow scheme, we were able to confirm that the 
pre-immobilized probe molecules retained their bio-reactivity toward their streptavidin target, 
providing a high signal-to-noise ratio suitable for further kinetic assay. By conducting the first kinetic 
experiment of streptavidin-biotin binding, the importance of surface probe density on the binding 
kinetics has been revealed, in which a low surface density was required to produce more accurate 
kinetic data while a high surface density showed the eminent capturing efficiency of our nanoslit 
biosensors. 
 Remarkably, we have established for the first time the reversed-buffer flow technique to 
generate the full kinetic sensorgrams (association and dissociation curves), which was demonstrated 
by mouse IgG/anti-mouse interaction in the nanoslit. This has been a golden feature of our device 
since this method has been typically impractical for the classical microfluidic immunoassay formats. 
Additionally, a model based on finite element method coupled with MATLAB has been developed 
for data fitting and eventually extracting on-and off-rates of the investigated biorecognition pairs. 
 The dimensionless numbers (Peclet and Damköhler numbers) have been central to examine the 
operating conditions of our system. Using these calculated numbers and the experimental 
verification with varying flow velocities, we have confirmed that the kinetic reactions occurring in 
nanoslits were free of mass transport limitation. Moreover, the kinetic data were successfully fitted 
to the analytical model (well-mixed model) and local-fit from the commercial software 
(BIAevaluation). The results showed a good consistency of estimated binding constants among each 
method, thus giving great possibility in applying our kinetic data obtained in nanoslits to various 
fitting approaches. 
 To further validate our biosensor platform, we have carried out the analogous kinetic assay using 
the SPR apparatus and the extracted binding constants were compared with those obtained from 
nanoslit biosensors. Additionally, kinetic assays performed with varying surface probe densities and 
the evaluations of labeling on the binding kinetics have ensured the accuracy of the determined 
kinetic parameters. The extracted values from our system were in good agreement with SPR 
measurement and previously reported values in the literature. Hence, it has extended the validity of 
nanoslit biosensors in quantifying kinetics of biomolecular interactions along with a noteworthy 
detection limit of 1 pM or 10 zeptomole, and a good repeatability of the sensor response (RSD = 
2.28%) at analyte concentration of 5 nM. 
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Chapter 5     
                                                   
One-shot kinetic assay in nanofluidic sensors 
with integrated concentration gradient 
generator 
 
In this chapter, we propose a new generation of our cost-effective micro-/nanofluidic system with 
an on-chip gradient-generating system, which enables a one-shot parallel kinetic analysis. The basic 
concept is to exploit the real-time sensing function of our previously validated nanoslit platform for 
high-throughput kinetic measurements by simply embedding a microfluidic gradient generator into 
the device. To provide a basic comprehension of the concentration gradient generator, the 
underlying theoretical background regarding the transport phenomena in fluids and a literature 
survey of on-chip diluter systems are presented. The design and the fabrication process of the 
proposed device are discussed. Furthermore, we experimentally validate the gradient-generating 
device through fluorescence observations. Lastly, we carry out one-shot kinetic assays of mouse 
IgG/anti-mouse IgG interactions to demonstrate the effectiveness of our device.   
5.1 Introduction 
The need for cost-benefit and high-throughput kinetic measurements with rapid determination of 
the affinity and kinetics is essential in numerous biochemical applications. This is particularly 
paramount in an early stage of the drug discovery process, where large libraries of therapeutically 
relevant compounds are screened to select a new drug candidate against a particular disease, based 
on their interaction affinity and stability [1].  
 In traditional kinetic studies employing affinity-based biosensors, a single analyte concentration 
is introduced over the ligand surface and the signal response is measured in real-time. The sensor 
surface is then regenerated to prepare a free ligand surface for the next cycle of measurement. These 
processes are generally repeated until a full series of analyte concentrations is measured, which are 
termed as ‘multi-cycle kinetics” [2]. The kinetic constants can be determined by fitting the binding 
curves to an appropriate model. The classical kinetic approach has several drawbacks. In order to 
achieve robust kinetic data with meaningful kinetic information, 4-6 analyte concentrations are 
typically required. As a result the total analysis time associated with multiple reagent exchanges can 
reach hours to days and the materials consumed in the process is increased.  
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 Furthermore, the surface regeneration practically becomes a profound bottleneck for high-
throughput analyses [3]. The core objective of the surface regeneration is to completely remove the 
remaining bound analytes from the surface and to ensure that the same ligand binding sites are 
available for analyte binding in the next cycle. Various regeneration buffers or cocktails (usually 
involving harsh basic or acid solutions) are available to accomplish effective regenerated surfaces [4], 
however, extensive fine-tuning work is required to select a proper regeneration buffer without 
damaging the immobilized ligand. The regeneration step commonly succeeds when the ligand 
surfaces are easy to regenerate but it is not always the case for high affinity small molecule/protein 
interactions. In addition, the multiple regeneration cycles, resulting from non-optimized regeneration 
cocktails, could lead to the denaturation of the immobilized ligand and eventually cause a 
progressive loss in surface binding capacity. This ligand loss may induce a vast impact on the 
measured kinetic data due to a run-to-run variability.  
 In the case where it is unfeasible or impractical to regenerate the surface ligand, the “kinetic 
titration series” procedure has been established to obtain sufficient kinetic information without the 
need of surface regeneration between each analyte binding cycle [5], thus saving resources and 
increasing throughput. This approach generates a “saw-tooth” binding profile (Figure 5.1a) because 
of the remaining analyte molecules bound to the sensor at reaction equilibrium after each injection 
with increasing concentration. Despites these advantages, the kinetic titration method demands 
sequential injections of a series of analyte concentrations with precise timing, therefore, it cannot 
totally eliminate time-extensive processes as well as tedious and error-prone manual dilution tasks.  
  
 
 
Figure 5.1 (a) A saw-tooth binding profile obtained from the kinetic titration series (from [5] ). (b) 
Flow cell configurations of the ProteOn’s crisscrossing flow path system used for one-shot kinetics 
(adapted from [3, 6]). After the ligand immobilization, the chip is rotated 90º for analyte injection. 
 
One-shot kinetic assay in nanofluidic sensors with integrated concentration gradient generator 
 
 147 
  Alternative to kinetic titration series, the “parallel titration” can be performed to measure 
kinetics on multiple ligand surfaces with no requirements for regeneration, as demonstrated in a 
flow-through ProteOn XPR36 assay system [6] (Figure 5.1b). This parallel-processing biosensor 
offers the benefits for rapid kinetic screening in drug discovery as well as real-time protein 
interaction monitoring in arrays. While this technology permits a one-shot parallel kinetic analysis, it 
is limited by the complexity of the orthogonal orientation of the chip and sophisticated 
instrumentation relying on the SPR apparatus.  
 Miniaturized nano-/microfluidic systems have addressed some of the challenges associated with 
the present bioanalytical approaches because they enable rapid biochemical assays in a highly parallel 
manner. This is particularly true when the number of sensors can be easily scaled up without making 
the system more complex. This technology offers great promise for multiplexing analysis to study 
the biological functions and cellular behaviors with reduced reagent consumptions and assay costs 
[7]. Microfluidic dilutors, allowing stable and tunable concentration gradient generations of 
biomolecular species at cellular length scales with spatial and temporal control, could potentially be 
used in applications ranging from rapid screening assays [8] to cell-based experiments [9]. 
 As compared to the traditional macroscopic formats, microfluidic gradient generators offer 
higher gradient resolutions and lower time scale to transport specific dose gradients to the cells due 
to miniaturization of the geometrical dimensions. They also enable cell monitoring in a real-time 
fashion. While most studies have utilized microfluidic gradient generators to elucidate cellular 
signaling pathways induced by chemical stimuli gradients, chemotaxis [10, 11], and cell culture [12], 
there have been a few efforts to implement this technology for one-shot parallel kinetic 
assays.    
 In this chapter, we developed a simple and effective micro-/nanofluidic device, 
exploiting an outstanding capability of the microfluidic gradient generators combined with 
the distinctive characteristic of the nanoslits for parallel kinetic measurements. Our system 
enables a one-shot kinetic operation where concurrent interrogations of the biomolecular 
interactions with a full titration series of analyte can be handled in one single experiment using a 
single-analyte injection. Basically, different concentrations of analyte solutions generated from the 
microfluidic gradient dilutors can be injected over the sensors located on independent nanochannels, 
and the concentration-dependent binding can be gathered at once using a bench-top fluorescence 
microscope and a CCD camera.  
 The well-designed gradient generator offers a means to automatically generate reproducible, 
simply-quantified concentration gradients that are stable in space and time for biological studies. 
Furthermore, the gradient dilutors require only a small amount of the input solutions and avoid the 
use of macroscopic tools, e.g., human-operated pipettes, to perform the dilutions outside the device, 
thus eliminating inaccuracy from manual operation. Notably, avoiding the need of surface 
regeneration substantially shrinks the analysis time and abolishes labor intensive tasks. High-
throughput and low material consumption features make this technology very appealing for 
therapeutic and diagnostic applications. 
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 To employ the microfluidic gradient generation as a tool for biological studies, one should 
envisage the underlying transport phenomena allowing the generation of chemical gradients across 
the microfluidic networks (which will be discussed in the following section). This fundamental 
understanding surely reaps the benefit to design and realize an effective micro-/nanofluidic system 
for biomolecular analysis. 
5.2  Principle of transport phenomena in microfluidic gradient 
dilutors 
Due to small dimensions of most microchannels and associated relatively low flow rates, the 
Reynolds number (𝑅𝑒) is often less than 100, and thus the fluid transport exhibits laminar flow [13]. 
This leverages the ability to control the fluid flow precisely and to quantify the gradients in a high 
accuracy manner. As a consequence of this laminar regime and because of the absence of 
turbulences, different fluids flowing side-by-side do not mix unlike what is observed at the 
macroscale, e.g., in the case where we stir a cup of water added with sugar crystals to attain a 
homogeneous solution. Molecular mixing in a microchannel rather occurs purely through diffusion. 
5.2.1 Navier-Stokes equation 
Fluid flows within a microfluidic device are governed by the Navier-Stokes equation assuming 
incompressible and Newtonian fluids. This equation balances the rate of momentum change with 
the convective, pressure and viscous forces, and also other externally applied forces (electrical or 
gravitational forces) as: 
𝜌
𝜕?⃗? 
𝜕𝑡
= −𝜌?⃗? . ∇?⃗? − ∇𝑃 + 𝜇∇2?⃗? + 𝐹                                              (5.1) 
?⃗?  (m.s-1) is the velocity field which is defined as the velocity of the fluid at a given point in space and 
time, 𝜌 is the fluid density (kg/m3), 𝜇 is the fluid viscosity (Pa.s), ∇𝑃 is the pressure gradient (Pa), 
and 𝐹  is the external force. In the case of our gradient dilutor solely based on pressure-driven flow, 
the term 𝐹  can be omitted from the equation. The equation can be further simplified by considering 
the microfluidic device with a low 𝑅𝑒 and a steady-state flow system, 𝜕?⃗? /𝜕𝑡 = 0, and the Navier-
Stokes equation now becomes the Steady Stokes equation as: 
∇𝑃 =  𝜇∇2?⃗?                                                                        (5.2) 
 With a simplified version of the Stokes equation, we can correlate the fluid flow velocity 
with the pressure gradients across the channel lengths (pressure differences between the 
channel inlet and outlet), by solving mass transport problems by means of numerical computation or 
even analytical solution with given appropriate assumptions.   
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5.2.2 Hydraulic analogy of Ohm’s law 
An analytical solution of the mass transport equation, assuming an unidirectional pressure-driven 
flow with no-slip boundary conditions and applying a finite Fourier transformation, results in a 
linear relationship between the pressure difference (∆𝑃, Pa) and the volumetric flow rate (𝑄, m3.s-1), 
which is termed as the Hagen-Poiseuille’s law. 
∆𝑃 = 𝑄𝑅𝐻                                                                        (5.3) 
RH is the hydraulic resistance of a rectangular microchannel [14] (Pa.s.m
-3). In the case of a high 
aspect ratio channel (i.e., 𝐻/𝑊 ≪1), the hydraulic resistance can be approximated as: 
𝑅𝐻 =
12𝜇𝐿
𝑤𝐻3
,                                                                       (5.4) 
where 𝐿 is the channel length, 𝑊 is the channel width, and 𝐻 is the channel height. The hydraulic 
resistance and the Hagen-Poiseuille’s equation are analogous to the electric resistance and the Ohm’s 
law (𝑉 = 𝐼𝑅), wherein 𝑉 is the voltage (V) across the conducting material, 𝐼 is the flowing current 
(A), and 𝑅 is the resistance of the resistor (). This analogy is valid when the flow is incompressible, 
viscous and laminar. The analogy of the electric and the hydraulic circuits allows us to design 
predictive pressure-driven microfluidic networks, particularly in the complete-mixing gradient 
generating devices (e.g., Christmas trees), prior to fabrication without using a specialized 
computational fluid dynamic (CFD) model [15].  
5.2.3 Convective-diffusive transport 
The propagation of concentration gradients inside a rectangular microfluidic channel occurs through 
mass convection and/or diffusion given as: 
𝜕𝐶0
𝜕𝑡
+ ∇. (?⃗? 𝐶0) = 𝐷∇
2𝐶0 + 𝑅,                                                       (5.5) 
where 𝐶0 is the concentration of a solute, 𝐷 is the diffusion coefficient of that solute within a 
solvent, and 𝑅 is the local reaction term. According to the conservation of mass, the convection-
diffusion equation for solute species balances the mass accumulation rate and the convective flux 
(∇. (?⃗? 𝐶0)) with the diffusive flux (𝐷∇
2𝐶0) and the rate of species generation (𝑅).  
 The velocity vector, ?⃗? , from the convective term is deduced from the abovementioned Navier-
Stokes equation. The net rate of specie reaction, 𝑅, is omitted from the mass transport equation of 
gradient generators since the chemical reactivity between the solute and the solvent is considered 
negligible. This is true when the biological solutes (e.g., stimuli, organic compounds, and fluorescent 
dye) have no chemical reaction with their diluents (mostly aqueous based solutions) in a gradient 
formation.  
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 For laminar flow in a straight microchannel with rectangular cross-section (Figure 5.2), the only 
inherent mixing mechanism is due to molecular diffusion.  
 
 
Figure 5.2 Schematic diagram of a rectangular channel with fluid flow along the channel length. 
 
 The fluid transport can be driven by the gradient of concentrations from a high 
concentration region to a lower concentration region as described by the Fick’s first law. In 
a steady state, the diffusion of molecular species is characterized by the diffusion coefficient (𝐷) as: 
𝐽 =  −𝐷
𝜕𝐶0
𝜕𝑥
,                                                                     (5.6)  
where 𝐽 is the diffusive flux or the rate of transfer per unit area of a section, and 
𝜕𝐶0
𝜕𝑥
 is the 
concentration gradient with respect to 𝑥 direction. On the other hand, Fick’s second law predicts 
how mass transport via diffusion changes with time in a non-steady state process. After an 
infinite time (𝑡 → ∞), the solute molecules tend to move leading to homogenization of the 
concentration in a domain.  
𝜕𝐶0
𝜕𝑡
= 𝐷
𝜕2𝐶0
𝜕𝑥2
                                                                     (5.7) 
 The solution of the Fick’s second law depends on the initial and boundary conditions. In the 
case of a semi-infinite planar diffusion, where two semi-infinite media (i.e., a solution with 
concentration of 𝐶0 and pure water (𝐶0 = 0)) are brought into contact either from removing a 
separation wall or from a parallel injection, the solution of this diffusion problem is written in the 
form of the error function as [16]:  
𝐶(𝑥, 𝑡) =  
1
2
𝐶0𝑒𝑟𝑓𝑐
𝑥
2√𝐷𝑡
,                                                        (5.8) 
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where erfc is the complementary error function,  erfc 𝑧= 1-erf 𝑧. This form relates the concentration 
(𝐶) at any position (𝑥) and time (𝑡) to the initial concentration (𝐶0), and the diffusion coefficient.  
 To describe the mass transport characteristic in a gradient generator, the Peclet number 
(𝑷𝒆𝑯) is primarily employed as an indication of the relative importance of convection to 
diffusion. It simplifies the convection-diffusion equation in the case of the pure convective-based 
or pure diffusive-based transport in which the problems can be simply solved analytically [17]. 
Nevertheless, in the complex problems where convective and diffusive transports are comparable, 
the numerical methods are applied to predict the velocity and the concentration gradient formed 
within microfluidic dilutors [18]. 
5.2.4 Mixing length in gradient generators 
The simplest case of fluid mixing in a microfluidic gradient generator is a T-sensor, wherein two 
streams with different specie concentrations flow alongside each other down a channel. In the T-
sensor, both convective and diffusive transports take place in the microfluidic channel, however, the 
convective mixing (axial diffusion) is normally considered negligible as compared to the traverse 
diffusive mixing. This is usually true for practical concentration gradient generators that exhibit a 
Peclet number greater than 1. In other words, the molecular species are transported along the 
channel length via convection whereas the molecular diffusion occurs across the channel width 
(Figure 5.3).  
 
 
 
Figure 5.3 Schematic diagram of a T-sensor microfluidic channel where the diffusion of molecules 
between two streams flowing side by side occurs across the channel width. 
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 Based on the relationship between the random walk distance, diffusivity and residence time, 
𝑥 = √𝐷𝑡 [19], the mixing time required for a fully diffusive mixing (the characteristic diffusion 
time) can be written as 𝑡 =
𝑊2
𝐷
, giving that the diffusion distance is about the same as the channel 
width (𝑥 ≈ 𝑊) [13]. The minimum length (𝑳𝒎) of a mixing channel required to achieve a 
complete mixing via diffusion, producing a fully homogenous solution can thus be estimated as:  
𝐿𝑚 = 𝑈𝑚𝑡 =
𝑈𝑚𝑊
2
𝐷
,                                                            (5.9) 
where 𝑈𝑚 is the area-averaged velocity in the mixing channel. The mixing length thus depends on 
the average flow velocity in the channel, the channel width, and the diffusivity of molecular species. 
In other words, the Peclet number dictates the length of the mixing channel needed for the 
complete mixing. At a high 𝑃𝑒𝐻 number, a longer channel length is required to homogenize two 
fluid streams due to a low degree of diffusive mixing.  
 The estimation of this mixing length is necessary to have an idea of the microchannel length that 
is suitable for the gradient generation with desired concentration profiles. In our case, we used this 
length as an indicative limit number, particularly, because we took advantage of the laminar 
diffusion-based partial mixing to generate traverse concentration gradients. This means that the 
length of our microfluidic channel should not exceed the minimum length required for the complete 
diffusional mixing (𝐿𝑚) or else there would be no concentration gradients at the output. 
5.3 Gradient generator achievements up-to-date 
Microfluidic concentration gradient generators offer a great promise in the study of cell biology 
including observation of the cell migration and proliferation responses to chemical gradients and 
cancer metastasis. The traditional in vitro techniques (Figure 5.4) including pipetting-format [20], 
Boyden chamber [21], and gel [22], restrict the generation of user-defined gradients with 
spatiotemporal distribution control, thus do not necessary elicit effective cell responses. 
Furthermore, these conventional assays suffer from the gradient instability arising from the 
accumulation/depletion in the reservoirs.  
  Till now, numerous configurations of microfluidic devices have been developed for generating 
chemical gradients that are predictable and reproducible with the ability to directly visualize the 
biological behaviors within cellular-mimic gradient environments. These appealing characteristics of 
the microfluidic devices enhance quantitative elucidation and reproducibility of biological 
experiments. In general, the microfluidic gradient generators can be classified into two main 
categories: diffusive-based and laminar flow-based devices.  
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Figure 5.4 (a) Micropipette gradient generation where the signaling molecules are loaded inside a 
micropipette and are pneumatically injected to the cell creating a gradient. (b) Boyden chamber used 
to form a gradient across the membrane where cells are seeded (from [23]).   
 
 Diffusive-based generators create a static concentration gradient environment relying solely on 
the molecular diffusion. This type of system is amenable for the cellular behavior analysis because 
there is no sheer stress induced by the presence of the flow field to the biological cells situated at the 
bottom of the channels [24]. Diffusion-based gradient generators are inexpensive due to no 
continuous fluid replenishment. This could be beneficial for certain experiments where expensive 
reagents or limited reagent volume are involved. The limitations of this system include the difficulty 
to control the shape of the generated concentration gradients as well as a long establishing time and 
complicated fabrication processes [25].  
 On the other end of the spectrum, laminar flow-based gradient generators allow a rapid 
dynamic control of more complex concentration gradient profiles by tuning the flow rates and the 
geometry of the flow channels [26]. They exploit the partial molecular diffusion in the presence of a 
laminar flow to generate spatially and temporally stable concentration gradients over time. Despite 
all these attractive features, the continuous flow is not suitable for the free-moving cell experiments 
because cells exposed to the shear flow tend to change their motility [27].  
 In the following part, the state-of-the-art microfluidic gradient generators, based on diffusive- 
and convective-based devices, will be reviewed together with their applications for kinetic assays. In 
our work, we chose the laminar flow-based gradient generator to integrate into the 
nanofluidic biosensors as it was easy to implement and fabricate. Furthermore, it also allowed a 
better control of the gradient profiles. 
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5.3.1 Diffusion-based gradient generators 
The concentration gradients produced by this approach are built-up by purely molecular diffusion 
between a high concentration source and a low concentration sink (Figure 5.5). The underlying 
principle is to prevent the convective fluid flow, by employing microchannels with a high fluidic 
resistance, porous membranes, or hydrogels, while permitting solely diffusion phenomenon to 
establish the gradient of chemical concentrations.   
 Saadi et al. [28] have designed a one-dimensional diffusion-based gradient generator in a ladder-
like microchannel to leverage on the cell migration in flow-free channels. This device was composed 
of two parallel microchannels acting as the source and the sink which were connected by an array of 
microgrooves (shallower channels). Due to a high resistance of the microgrooves, the bulk fluid flow 
was restrained in the main channels while the diffusion was the prevalent transport in the 
microgrooves where the gradients were formed. In this configuration, a symmetric design of the 
ladder chamber was indispensable to provide sustained chemical gradients by a pressure balance.  
 
 
Figure 5.5 (a) A ladder-like microchannel, employing a high fluidic resistance of microgrooves to 
establish the concentration gradients via pure diffusion, used for neutrophil chemotaxis studies 
(from [28]). (b) A simple flow-free gradient generator composed of reservoirs of a source and a sink 
isolated from the gradient region by high fluidic resistance porous membranes (from [29]). (c) A 2D 
circular chamber generating the gradients by the pressure balance among three access source and 
sink ports (from [30]).  
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  Atencia and co-workers [30] have developed a more rapid means to generate concentration 
gradients on a 2D circular chamber through a balance of the pressure between three access ports, 
serving as sources and sinks. By periodic switching of these access ports, the concentration gradient 
in the chamber was formed and established in a time scale of 15 min. Furthermore, hydrogels acting 
as a convective flow barrier can be incorporated into the microchannel to generate gradient 
hydrogels. Hydrogel scaffolds containing extracellular matrix (ECM) proteins recreate real tissues-
like environments in vitro and they are ideal for investigation of the cell migration and cell culture in 
response to specific chemical gradients, such as growth factors [31] (Figure 5.6).   
 
Figure 5.6 A schematic of a microfluidic device used in cell migration assays under a gradient of 
growth factor. This microfluidic cell composed of three flow microchannels separated by collagen 
hydrogel scaffolds between each other. The cells were cultured in the center and the stimuli agents 
in the condition channels diffused toward the cell channel, forming a gradient (adapted from [31]).    
   
 The major drawback of the flow-free gradient generation techniques is the lack of a 
dynamic control of concentration profiles. To unravel this problem, many attempts to integrate 
active valves into diffusion-based gradient devices have been done, enabling more precise 
manipulation of the chemical gradient distribution [32, 33]. This approach also includes 
“microfluidic multi-injector”, exploiting the on-chip valves for pulsatile solution release with an 
exact time and volume into the chamber for a temporal control of the gradient distributions. 
5.3.2 Laminar flow-based gradient generators 
Unlike diffusion-based devices, flow-based gradient generators provide more tunable and wider 
ranges of concentration profiles including linear, logarithm and superimposed profiles. The desirable 
gradients stabilize faster as compared to the diffusion-based systems and they can be maintained 
over long assay periods as soon as the convective flow is constantly preserved. The flow-based 
gradient generators rely on fluid streams, composed of different chemical species or concentrations 
that are brought into contact in a laminar flow fashion within a microchannel. The chemical species 
are allowed to diffuse across the interface as they flow downstream. The laminar flow-based devices 
can be divided into two sub-categories: a complete-mixing and a partial mixing. 
5.3 Gradient generator achievements up-to-date 
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 The most common design of the complete-mixing gradient generators with a pre-mixer 
microchannel network was first introduced as the “Christmas tree” by Jeon et al. [34]. Different 
solutions are introduced at the inlet streams on top of a pyramid network and the fluid streams are 
repeatedly split and mixed through serpentine networks. They are then recombined to produce 
multiple streams of concentrations with different portions of the chemical species from the input. 
At the end of the network, theses streams are merged into a single wide microchannel to yield the 
desired gradient distributions.  
 Based on this basic Christmas tree design, several gradient generators were developed to realize 
more complex concentration shapes ranging from linear [35], polynomial [34], and periodic [36] 
(Figure 5.7a). This was done by tuning the configuration of the input ports and varying the input 
flow rates. These types of microfluidic devices have been widely used in cellular studies including 
chemotaxis [37, 38], drug screening [39], and on-chip sensors such as immunoassays [40]. Campbell 
and Groisman [41] have improved the aforementioned splitting-and mixing architectures by 
modifying the length of the vertical serpentine channels (hence the flow resistances) to make more 
well-controlled mixing ratios and reduce the network stages (Figure 5.7b). This allowed the 
generation of monotonic concentration profiles with diverse shapes such as exponential and double-
parabolic profiles while keeping the network relatively compact. 
 
 
 
Figure 5.7 (a) A photograph of the microfluidic device used for gradient generations, based on 
splitting-mixing networks [36]. (b) A micrograph of the microfluidic platform for the generation of 
an exponential concentration gradient profile. (c) A fluorescence image showing FITC distributions 
in the test channel. (d) A plot of the concentration of FITC as a function of the position across the 
test channel showing a concentration exponential profile (adapted from [41]).  
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 Another attractive microfluidic gradient generator involves an on-chip serial dilution, employing 
stepwise dilutions to reduce the concentration of the sample through successive dilutions in the N 
cascaded-mixing stages (Figure 5.8a). In this manner, stepwise linear, 2-fold, and Gaussian 
concentration profiles can be achieved [42]. This method is capable of generating arbitrary output 
flow rate gradients, which is conceivably appropriate for some specific applications such as flow rate 
dependent assays. However, this network requires long diffusive mixing channels for the complete 
mixing within a low flow rate scheme, thus limiting miniaturization of the operative devices.  
 
 
Figure 5.8 (a) An image of the fabricated serial dilution device comprised of N cascaded mixing 
stages for monotonic and arbitrary gradient generations. (b) A fluorescence image of the FITC 
distribution. (c) The intensity profiles for a Gaussian concentration profile (from [42]). (d) The serial 
network comprised of different cross-sectional channels (from [43]).  
 
 An alternative and more compact on-chip serial dilution was demonstrated by Sugiura et al. [43] 
(Figure 5.8d). The thin resistance microchannels and thick diffusion-mixing microchannels, allowing 
a long residence time for sufficient mixing, were utilized in their configurations. This method 
provided a wide range of concentrations spanning up to 6 orders of magnitude, which could be 
beneficial for dose-response evaluations as well as high-throughput drug screening and optimization. 
The applications of the serial microfluidic networks are prevalent ranging from SERS-based 
immunoassays [44] to cell perfusion experiments [45].   
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 The above complete-mixing based microfluidic generators are often bulky and prone to leakage 
and clogging with a large accumulated dilution error from their previous dilution stages. 
Furthermore, the performances of gradient generators are dictated by a highly precise flow control 
from the external pumps as the desired concentration profiles are extremely sensitive to the 
volumetric flow rate ratio between buffer and sample solutions at the inlets.  
 While the complete-mixing is desirable for most bio-related applications, partial-mixing based 
gradient generators such as Y-type or T-type networks are simpler in design and fabrication, 
enabling a steady-state concentration gradient formation perpendicular to the flow field (Figure 5.9). 
The parallel-flow T-shape configuration consists of two input channels that merge into a single main 
mixing channel and multiple outputs, depending on the user-defined applications. The diffusion 
magnitude is strongly dependent on the residence time between the adjacent input streams, which is 
controlled by regulating the input flow rates and the geometry of the mixing channel. On the other 
hand, the shape of the gradient can be dynamically modulated by the choice of branch flow rates 
and the solution concentrations.  
 
 
Figure 5.9 (a) A Y-shape laminar microfluidic diffusion dilutor comprising of two analyte inputs 
splits into an array of parallel channels (from [46]). (b) A T-type microfluidic network used in the 
chemotaxis assays (from [47]).  
 
 Despite the simplicity of the T-shape dilutor, the obtained concentration profile across the 
channel only exhibits a characteristic sigmoidal shape whose steepness depends on the flow speed 
and the position along the channel. The T-type microfluidic networks (more commonly known as T-
sensor) have been previously utilized to perform biological assays such as enzyme kinetics [48] as 
well as to determine the chemical concentration and the molecular diffusion coefficient of 
bimolecular species [49].   
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5.3.3 Gradient generators for kinetic analysis 
The most advanced optical biosensor technologies, such as SPR, can only interrogate a single analyte 
stream in a single experiment, thus limiting the number of binding interactions being studied. To 
address this limitation, Ouellet et al. [50] have developed a SPR imaging format, combining 264 
element-addressable chambers (10 µm deep) with a microfluidic dilution network, in order to 
simultaneously probe multiple binding events with up to 6 different analyte concentrations in one 
single experiment (Figure 5.10). The developed dilution network accommodated the chaotic 
advection micromixers which were adapted from the previous work [51], leading to the generation 
of the concentration gradients with a dynamic concentration range of 32. They demonstrated the 
utility of this device to acquire the kinetic information of an anti-IgG/thrombin binding in a parallel 
fashion.  
 
Figure 5.10 (a) A design of the microfluidic device consisting of 264 separate addressable chambers 
isolated by microvalves and combined with a dilution network. (b) SPRi sensorgrams at varying 
analyte concentrations created by the dilution network (from [50]).   
  
 While this technology facilitates high-throughput and parallel binding kinetic measurements in a 
single-experiment, the use of chaotic advection micromixers is laborious in layout and fabrication. In 
addition, it necessitates a high level of washing loops, microvalve and pump systems, which in turn 
renders the operation protocol expensive and complicated to be implemented. Another example of a 
microfluidic device exploiting concentration gradient generations and based on droplet formation 
and laminar diffusive mixing, was reported by Bui et al. [52]. Despite its application for in-situ 
enzyme kinetic measurements, this device merely allowed the generation of a linear concentration 
profile, thus limiting its usage for relevant kinetic studies. 
5.4 Requirement of microfluidic gradient generator-incorporated nanoslit system for kinetic study 
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 From latest achievements of microfluidic gradient generators for kinetic analysis stated above, 
there is still plenty of room for improvement and eventually development of a more simple and 
effective device that allows reaction kinetics of multiple binding events to be probed in a parallel 
fashion. In this framework, we propose to incorporate a concentration gradient generator to the 
biofunctional nanoslits for one-shot parallel kinetic studies. The imperative requirements needed for 
the device to generate meaningful kinetic data and the concept of our approach will be presented in 
the following section.  
5.4 Requirement of microfluidic gradient generator-incorporated 
nanoslit system for kinetic study 
The main requirements of an on-chip dilutor nanoslit platform for studies of protein binding 
kinetics can be listed as follows: 
 The gradient generation system should produce a concentration range of approximately 2 
orders of magnitude (0.1𝐾𝐷 -10𝐾𝐷), a typical range for kinetic studies. 
 The time required to establish a stable gradient should be as short as possible to enable the 
observation of the initial association phase of the kinetic reactions. 
 The gradient has to be stable and controllable during a time span of kinetic experiments 
(typically in a range of 5-15 min). This is particularly important to achieve robust and 
accurate kinetic information of the observed protein interactions.  
 The flow velocity at each output should be the same and constant to permit accurate 
quantification of kinetic parameters within the gradient. It is necessary that all sensors 
situated at each nanoslit are exposed to an identical flow speed of the target solutions. 
 The dilution network integrated to the nanoslit system should allow an in-situ 
functionalization and a reversed-buffer flow operation.         
 
 All abovementioned concentration gradient generators are often suitable for end-point biological 
assays because they usually require some time to establish a stable concentration gradient. Here, we 
employed a simple Y-shape dilutor to generate partial-mixing concentration gradients 
resulting in a suitable concentration range for protein kinetic studies. Using a well-tuned flow 
velocity and an optimized characteristic length, this method provided reasonably rapid gradient 
establishment which allowed kinetic reactions to be measured in real-time, particularly, at the 
beginning of the binding reaction. This time scale was important as the sensor response should be 
monitored under a constant analyte concentration, which was a prerequisite for accurate 
determination of the kinetic parameters by means of an analytical model.  
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5.5 Device concept and design validation 
In this present work, we incorporate a Y-type microfluidic dilutor with the previously validated 
nanoslit platform, enabling rapid generation of stable concentration gradients and allowing kinetic 
assays for different target concentrations to be carried out simultaneously. To this end, we designed 
the device with respect to those requirements stated earlier and we validated this design by means of 
finite element simulations.  
5.5.1 Chip design 
The chip dimensions were 16×16 mm2 resulting in 16 individual chips on a 100 mm silicon wafer 
(Figure 5.11). Each chip composed of three main components: (1) a Y-shaped microfluidic gradient 
network, referred as a main microchannel for the generation of sample concentration gradients, (2) 
nanoslits used for kinetic studies, and (3) a microchannel used for in-situ functionalization and 
reversed-buffer flow operation. In principle, we introduced a buffer solution in one inlet of the Y-
shaped microchannel and a sample solution with the maximum concentration for kinetic studies in 
another inlet. The Y-shape microchannel allowed two confluent streams of liquid to be combined at 
the junction and diffusively mixed in the main channel as they flowed downstream side by side. The 
geometry of the main microchannel was designed according to the desired concentration gradient 
profiles with respect to applied pressures or flow velocities (which we wanted similar to the ones 
used in the previous kinetic experiments presented in Chapter 4). The dimensions of the main 
microchannel were 10 µm in height, 2.8 mm in length, and 750 µm in width. This 10 µm deep 
microchannel was previously employed in a typical T-sensor to diminish the artifacts due to the 
parabolic velocity profile, inducing the non-uniformity of diffusing analytes across the channel 
height (known as the “butterfly effect”) [53].   
 To obtain the concentration gradients at the output, we needed to ensure that the designed 
channel length of the main microchannel did not exceed the minimum length (𝐿𝑚) needed for two 
liquid streams to completely mix via diffusion. 𝐿𝑚 required for complete mixing across the channel 
width (750 µm) for molecules with a diffusion coefficient 𝐷 = 1×10-11 m2/s (for a 150 kDa protein) 
and a fluid flow velocity 𝑈𝑚 = 7 µm/s, can be estimated to be 394 mm (𝐿𝑚 = 𝑈𝑚𝑊
2/𝐷). With our 
designed channel length (2.8 mm), the two solutions streams do not completely mix to a 
homogeneous solution and the concentration profile of the diffusive species still meets our 
requirements in terms of the concentration range at the output (see the simulation results in the 
following section).    
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Figure 5.11 Design of the gradient devices. A sketch of the 100 mm silicon wafer pattern contains 
16 individual chips whose dimensions are 16 × 16 mm2. Each device consists of a main Y-shape 
microchannel network with 10 separated outputs wherein each of them is linked to a nanoslit. Two 
sensor patches are situated on the bottom of each nanoslit. The output microchannel on the right 
side of the design serves as the input channel for nanoslits functionalization and it is also used 
during the reversed buffer flow operation.   
 
 After a fixed distance of 2.8 mm downstream, the main microchannel was partitioned into a 
series of 10 parallel narrow microchannels to permanently separate distinct sample concentrations 
that emanated from the main flow stream before entering the nanoslits. The width of these narrow 
microchannels was designed to be the same as that of the nanochannels (50 µm) and as a result the 
length was set to induce homogeneous sample concentrations at their outputs. This length scale was 
vital because the sample solutions that flowed in the output microchannels were not homogenous 
along the 50 µm width and thus a sufficient distance was needed to completely mix the sample 
streams in order to produce homogeneous solutions. This distance was strongly dependent on the 
applied flow velocity. The importance of this narrow microchannel length to generate separate 
homogenized sample solutions at the outputs is shown in the following section (design validation 
with finite element simulations). Furthermore, we designed the Y-shaped microfluidic gradient 
network to be symmetrical in order to guarantee the same flow velocity at all outputs, which was 
indispensable for parallel kinetic measurements.   
 For the kinetic study aim, each microchannel conveying different concentrations of target 
solutions was linked to a nanoslit embedding two square gold patches. The dimensions of the 
nanoslits and the gold sensors were similar to those of the fabricated device presented in Chapter 3, 
except that the nanochannel length was reduced to 300 µm. Another 400 µm wide microchannel was 
joined to all nanochannels to serve as the outlet as well as to enable the in-situ surface 
functionalization and the reversed-buffer operation during the dissociation phase. The total area of 
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10 nanochannels covered about 750 × 350 µm2. As a consequence a 10X microscope objective was 
utilized to conveniently observe kinetic reactions in all channels within the same field of view.   
5.5.2 Design validation with finite element simulations 
To optimize and validate the design of our gradient device prior to fabrication, we directly exported 
the gradient dilutor geometry drawn in AutoCAD to COMSOL Multiphysics in order to predict the 
gradient of concentrations generated at the output channels.  
 We built a 2D model of the Y-shape microchannel structure only (excluding nanochannels) 
using a Creeping flow physical module (Stokes flow) with incompressible flow by neglecting the 
inertial term from the laminar flow equation. We also assumed a shallow channel approximation by 
taking the effect of the boundaries that are usually excluded in a simple 2D laminar flow model. This 
gave rise to a flat velocity profile in the middle of the channel (with velocity variations very close to 
the channel walls) covering a region of 10 µm, i.e., approximately the channel thickness (Figure 5.12). 
This flat velocity profile is commonly observed in rectangular cross-section channels with low aspect 
ratios (𝐻/𝑊 < 1). 
 
 
Figure 5.12 (a) A 2D flow velocity field obtained from the COMSOL modeling. (b) A flow velocity 
plot across the channel width. (c) A zoom-in 2D velocity field close to the channel wall. A color 
map indicates the local velocity magnitude.  
 
 The calculated velocity field was then used as an input for obtaining the output concentration 
gradient using the transport of diluted species interface. The input concentrations at the Y-junction 
inlets were 0 mol/m3 (for the buffer solution) and 12 mol/m3 (for the concentrated sample 
solution), and the diffusion coefficient of an IgG (1×10-11 m2/s) was directly applied to precisely 
envisage the real conditions of the kinetic experiments.  
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 The applied pressure was calculated using the total resistance of the fluidic device comprising the 
microchannel and nanochannel network in order to obtain the actual flow rate in the final device. 
We varied the applied pressures in the two inlets while keeping the pressure at the outlet to 0 to 
investigate spatial concentration profiles at the outputs. A triangular mesh size of 20 µm was 
employed for all domains except at the channel walls where a finer mesh size of 5 µm was created to 
obtain more accurate results (Figure 5.13). The numerical solution was obtained using the stationary 
model. 
 
 
Figure 5.13 (a) A simplified electrical circuit of our gradient generator network used for 
hydrodynamic resistance calculation. (b) 2D mesh geometries built in the simulation model.  
 
 The concentration profiles obtained from the 2D model (Figure 5.14) show that the chemical 
species diffuse across the channel width. The numerical computation resulted in the generation of a 
concentration gradient at the output channels in the range of 0.013 – 12 mol/m3 for an applied 
pressure of 4.6 Pa at each inlet. The plot of concentration across the channel width at a fixed 
distance downstream (black lines in the main channel) shows a characteristic sigmoidal diffusion 
curve which typically can be solved using an analytical model based on the diffusion of semi-infinite 
media as described earlier (equation 5.8).  
 On the other hand, the plot of the concentration profiles within distinct parallel narrow 
microchannels (red lines in the narrow channels) shows that the concentration of the sample 
solutions is not uniform across the 50 µm width near the entrance of these separated microchannels. 
However, once the liquid moves toward the outlets (with a given distance of 1 mm), the solutions 
are completely mixed and stabilized, resulting in flat concentration profiles for all channel outputs. 
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This device validation thus underlines the importance of an adequate length of the narrow 
microchannel needed to achieve well isolated homogenized concentrations suitable for kinetic 
studies downstream.  
 
 
 
Figure 5.14 Concentration profiles inside a gradient microfluidic device at different positions 
downstream obtained from a stationary study in the 2D modeling. A color map indicates the local 
concentration of the sample.  
  
 From Figure 5.15, the flow velocity across the channel width is minimized at the stagnation 
point (Y-junction), where the two inlet channels encounter due to the corner effect, and it increases 
rapidly until the flow is fully developed when the fluid moves downstream. A normal flat velocity 
profile is observed in the main microchannel as expected for a thin and wide rectangular channel. 
Close to the entrance of 10 narrow microchannels, the velocity profile is again distorted due to the 
corner effect at the interface between the main and narrow channels. The velocity profile is finally 
stabilized in each narrow channel having the same velocity magnitude (7.0 µm/s), except for the first 
and the last channels whose velocity are slightly lower (6.9 µm/s). 
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Figure 5.15 Velocity profiles inside a gradient microfluidic device at different positions along the 
channel length obtained from stationary study in the 2D modeling. 
  
 The flow velocity has a major influence on the steepness of the output concentration gradient 
profile wherein a wide sigmoidal concentration profile is obtained at a low flow velocity. 
Nevertheless, too high a flow velocity can lead to non-homogeneity of the sample solutions at the 
exit as they do not experience enough residence time to mix while flowing along the narrow 
microchannels. Hence, there is a tradeoff between the concentration range generated from the 
gradient device and the homogeneity of the sample solution.    
 Still, the simulation results showed that with the selected geometry and inlet pressure, our Y-
shape microfluidic dilution network enabled gradient generation with a range of concentrations 
spanning approximately two orders of magnitude, and all channel outputs possessed virtually 
identical flow velocities, thus partially validating our microfluidic gradient design. 
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5.6 Device fabrication 
The concentration gradient generator-integrated nanoslit devices were fabricated using standard 
photolithography and dry etching techniques as described in Chapter 3. The schematic diagram of 
the device fabrication and associated SEM images are shown in Figure 5.16 and Figure 5.17, 
respectively. The chip packaging and device bonding were also similar to those described in Chapter 
3.   
 
 
 
Figure 5.16 A schematic diagram of the fabrication procedures for gradient generator-integrated 
nanoslit devices.  
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Figure 5.17 SEM pictures of the etched channels. 
 
5.7 Experimental validation of the concentration gradient generator 
To validate the efficiency of the dilutor for generating accurate concentrations of a target solution in 
the gradient channels, we utilized fluorescent molecules to visualize the local concentration by 
means of fluorescence microscopy.  
5.7.1 Fluorescence calibration 
Prior to conducting the experiment with the fabricated on-chip dilutor, we should know how the 
measured fluorescence intensity correlates with the fluorescently labeled analyte concentration 
(Alexa Fluor-647 conjugated mouse anti-rabbit IgG, mIgG-AF 647). This would allow an accurate 
quantification of the target concentration within the gradients. To this end, we sequentially injected 
different solutions of mIgG-AF 647 ranging from 0 to 20 nM to the same fluidic chip. This 
concentration range corresponded to the one used in kinetic assays of the anti-IgG/IgG interaction. 
The fluorescence signals of microchannel areas filled with various analyte concentrations were 
recorded using an inverted fluorescence microscope and a CCD camera.  
 The average fluorescence intensities of 10 different regions of interest located in the main 
microchannel (35 µm × 35 µm) were obtained with associated standard deviations, and they were 
subtracted with the background fluorescence (a microchannel filled with the buffer solution). A 
standard curve correlating the measured fluorescence intensity with the fluorescently labeled IgG 
concentration was plotted (Figure 5.18), showing a linear relationship (𝑅2 = 0.9975) within the 
investigated concentration range (0-20 nM). 
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Figure 5.18 A calibration curve correlating the fluorescence intensity of fluorescently labeled IgG 
with the concentration ranging from 0-20 nM, showing a linear relationship.  
 
 It is worth to mention that we did not use this calibration curve to directly determine the 
target concentration for each experiment because there could be any intensity variations 
arising from day-to-day experimental conditions. Instead we exploited this linear relationship to 
correlate the fluorescence intensity measured from the gradient outputs with that of the known 
target concentration close to the inlet of the chip.   
5.7.2 Concentration gradient visualization  
Once completing the fluorescence intensity calibration, we experimentally validated the on-chip 
generation of concentration gradients through fluorescence observations. The schematic diagram of 
the experimental setup is shown in Figure 5.19. The key prerequisite for creating a stable 
concentration gradient using the Y-type gradient network was to maintain the pressure 
equilibrium between two feeding streams (sample and buffer) at the inputs.  
 As the nanochannels displayed an extremely high fluid resistance (1000 times) with respect to 
the Y-shape microchannel network, the fluids tended to undergo a backflow which pushed the 
liquid back into one of the inlet reservoirs. Therefore, it was compulsory to equilibrate the flow 
pressure at the two entrances by using a single pressure source to feed both inlets by means of a Y-
barbed connector. In this manner, two fluid streams were mainly forced to enter and flow along the 
Y-shape network, thus improving the flow stability in the main microchannel. 
5.7 Experimental validation of the concentration gradient generator 
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 On top of that, we needed to ensure that equal amounts of liquid were fed on each reservoir by 
a pipette. The imbalance of pressures or reservoir levels would result in an asymmetric sigmoidal 
concentration gradient profile because two sample streams introduced from the inlets would not 
encounter at the center of the stagnation point (Y-intersection).  In practice, the pressure imbalance 
was difficult to circumvent which in turn had an influence on the stability and the reproducibility of 
generated concentration gradients.  
 
 
Figure 5.19 Schematic diagram of the experimental setup used to create the concentration gradients.  
 
 To visualize the generated gradient, a 20 nM solution of mIgG-AF 647 was introduced on the 
right inlet whereas a buffer solution was injected from the left one. An analyte-buffer interface was 
observed virtually at the center of the Y-junction (Figure 5.20a). Two solutions flowed adjacently 
and mixed via diffusion as they moved downstream. As a result, a broader fluorescence region was 
observed. The diffusion profile exhibited a characteristic sigmoidal shape as expected (Figure 5.20b). 
The normalized fluorescence intensities at different positions along the main microchannel also 
fitted well with an analytical model based on diffusion equations.  
 The fluorescence signals inside the small microchannel outputs were recorded. A gradient of 
concentration was observed as the fluorescence intensity varied across all outputs. To determine the 
analyte concentrations at different microchannel outputs, the average fluorescence intensity of each 
microchannel measured from ten different regions of interest (8 µm × 8 µm) was first subtracted 
with the background fluorescence corresponding to each microchannel filled with the buffer 
solution. 
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Figure 5.20 (a) A fluorescence image of the device injected with a buffer solution on the left inlet 
and a fluorescent IgG solution (20 nM) on the right inlet. (b) A plot of normalized fluorescence 
intensities across the channel width at different distances downstream, 0 µm (𝑥1), 1450 µm (𝑥2), and 
2650 µm (𝑥3), showing the analyte-buffer interface at the stagnation point (inset). The black lines are 
the intensity profiles obtained from an analytical model. 
 
  The average intensities at different outputs were then normalized to the intensity of the fully 
concentrated analyte solution (channel with maximum fluorescence intensity), which was the same 
intensity level as the region close to the inlet (Figure 5.21). Knowing a linear relationship between 
the fluorescence intensity and the analyte concentration, we could estimate the analyte concentration 
at different microchannel outputs as summarized in Table 5.1. Although the Y-shape dilutor 
generated merely a sigmoidal shape of concentrations, the generated gradient profile offered 
us a sufficient number of different analyte concentrations (5-6 data points) within a suitable 
range for kinetic analysis.  
5.7 Experimental validation of the concentration gradient generator 
 172 
 
Figure 5.21 A plot of normalized fluorescence intensity at the different microchannel outputs (inset) 
generated by the on-chip dilutor, exhibiting a sigmoid diffusion curve. The error bars represent the 
fluorescence variations from 10 different regions of interest. 
 
Table 5.1 Summary of normalized fluorescence intensities and output analyte 
concentrations obtained from the on-chip dilutor. 
Output number Normalized signal Analyte 
concentration (nM) 
0 0.018 0.36 
1 0.030 0.60 
2 0.050 0.99 
3 0.12 2.5 
4 0.29 5.8 
5 0.53 10 
6 0.80 16 
7 0.95 19 
8 0.99 20 
9 1.0 20 
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 With an optimized flow velocity of the injected solutions at the inlet reservoirs, our device was 
capable of producing the gradients with a concentration range of approximately 2 orders of 
magnitude and with an adequate number of different analyte concentration values required 
for kinetic studies. The concentration ratio between the last channel (the fully concentrated 
solution) and the first channel (the most diluted solution) was found to be approximately 55. 
Therefore, this experiment validated the effectiveness of our simple on-chip dilutor as a 
concentration gradient generating-device for being used in kinetic assays of biomolecular 
interactions (which will be discussed in the following section).  
5.8 One-shot parallel kinetic measurements 
Here, we demonstrated the performance of our on-chip dilutor-integrated nanoslit biosensor system 
to simultaneously interrogate protein binding kinetics of a full analyte concentration series in a single 
experiment. We chose to study the kinetics of the anti-IgG/IgG interaction model for the 
demonstration purpose.  
 Since the kinetic data of each analyte concentration was procured from different sensor surfaces 
located in different nanoslits, we assumed that each sensor exhibited an equal sensing performance 
in terms of binding efficiency, hence the same surface probe density, giving that an identical 
functionalization protocol was applied.  
 The chip preparation and in-situ surface functionalization protocol used to immobilize the 
receptors on the sensor surface were similar to the ones used in the experiment detailed in Chapter 
4. For the kinetic study, a 20 nM solution of mIgG-AF 647 was used as a sample input 
concentration. During the association phase, the interaction of the analyte at various concentrations, 
generated from the concentration gradient dilutor, with the receptor immobilized sensor surfaces 
located on 10 separate nanochannels were monitored simultaneously under the fluorescence 
microscope.  
 In order to monitor the dissociation phase, we stopped the fluid flow at the Y-junction input 
and simultaneously applied a reverse flow, thus introducing a fresh buffer solution from the outlet 
channel. In this way, the capability of our device to generate both association and dissociation curves 
without additional buffer loading step were still preserved while creating concurrent possibility of a 
one-shot parallel kinetic measurement thanks to the incorporated gradient dilution feature.   
 The fluorescence intensities at different microchannel outputs were also measured in real-time 
during the association phase (Figure 5.22). It can be observed that the fluorescence intensities were 
stabilized within 2 min, which was way shorter than the association time used in the experiment. 
Furthermore, fairly uniform analyte concentrations were achieved during the time period of the 
association process. This permitted us to extract the kinetic parameters using an analytical well-
mixed model, assuming a constant and uniform analyte concentration above the sensor. 
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Figure 5.22 Transient fluorescence profiles as a function of time at various microchannel outputs 
during the association phase. 
 
 The analyte concentrations at various outputs were determined to be 0.57 nM to 20 nM (Figure 
5.23). From the fluorescence image of the device (inset), the fluorescence signals on the sensor 
patches gradually increase from the left channel to the right one, corresponding to the lowest to the 
highest target concentrations. As the analyte concentrations in the last four outputs (output 6-9) 
were nearly identical, only the output 1-6 were selected for kinetic constant determination, giving 
adequate concentration ranges for curve fitting.  
 Figure 5.24 depicts the kinetic sensorgrams of anti-IgG/IgG reaction at various analyte 
concentrations obtained from the on-chip gradient generator-integrated nanoslit device. To 
determine the binding constants of this interaction, the data were fitted with a well-mixed model, 
assuming a simple 1:1 interaction. The plot of the apparent time constant as a function of the analyte 
concentration yielded a linear fit with a slope of 0.00053 and 𝑅2 of 0.9909 (Figure 5.25). A derived 
slope of 0.00053 nM-1s-1 resulted in an on-rate of 5.3×105 M-1s-1.  
 The dissociation constant was extracted by fitting the dissociation curves with a first-order 
exponential decay. The average off-rate constant was calculated to be 7.8×10-4s-1. Therefore, the 
equilibrium dissociation constant (𝐾𝐷) which is the ratio between 𝑘𝑑 and 𝑘𝑎 can be estimated to be 
1.5 nM. These values were shown to be in a good agreement with the extracted rate 
constants obtained from the previous nanoslit device using the conventional kinetic assay 
(Chapter 4).  
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Figure 5.23 The concentration at various microchannel outputs (inset) obtained from the gradient 
chip. The error bars were obtained from ten different regions of interest. 
 
 
Figure 5.24 Kinetic curves of the analyte-immobilized receptor interactions at various analyte 
concentrations using the gradient integrated-nanofluidic chip. The curves were fitted with a well-
mixed model for the association phase and an exponential decay for the dissociation phase. The 
error bars represent the standard errors. 
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Figure 5.25 A plot of the apparent time constants as a function of the analyte concentrations. 
 
 In addition, we conducted two additional kinetic measurements on the different gradient dilutor 
devices. The extracted kinetic parameters and experimental conditions for all kinetic assays are 
summarized in Table 5.2. The consistency among different kinetic experiments confirmed the 
robustness of our kinetic data performed in the developed gradient chips. Furthermore, our 
device operated in a reaction-limited regime but not a mass transport-limited because varying the 
flow velocity did not contribute a significant change in the estimated kinetic constants.   
Table 5.2 Summary of kinetic parameters obtained from 3 experimental conditions with 3 
different gradient chips. 
Experiment Concentration 
ranges 
(nM) 
Flow velocity in 
a nanochannel 
(µm/s) 
𝒌𝒂 
(M-1s-1) 
𝒌𝒅  
(s-1) 
𝑲𝑫 
(nM) 
1 0.41-19 445 6.00.3×105 9.30.5×10-4 1.6 
2 0.74-19 667 5.30.3×105 7.80.9×10-4 1.5 
3 0.40-13 489 6.60.4×105 8.70.9×10-4 1.3 
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5.9 Conclusion 
We have established for the first time a simple and effective on-chip gradient generator-based 
nanoslit biosensors by combining a Y-type microfluidic feature for concentration gradient 
generation via laminar diffusive mixing and the nanoslit biosensor platform. The newly developed 
device has enabled one-shot parallel kinetic assays by monitoring interactions between multiple 
analyte concentrations and surface-immobilized probes simultaneously in a single experiment 
without time-extensive surface regeneration.  
 We have designed the device according to the desired concentration ranges and operational flow 
velocities. Numerical simulations showed that the device enabled a stable gradient generation with 
the concentration range of 2 orders of magnitude and the equal flow velocity for all outputs, thus 
confirming the functionality of the device. To validate the effectiveness of the gradient generation, 
we have visualized the gradient formation in the enclosed-dilution device using a fluorescence 
microscope. The results confirmed that the generated concentration was stable and could be 
maintained downstream. The desired concentration ranges have been achieved by tuning the applied 
pressure at the inlets although it was burdensome to achieve a precise pressure balance between the 
two inlets. This is due to a high resistance of the existing nanoslit network as well as the inevitable 
variations in the amount of sample loaded into each reservoir and the way we assembled the fluidic 
chip. 
 Future improvement allowing more user-oriented operation is to include a pressure balancing 
fluidic circuit with a high flow resistance network, which can potentially reduce the pressure 
difference between two fluid streams coming from two reservoirs and two individual pressure 
tubing. This would definitely improve the reproducibility of the generated concentration gradients.  
 The ability of this device to accommodate parallel kinetic measurements at multiple analyte 
concentrations has been investigated by monitoring the binding of fluorescently labeled mouse IgG 
and the surface-immobilized anti-IgG. The results obtained from kinetic analysis and good 
agreement of the extracted kinetic parameters with the previous work and the SPR setup further 
validated the utility of this device to provide accurate and robust kinetic information across parallel 
experiments. Furthermore, this approach offered time-saving assays (20 min instead of hours) and 
substantially reduction of reagent consumption per assay as compared to the traditional kinetic 
experiments (e.g., in SPR setup)  
 Our compact device is operated using one pressure controller and a conventional bench-top 
fluorescence microscope. Therefore it is highly desirable for everyday practice of experimental 
biologists. This simple and inexpensive platform with reduced material and equipment resources 
brings us a step closer toward real-world applications, such as high-throughput drug-screening and 
clinical diagnostics.  
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General conclusion  
 
 
 Real-time kinetic studies of protein-protein interactions are of particular importance in 
understanding biological functions at the cellular level, facilitating the discovery of novel therapeutic 
drugs and the improvement of medical remedy to cure human diseases. A variety of affinity-based 
biosensors have been employed to elucidate protein binding kinetics in real-time, which enable the 
quantification of distinct kinetic constants, on-and off-rates. Each technique has its own advantages 
and inconveniences, depending on the requirements of a particular application. During the past 
years, nanofluidics has been extensively exploited for biophysical studies, molecular separation and 
pre-concentration, as well as single-molecule analysis, owing to its unique features at the nanoscale. 
Surprisingly, little effort has been placed on developing nanofluidics-based biosensor, and in 
particular for real-time kinetic studies. This is attributed to several technological and biological 
challenges (e.g., preservation of biological entities during device assembly). 
 In the frame of this PhD work, we have developed a cost-effective nanofluidic biosensor 
platform for real-time monitoring of protein binding kinetics in physiological media. Our approach 
exploited biofunctionalized planar extended-nanochannels or nanoslits in combination with a 
conventional fluorescence microscope, enabling the quantification of kinetic parameters of protein-
protein interactions. The nanoslits exhibit several unique characteristics which cannot be attained in 
typical microfluidic formats. A considerable reduction of the fluorescence background signal within 
the nanoconfined-analytical space permits real-time monitoring of protein association and 
dissociation processes without the need of reagent wash and without using sophisticated techniques, 
such as SPR or TIRF. Furthermore thanks to the molecular confinement between the analytes in 
solution and the immobilized-probes on the surface, the binding reactions in the nanoslits can be 
dramatically enhanced, leading to a maximized target capture efficiency and optimized response 
times. In this framework, we have fabricated nanofluidic devices and conducted kinetic studies of 
protein interactions. In order to validate our platform, our sensor performances were compared with 
the existing technology, such as SPR. The outcomes of this study bridging technological and 
biological aspects are summarized below.  
 In the first part, we have focused our efforts on the conception and implementation of 
nanofluidic biosensor devices, including the fabrication process, the nanochannel bio-
functionalization, as well as the chip packaging. The devices, consisting of 2-D nanoslits connected 
to microchannels, were fabricated using silicon microfabrication technology. We have decided to 
pattern a gold sensing layer at the bottom of the nanoslits for two main purposes. Firstly, elucidation 
of protein interactions on a gold surface has empowered us to compare our biosensor performances 
with the established SPR technique, providing that the similar grafting protocol was used. Secondly, 
local selective grafting of receptor biomolecules in the nanochannel was possible through gold-thiol 
surface chemistry. We have selected two representative biological interaction models with different 
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binding affinities: streptavidin/biotin and IgG/anti-IgG pairs, to demonstrate our platform 
effectiveness. Furthermore, we have successfully implemented a bio-functionalization protocol and a 
room-temperature sealing procedure that ensured the preservation of bioactivity of the immobilized 
receptors and allowed the optical visualization of kinetic reactions through a hybrid silicon/h-PDMS 
coated glass fluidic chip. Customized chip assembly/packaging was also constructed for world-to-
chip interface. Since our platform employed a pressure-driven flow system as a liquid pumping 
mechanism, we have carried out the flow calibration to correlate the applied pressure to the flow 
velocity in the nanoslits. The exact values of the applied flow velocity were important to identify the 
operational regimes of our biosensor system, and more importantly to allow the comparison of our 
experimental assays with the simulated data (because the flow velocity was used as an input 
parameter in the simulation model to predict the sensor responses). 
 In the second part of this study, special emphasis was placed on the validation of our platform 
for kinetic constant quantification of two dedicated protein-protein interaction pairs. Prior to 
conducting kinetic assays, we have evaluated the bio-functionality of the pre-immobilized receptors 
in an enclosed fluidic chip by means of fluorescence observations. We have confirmed that the 
preceding grafted receptors maintained their bio-functionality toward the target analytes and the 
sensor exhibited a high signal-to-noise ratio. Rigorous kinetic studies of two dedicated biological 
systems were then carried out. For streptavidin-biotin binding, we have confirmed that the grafting 
density of the receptors on the sensor surface played a crucial role in kinetic reactions and the 
accuracy of the estimated kinetic parameters. In addition, we have also implemented a simplified 
protocol in order to achieve full kinetics (association and dissociation curves) of IgG/anti-IgG 
interaction in one single experiment without extra washing steps via a reversed-buffer flow manner. 
This achievement was attributed to the unique features of our system which involved a drastically 
reduced fluorescence background and high capture efficiency. We have demonstrated that the 
kinetic data obtained from the nanoslits could be readily employed with different fitting 
methodologies, including finite element method, analytical model, and a commercialized software 
package, to quantify the kinetic parameters. The extracted kinetic parameters obtained from the 
nanoslits were in accordance with those obtained from the SPR and the values found in the 
literature. These results thus validated our biosensor platform to be used as an alternative tool for 
real-time kinetic studies of biomolecule interactions with the detection limit of 1 pM or 10 
zeptomole for IgG detection.  
 Finally, we have proposed a new generation of our nanoslit biosensor which enabled a one-shot 
parallel kinetic measurement in a time-saving manner. We have exploited real-time sensing 
performance of our validated biofunctionalized nanoslits for high-throughput kinetic assays by 
integrating a Y-type microfluidic gradient generator into the final device. This integrated device has 
allowed stable concentration gradients to be automatically created and consequently enabled 
simultaneous interrogation of multiple binding reactions of different target concentrations in a single 
experiment without the need of surface regeneration. We have validated the device design for 
gradient generation using both finite element simulation and experimental verification. With an 
optimized flow velocity, our device generated a gradient of concentration in a range of 
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approximately 2 orders of magnitude and provided us a sufficient number of different analyte 
concentrations (5-6 concentration points) for accurate quantification of kinetic parameters. 
Furthermore, one-shot parallel kinetic assays were investigated through the IgG/anti-IgG 
interaction model and the estimated kinetic parameters were found to be in good agreement with 
those obtained from the previously presented kinetic assays in our nanoslit biosensors using multiple 
association and dissociation cycles. Therefore, our proposed device offered the possibility to 
produce robust kinetic data, with significantly reduced overall assay time (10 times) and lower 
reagent consumption (1000 times) relative to the traditional kinetic experiments, such as in SPR 
setup. We believe that this innovative technology will drive future advancements not only in the 
discipline of biomedical and personalized medicine, but also in basic chemical/biological research. 
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Abbreviations  
 
 
A   Amyloid Beta 
AMP  Adenosine Monophosphate  
AR   Aspect Ratio 
ATP  Adenosine Triphosphate 
BAT  Biotinylated Thiol 
BSA  Bovine Serum Albumin 
CCD  Charge-Coupled Device 
CDRs  Complementary-Determining   
                           Regions 
CFD  Computational Fluid Dynamic 
CNTs  Carbon Nanotubes 
CRP  C-Reactive Protein 
DEP  Dielectrophoresis 
DLP  Diffusion-Limited Patterning 
DNA  Deoxyribonucleic Acid  
DRIE  Deep Reactive Ion Etching 
EBL  Electron Beam Lithography 
ECM  Extracellular Matrix 
EDL  Electrical Double Layer 
ELISA  Enzyme-Linked Immunosorbent  
                          Assay 
EMCCD Electron Multiplying Charge-Coupled  
                          Device 
EPR  Electron Paramagnetic Resonance 
FCS  Fluorescence Correlation  
                          Spectroscopy 
FEM  Finite Element Method 
FET  Field-Effect Transistor 
FIB   Focused Ion Beam 
FITC  Fluorescein Isothiocyanate 
FP   Fluorescence Polarization 
FRET  Förster Resonance Energy Transfer 
GOx  Glucose Oxidase  
HAR  High Aspect Ratio 
HMDS  Hexamethyldisilazane 
h-PDMS Hard-Polydimethylsiloxane 
ICP  Ion Concentration Polarization 
ID   Internal Diameter 
IgG  Immunoglobulin G 
IR   Infrared  
IRIS  Interferometric Reflectance 
                          Imaging Sensor 
IS-FET  Ion-Selective Field-Effect 
                          Transistor 
ITC  Isothermal Titration Calorimetry 
QCM  Quartz Crystal Microbalance 
QCM-D Quartz Crystal Microbalance with 
                          Dissipation monitoring  
LED  Light-Emitting Diode 
LIF   Laser-Induced Fluorescence  
LOD  Limit of Detection 
LPSR  Localized Surface Plasmon  
                          Resonance  
mAB  Monoclonal Antibody 
MEMS  MicroElectroMechanical System 
mIgG-AF Alexa-Fluor conjugated mouse 
                          anti-rabbit immunoglobulin 
NA   Numerical Aperture 
NMR  Nuclear Magnetic Resonance 
NW-FET Nanowire Field-Effect Transistor 
OD  Outer Diameter 
OEG  Olio (Ethylene Glycol) 
OWLS  Optical Waveguide Lightmode 
                          Spectroscopy 
PBS  Phosphate Buffer Saline 
PCR  Polymerase Chain Reaction 
PDE  Partial Differential Equation 
PDMS  Polydimethylsiloxane 
PEG  Poly (Ethylene Glycol) 
PSA  Prostate-Specific Antigen 
PSQ  Polysilsesquioxane 
RI   Refractive Index 
RIE  Reactive Ion Etching 
ROI  Region of Interest 
RSD  Relative Standard Deviation 
RU   Resonance Unit 
SAM  Self-Assembled Monolayer 
SE   Standard Error  
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SEM  Scanning Electron Microscope 
SERS  Surface-Enhanced Raman 
                          Spectroscopy 
SiN   Silicon Nitride 
SNARE Soluble N-ethylmaleimide-sensitive 
                          factor Attachment Receptor 
SPFS  Surface Plasmon-enhanced 
                          Fluorescence Spectroscopy 
SPR  Surface Plasmon Resonance 
SPRi  Surface Plasmon Resonance Imaging 
ssDNA  Single-Stranded Deoxyribonucleic 
                          Acid 
ST-AF  Alexa-Fluor conjugated 
                          streptavidin  
TIRFM  Total-Internal-Reflection 
                          Fluorescence Microscopy 
µTAS  Micro-Total-Analysis-Systems 
UV   Ultraviolet 
VUV  Vacuum Ultraviolet 
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Appendix A 
Device fabrication process 
 
1. Substrate 100 mm p-type silicon wafer, thickness = 525 µm 
2. Substrate cleaning 
 Piranha solution (H2SO4/H2O2; 1:1 v/v) 2 min 
 5% HF buffer solution 30 s 
 Piranha solution (H2SO4/H2O2; 1:1 v/v) 2 min 
 Dehydration 10 min at 200 ºC 
Nanochannel etching 
4. Define nanochannel 
dimension (first mask) 
 HMDS deposition 
 Spin-coating ECI 3012 photoresist (EVG 120), soft-baking, 2.6 
µm thick 
 UV exposure (MA 150, Karl Suss Inc.) 12.5 s at 20 mW/cm2, 
vacuum contact 
 Post-baking and development 
 Post-baking 60 s at 115 ºC 
5. Nanochannel etching 
 RIE (Alcatel)  
 Resist dissolution in acetone and/or oxygen plasma (800W, 10 
min) 
 Nanochannel depth = 550 ± 20 nm 
6. Substrate cleaning  Oxygen plasma (800W, 5 min) 
Microchannel etching 
7. Define microchannel 
dimension (second 
mask) 
 HMDS deposition 
 Spin-coating ECI 3012 photoresist (EVG 120), soft-baking, 2.6 
µm thick 
 UV exposure (MA 150, Karl Suss Inc.) 12.5 s at 20 mW/cm2, 
vacuum contact 
 Post-baking and development 
 Post-baking 60 s at 115 ºC 
8. Microchannel etching 
 DRIE (Alcatel) 
 Resist dissolution in acetone and/or oxygen plasma (800W, 10 
min) 
 Microchannel depth = 5 ± 0.4 µm 
9. Thermal oxidation 
 Piranha cleaning (2 min) + 5% HF (30 s) 
 Thermal oxidation, oxide thickness 200 nm 
10. Substrate cleaning  Oxygen plasma (800 W, 5 min) 
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Metal deposition 
11. Define gold patch 
dimension (third mask) 
 HMDS deposition 
 Spin-coating AZ-NLOF 2035 photoresist (EVG 120), soft-
baking, 5 µm thick 
 UV exposure (MA 150, Karl Suss Inc.) 7.5 s at 20 mW/cm2, 
vacuum contact 
 Post-baking and development 
12. Gold deposition   Gold evaporation Cr/Au (5/100 nm) 
13. Lift-off process  Acetone bath  
14. Annealing  20 min at 250 ºC under N2H2 
15. Substrate lamination 
 Dry photoresist PH2050 
 Shipley laminator (RT + 110 ºC) 
16. Hole drilling 
 Sandblasting machine (aluminum oxide particles), hole diameter 
1 mm 
 Resist dissolution (acetone bath with ultrasonics + oxygen 
plasma (800 W, 5 min) with a faraday cage 
17. Dicing 
 Spin-coating of photoresist (wafer protection), soft-baking 
 Dicing 16 individual chips (dimensions: 16×16 mm2) 
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Appendix B 
Materials and reagents 
 
Biotinylated tri(ethylene glycol) undecane thiol (BAT) (HS-(CH)n-OEG-biotin) was purchased from 
Nanoscience Instruments (USA). 11-mercapto-1-undecanol (MUD) (HS-(CH2)11-OH), bovine 
serum albumin (BSA) were purchased from Sigma-Aldrich (France). Tween-20 was purchased from 
ACROS Organics (France). Biotinylated anti-mouse IgG (Ref. No. 115-065-003) and Alexa Fluor 
647 conjugated monoclonal mouse anti-rabbit IgG (Ref. No. 211-602-171) were purchased from 
Jackson ImmuoResearch (UK). Alexa Fluor 488 conjugated streptavidin and Alexa Fluor 660 
conjugated goat anti-rabbit were purchased from Invitrogen, Inc. All proteins were diluted in 
phosphate buffer saline (PBS) (10 mM PBS, 0.138 M NaCl, 0.0027 M KCl, pH 7.4) purchased from 
Sigma-Aldrich (France). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 
 
 189 
Appendix C 
Validation of the full functionalization protocol using 
quartz crystal microbalance (QCM) apparatus 
 
QCM-D (E1, Q-sense instrument) was used to perform all QCM-D measurements (Figure A-1). 
AT-cut 5 MHz quartz crystal sputtered coated with a 100 nm thick Au layer were obtained from Q-
sense AB. All measurements were performed at a controlled temperature of 20 ºC, using degassed 
solutions. 
 
 
 
Figure A-1 QCM-D experimental setup used to verify the functionalization protocol. 
 
For off-line sensor modification, the gold crystal sensors were cleaned in a piranha solution 
(H2SO4:H2O2, 70:30 % v/v) for 2 min. After rinsing the surface with DI water, the sensors were 
dried gently under nitrogen flow. The quartz crystals were immediately incubated in a 0.5 mM 
ethanolic solution of biotin terminated thiol and 11-mercapto-1-undecanol in 1:9 mole ratio for the 
sensor for > 12 h, protected from the light, at room temperature to form SAMs. After incubation, 
the sensors were rinsed with ethanol once and DI water twice to remove any non-covalently bound 
thiol molecules. 
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For online measurement, the applied flow rate for the buffer and biomolecules were 100 
µl/min and 50 µl/min, respectively. First, a phosphate buffer saline (PBS) solution (1X, pH 7) was 
injected until the baseline signal was stabilized. A 500 nM (26.5 µg/ml) streptavidin solution 
prepared in PBS buffer (1X) was introduced for 20 min, followed by rinsing with buffer solution. 
Similarly, streptavidin sensors were exposed to biotinylated anti-mouse (166.7 nM, 25 µg/ml in 
PBS), until the saturation was reached. The simplified schematic illustration of the assay procedures 
used in this QCM-D measurement and the plot of the frequency and the dissipation changes for 
streptavidin and biotin-anti-mouse adsorption on monolayers with 10% biotin content are shown in 
Figure A-2. 
 
 
 
Figure A-2 (a) Schematic illustration describing the conjugation of streptavidin onto self-assembled 
monolayer containing 10% biotin and subsequent molecular recognition of biotin-anti-mouse onto 
streptavidin-modified surface. (b) QCM-D responses (frequency and dissipation shifts) 
corresponding to the immobilization of streptavidin and biotin-anti-mouse to the biotinylated 
monolayer surface. 
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To validate the full functionalization protocol, biotin-anti-mouse immobilized sensor surface 
(receptor immobilized surface) was exposed to non-targeted analyte solution (50 nM, Alexa Fluor 
660 goat anti-rabbit in PBS buffer, pH 7) and specific analyte (50nM, Alexa Fluor 647 mouse anti-
rabbit in PBS buffer, pH 7). The resonance frequency shifts were recorded in real-time as shown in 
Figure A-3. It was observed that there was no noticeable change in resonance frequency (f = 0.00 
± 0.20 Hz) upon irrelevant analyte injection while introduction of specific analyte exhibited a 
relatively significant change in resonance frequency (-10.4 Hz), corresponding to mass adsorption 
with coupled water mass of 184 ng/cm2 (7.32×103 molecules/µm2).   
 
 
 
Figure A-3 Resonance frequency shifts upon exposure of specific analyte (mouse anti-rabbit IgG) 
and non-specific analyte (goat anti-rabbit IgG) onto anti-mouse immobilized sensor surface. 
 
To summarize, the full surface functionalization protocol was successfully validated using 
QCM-D measurements. Streptavidin was specifically bound to biotinylated SAMs forming a rigid 
organized monolayer on the gold surface due to high affinity of these protein-ligand pairs. 
Additionally, streptavidin-biotin linkage is a robust model that can be used for further 
functionalization of biotin-tagged antibody receptor of interest. Importantly, immobilized anti-
mouse receptor could specifically recognize specific target analytes while minimizing undesirable 
interference adsorption of non-targeted protein molecules. Therefore, this surface modification 
procedure was valid for implementation of sensing layer construction on our nanofluidic biosensor 
platform. 
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Appendix D 
Compositions and preparation of h-PDMS mixtures 
 
Five product compositions for hard-PDMS preparation, vinyl PDMS copolymer, vinyl modified 
silica Q resin, platinum-divinyltetramethyldisiloxane, hydrosilane prepolymer and 2,4,6,8-
tetramethyl-tetravinylcyclotetrasiloxane, were purchased from abcr GmbH & Co. Kg (Germany) and 
Sigma-Aldrich (France). 
Compositions and preparation 
Compounds Quantity 
1) VDT 731 (7-8% vinylmethylsiloxane dimethylsiloxane cop.) 6.8 g 
2) VQM 135 (vinyl Q-resin dispersion) 1 g 
3) Modulator (tetramethyl-tetravinyl cyclotetrasiloxane) 50 µL 
4) SIP6831.1 catalyst (platinum cyclovinylmethylsiloxane complex in 
xylene 2.1~2.4% Pt) 
10 µL 
Slowly mix the mixture in an ice bath 
to prevent overheating of the mixture which induces undesirable polymerization 
5) HMS 301 (methylhydrosiloxane dimethylsiloxane cop.) 2 g 
Slowly mix the products in an ice bath until obtaining a homogenous mixture 
Store the mixture at -20 ºC until use (maximum 2-week storage) 
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Appendix E 
Sensor preparation and receptor immobilization with 
BIACORE setup 
 
 
Sensor preparation 
 
The piranha cleaned gold chip was immersed in a 0.5 mM mixture solution of biotin-terminated 
thiol and 11-mercapto-1-undecanol overnight, in the dark at room temperature. The modified gold 
surface was then washed twice with absolute ethanol (gentle stirring) to remove excess thiol 
compounds and washed several times with deionized water. The biotin modified gold surface was 
assembled according to the manufacturer’s instructions and the user-modified sensor chip was 
docked in the BIACORE 3000. 
 
Receptor immobilization 
 
Running buffer of 10 mM PBS, pH 7.4, 0.138 M NaCl, 0.0027 M KCl, and 0.05% Tween-20 was 
injected at a constant flow rate of 5 µL/min for 20 min to stabilize the system. For streptavidin 
immobilization, a 165 µg/ml solution of Alexa Fluor 488 conjugated streptavidin (ST-AF 488) in 
PBS buffer was injected at 10 µL/min for 7 min to achieve a saturation level. After successful 
immobilization of streptavidin on two separate flow channels, the receptor was subsequently 
immobilized only on the second flow cell by injecting a 14 µg/ml solution of biotin anti-mouse in 
PBS buffer at a flow rate of 10 µL/min. The first flow cell was used as a control without anti-mouse 
receptor immobilization. 
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Kinetic monitoring of protein-protein interactions offers fundamental insights of their cellular 
functions and is a vital key for the improvement of diagnostic tests as well as the discovery of novel 
therapeutic drugs. Surface plasmon resonance (SPR) is an established biosensor technology routinely 
used for kinetic studies of biomolecular interactions. While SPR offers the benefits of real-time and 
label-free detection, it requires expensive and sophisticated optical apparatus and highly trained 
personnel, thus limiting the accessibility of standard laboratories. In this PhD project, we have 
developed an alternative and cost-effective biosensor platform exploiting biofunctionalized 
nanofluidic slits, or nanoslits, combined with a bench-top fluorescence microscope. Our approach 
enables the visualization of protein interactions in real-time with the possibility to determine 
associated kinetic parameters along with optimized response times and enhanced binding efficiency. 
We have demonstrated the effectiveness of our devices through kinetic studies of two representative 
protein-receptor pairs with different binding affinities: streptavidin-biotin and mouse IgG/anti-
mouse IgG interactions. Good agreement of extracted kinetic parameters between our device, SPR 
measurements and literature values indicated that this approach could be readily applicable to study 
kinetics of protein interactions with sensitivity down to 1 pM on a large scale of dissociation 
constants. In addition, we have incorporated a microfluidic gradient generator to our validated 
nanoslit device, which has allowed one-shot parallel kinetic measurements to be realized in a single-
experiment. This integrated system provides advantages of diminished material consumption and 
analysis time over the conventional kinetic assays. We believe that this innovative technology will 
drive future advancements not only in the discipline of biomedical and personalized medicine, but 
also in basic chemical/biological research.  
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Résumé 
L’analyse cinétique d’interactions de protéines offre une multitude d’informations sur les fonctions 
physiologiques de ces molécules au sein de l’activité cellulaire, et peut donc contribuer à 
l’amélioration des diagnostics médicaux ainsi qu’à la découverte de nouveaux traitements 
thérapeutiques. La résonance plasmonique de surface (SPR) est la technique de biodétection optique 
de référence  pour les études cinétiques d’interaction de molécules biologiques. Si la SPR offre une 
détection en temps réel et sans marquage, elle nécessite en revanche des équipements coûteux et 
sophistiqués ainsi que du personnel qualifié, limitant ainsi son utilisation au sein de laboratoires de 
recherche académiques. Dans ces travaux de thèse, nous avons développé une plateforme de 
biodétection basée sur l’utilisation de nanofentes biofonctionnalisées combinées avec une détection 
par microscopie à fluorescence. Ce système permet l’observation en temps réel d’interactions 
protéines-protéines et la détermination des constantes cinétiques associées, avec des temps de 
réponse optimisés et une excellente efficacité de capture. La fonctionnalité du système a été 
démontrée par l’étude des cinétiques d’interaction de deux couples modèles de différentes affinités : 
le couple streptavidine/biotine et le couple IgG de souris/anti-IgG de souris. Une très bonne 
cohérence entre les constantes cinétiques extraites, celles obtenues par des expériences similaires 
réalisées en SPR et les valeurs rapportées dans la littérature montre que notre approche pourrait être 
facilement applicable pour l’étude cinétique d’interactions de protéines avec une sensibilité allant 
jusqu’au pM, sur une large gamme de constantes de dissociation. De plus, nous avons intégré un 
générateur de gradient de concentrations microfluidique en amont de nos nanofentes, permettant 
ainsi des mesures simultanées de cinétiques d’interactions à différentes concentrations d’analyte en 
une seule expérience. Ce système intégré offre de nombreux avantages, tels qu’une réduction de la 
consommation des réactifs et des temps d’analyse par rapport aux approches séquentielles classiques. 
Cette technologie innovante pourrait ainsi être un outil précieux non seulement pour les domaines 
du biomédical et de la médecine personnalisée mais aussi pour la recherche fondamentale en chimie 
et biologie.   
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